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S u m m a r y ,
Hepatic microsomal preparations from male and female rats were delipidated by 
column chromatography following cholate solubilisation. The enzyme activity was 
assayed using lignocaine as the substrate for the mixed function oxidase. The N- 
deethylation of lignocaine catalysed by delipidated microsomal proteins from male and 
female rat liver is greater when reconstituted in microsomal lipid than in 
dilauroylphosphatidylcholine (DLPC). The 3-hydroxylation of lignocaine is unaffected 
by this treatment. The above effect is mimicked by incorporation of 
dilauroylethanolamine (DLPE) into the DLPC vesicles with male- but not the female- 
derived enzymes. Microsomal lipids derived from the male were more effective than 
female-derived lipids in reconstituting enzyme activities with both male- and female- 
derived enzymes. There is, thus, a sex- and pathway dependent effect of the lipids: the 
male-specific N-deethylase pathway is more affected by lipid composition and then more 
so in the male-derived enzyme. It is possible, therefore, that some of the sex differences 
m drug metabolism may/related to changes in lipid composition. In addition, the sex- 
dependence of the metabolism of lignocaine was maintained in the reconstituted system, 
indicating that this is a suitable system for investigating the role of lipids in maintaining 
sex-specific drug metabolism. We have extended this work with the isolation of the 
isozyme of cytochrome P-450 responsible for the N-deethylation of lignocaine. The 
male-specific cytochrome P-450 isozyme, lignocaine N-deethylase, was purified to 
electrophoretic homogeneity from liver microsomes of untreated male rats with high 
retention of bioactivity. The purified N-deethylase was an efficient catalyst of the 16a- 
hydroxylation of androst-4 ene3,17-dione (specific activity of 10 nmole product/min/ 
nmole cytochrome P-450). The isozyme, together with purified NADPH-cytochrome P- 
450 reductase, was reconstituted using known lipids and the drug-metabolising activity 
assayed using lignocaine as substrate. The results showed that the purified isozyme only 
N-deethylated lignocaine and led to the following conclusion, (I) Mixed
XI
dilauroylphosphatidylcholine (DLPC)/dilauroylphosphatidylethanolamine (DLPE) 
vesicles gave a higher N-deethylase activity than DLPC vesicles. (II) The N-deethylation 
of lignocaine catalysed by a purified male-specific cytochrome P-450 from rat liver is 
greater when reconstituted in microsomal lipid than in DLPC. (Ill) Microsomal lipids 
derived from male were more effective than female-derived lipids in reconstituting 
enzyme activities. These data indicated that it is a direct interaction of the lipid with the 
enzyme (s) or an alteration of the protein-protein interactions caused by the lipid which 
leads to the change in enzyme activity and that it is the isozyme responsible for the N- 
deethylation that is particularly affected in this way. In order to assess which portion of 
the microsomal lipid causes these changes, the microsomal lipid has been fractionated 
into phospholipid and neutral lipid. Using delipidation and subsequent relipidation of 
microsomal lipid preparation, we have confirmed that the phospholipid is the most 
effective portion for the maintenance of the drug metabolism and the sex differences in 
drug metabolism. It is clear that the male-derived phospholipid was more efficient than 
the female-derived phospholipid when incorporated into both male- and female-derived 
delipidated microsomes. The mixture of phospholipid and neutral lipid fractions was 
very effective, indeed it restored the N-deethylase activity to the level of the 
microsomes. Experiments were carried out using the male-specific isozyme responsible 
for the N-deethylation of lignocaine and again it was shown that the phospholipid 
fraction was the most effective fraction when reconstituted with this isozyme, but it was 
less effective than the whole microsomal lipid. It is only when the combination of 
phospholipid and neutral lipid was used that the control activity was achieved. Again the 
male derived phospholipid was more effective than the female-derived phospholipid. We 
analysed the phospholipid composition and our analysis shows sex differences in 
microsomal phospholipid composition and in fatty acid acyl chain of the microsomal 
phospholipid. Also the analysis of the phospholipid from the diabetic animals showed 
that the streptozotocin treatment does alter the phospholipid composition and the ratio of
XII
acyl chains found. All these changes might be associated with differences in enzyme 
activity. We have extended this work using delipidated solubilised microsomes, 
prepared from male Wistar rats, incorporated into vesicles prepared from various PCs 
(phosphatidylcholine) containing fatty acids of differing chain length and degree of 
unsaturation. All of the PCs were found to restore the N-deethylase activity of the 
cytochrome P-450 but to differing extents. Phosphatidylcholines having longer acyl 
chains were more efficient and the unsaturated PC (18:1) reconstituted the enzyme 
activity better than did the saturated PC of the same chain length (18:0). Diarachidoyl 
(20:4) PC gave the highest enzyme activity. It seems therefore that the longer the chain 
length and the more unsaturated the acyl side chain is, the better it is at reconstituting 
lignocaine N-deethylase activity. Lignocaine N-deethylase activity is, thus, activated 
preferentially by long chain, unsaturated fatty acyl side chains on the phospholipid. This 
would seem to correlate well with the higher content of linoleate (18:2) and arachidonate 
(20:4) and the lower content of stearate (18:0) in the male-derived lipid fraction, which 
also activates the N-deethylase activity. Our results indicated clearly that the arachidonic 
acid is the most likely candidate for further investigation to ascertain its role in 
maintaining the drug metabolising activity.
XIII
LIST OF TABLES
Page
1. The contents of the drug metabolising system from mature male Wistar rats.
These results are from a typical experiment...................................................................74
2. The contents of the drug metabolising system from mature female Wistar
rats. These results are from a typical experiment.......................................................... 75
3. A summary of the results obtained using the delipidated microsomal
prepara tion ....................................................................................................................86
4. Purification of the male specific cytochrome P-450 isozyme, lignocaine N-
deethylase from untreated male liver microsomes......................................................... 91
5. Purification of NADPH-cytochrome P-450-reductase from male sodium
phenobarbital treated rats................................................................................................ 93
6. Summary of the results obtained from incorporating the male-specific 
cytochrome P-450 into vesicles prepared from DLPC; DLPE/DLPC
mixtures and total microsomal lipid...............................................................................103
7. A summary of the results obtained from the incorporation of the delipidated 
microsomal preparation into vesicles prepared from lipid fractions extracted
from male and female rat livers...................................................................................... 110
8. Changes in body and liver weights in normal and streptozotocin-diabetic rats 119
9. The effects of incorporation of male delipidated proteins into vesicles
prepared from control; 3-day and 21-day diabetic male microsomal lipid................... 127
10. The effect of lipids derived from diabetic rat livers on the N-deethylating
activity of a male-specific isozyme of cytochrome P-450..................................  132
XIV
LIST OF FIGURES
Page
1. The mixed function oxidase system found in microsomes (endoplasmic
reticulum) performs many different functionalisation reactions.................................. 5
2. Phase one Hepatic Microsomal Metabolism of 4-Androstene-3,17-Dione................... 12
3. A refined fluid mosaic model of a biological membrane................................................ 15
4. Scheme of oxidative and reductive function of the microsomal drug metabolism
system ............................................................................................................................ 32
5. The phase one hepatic microsomal metabolism of lignocaine........................................36
6. Schematic representation of phospholipid separation by two-dimensional
thin layer chromatography.............................................................................................. 56
7. Sex differences in the metabolism of lignocaine using haemoglobin-free
microsomes from mature male and female rat liver.......................................................72
8. Determination of Optimum ProteinrLipid Ratio for Reconstitution. Using 
microsomal lipid and delipidated microsomes derived from male rat liver.
0.1 nmole cytochrome P-450 was used in each reconstitution..............................77
9. The effect of incorporating enzymes derived from female rat liver into vesicles
prepared from dilauroylphosphatidylcholine (DLPC) and dilauroylphos- 
phatidylethanolamine (DLPE )/DLPC mixture (1:3 w/w) on metabolism of 
lignocaine.........................................................................................................................80
10. The effect of incorporating enzymes derived from male rat liver into vesicles
prepared from dilauroylphosphatidylcholine (DLPC) and dilauroylphos- 
phatidylethanolamine (DLPE )/DLPC mixture (1:3 w/w) on metabolism of 
lignocaine.........................................................................................................................81
11. The effect of incorporating enzymes derived from male rat liver into 
dilauroylphosphatidylcholine (DLPC) and male microsomal lipid on
metabolism of lignocaine.....................................................  82
XV
Page
12. The effect of incorporating enzymes derived from female rat liver into 
dilauroylphosphatidylcholine (DLPC) and male microsomal lipid on
metabolism of lignocaine................................................................................................ 83
13. The effect of incorporating enzymes derived from male rat liver into
microsomal lipids derived from male and female rat liver on metabolism of 
lignocaine......................................................................................................................... 84
14. The effect of incorporating enzymes derived from female rat liver into 
microsomal lipids derived from male and female rat liver on metabolism of 
lignocaine......................................................................................................................... 85
15. DE52 column profiles of partially purified male-specific cytochrome P-450 
isozyme from male rat.The P-450 peaks eluted from the DE52 column with 
10 mM potassium phosphate buffer pH 7.4 containing 20% glycerol, 0.5%
Na cholate, 0.2% Emulgen 913, 0.1 mM EDTA and 20 mM KC1..............................89
16. SDS-PAGE of purified cytochrome P-450 isozyme from adult untreated 
male. The samples were analysed as described in Materials and Methods,
2.15., shown are : A, purified NADPH-cytochrome P-450-reductase; B, 
microsomes from untreated male rats; C, DE52 (FI) column eluate; D, HTP 
column eluate; E, standards........................................................................................... 90
17. The metabolism of androst-4-ene-3,17-dione in a reconstituted system 
containing NADPH cytochrome c (P-450) reductase, cytochrome P-450 
(fraction FII) and microsomal lipid. All components derived from male rat
liver m icrosom es......................................................................................................95
18. The metabolism of lignocaine in a reconstituted system containing NADPH
cytochrome c (P-450) reductase, cytochrome P-450 (fraction FII) and 
microsomal lipid. All components derived from male rat liver microsomes............... 96
19. The metabolism of androst-4-ene-3,17-dione in a reconstituted system 
containing NADPH cytochrome c (P-450) reductase, cytochrome P-450 
(fraction FI) and microsomal lipid. All components derived from male rat
liver m icrosom es......................................................................................................97
XVI
Page
20. The metabolism of lignocaine in a reconstituted system containing NADPH 
cytochrome c (P-450) reductase, cytochrome P-450 (fraction H) and 
microsomal lipid. All components derived from male rat liver microsomes.............. 98
21. The effect of incorporating the male-specific cytochrome P-450 isozyme into 
vesicles prepared from dilauroylphosphatidylcholine (DLPC) and 
dilauroylphosphatidylethanolamine (DLPE)/DLPC mixture (1:3 w/w) on 
metabolism of lignocaine.................................................................................................100
22. The effect of incorporating the male-specific cytochrome P-450 into vesicles 
prepared from microsomal lipids derived from male and female livers on the 
metabolism of lignocaine................................................................................................ 101
23. The effect of incorporating the male-specific cytochrome P-450 isozyme into 
vesicles prepared from DLPC or male- and female-derived microsomal lipids 102
24. The effects on lignocaine N-deethylase activity of incorporating male protein 
into vesicles prepared from male- and female-derived microsomal lipid
frac tio n s .........................................................................................................................106
25. The effects on lignocaine 3-hydroxylase activity of incorporating male 
protein into vesicles prepared from male- and female-derived microsomal
lipid fractions...........................................................................................................107
26. The effects on lignocaine N-deethylase activity of incorporating female 
protein into vesicles prepared from male- and female-derived microsomal
lipid fractions...........................................................................................................108
27. The effects on lignocaine 3-hydroxylase activity of incorporating female 
protein into vesicles prepared from male- and female-derived microsomal
lipid fractions.......................................................................................................... 109
28. Microsomal phospholipid composition in the liver of male and female rats.
Fractions analysed were phosphatidylcholine (PC), phosphatidylethanolamine
(PE), phosphatidylinositol (PI) and phosphatidylserine (PS)...................................... 112
XVII
Page
29. Microsomal phospholipid fatty acid composition in male and female liver.
Fatty acid composition was determined by gas chromatography as described
in Materials and Methods section (2.18.). Male (n = 5) and female (n = 5)................114
30. The effect on activity of lignocaine N-deethylase of incorporating enzymes 
derived from male rat liver into vesicles prepared from phosphatidylcholines
having different acyl chains............................................................................................ 116
31. The effect on activity of lignocaine 3-hydroxylase of incorporating enzymes 
derived from male rat liver into vesicles prepared from phosphatidylcholines
having different acyl chains; 3-day and 21-day diabetic rat livers.............................. 117
32. The effect on lignocaine N-deethylase activity of incorporating male-derived 
delipidated microsomal protein into vesicles prepared from the microsomal
lipids derived from control; 3-day and 21-day diabetic rat livers................................. 121
33. The effect on lignocaine 3-hydroxylase activity of incorporating male-derived 
delipidated microsomal protein into vesicles prepared from the microsomal lipids 
derived from control; 3-day and 21-day diabetic rat livers.......................................... 122
34. The effect on lignocaine N-deethylase activity of incorporating male-derived 
delipidated microsomal protein into vesicles prepared from the microsomal 
phospholipid derived from control; 3-day and 21-day diabetic rat livers.....................123
35. The effect on lignocaine 3-hydroxylase activity of incorporating male-derived 
delipidated microsomal protein into vesicles prepared from the microsomal 
phospholipid derived from control; 3-day and 21-day diabetic rat livers.....................124
36. The effect on lignocaine N-deethylase activity of incorporating male-derived 
delipidated microsomal protein into vesicles prepared from the mixture of 
phospholipid and neutral lipid derived from control; 3-day and 21-day diabetic
rat livers ......................................................................................................................125
XVIII
Page
37. The effect on lignocaine 3-hydroxylase activity of incorporating male-derived 
delipidated microsomal protein into vesicles prepared from the mixture of 
phospholipid and neutral lipid derived from control; 3-day and 21-day diabetic
ra t liv ers ......................................................................................................................126
38. The effects of incorporating male-specific cytochrome P-450 isozyme into 
vesicles prepared from control; 3-day and 21-day diabetic male-derived 
microsomal lipids (N-deethylase activity)......................................................................129
39. The effects of incorporating male-specific cytochrome P-450 isozyme into 
vesicles prepared from phospholipid derived from control; 3-day and 21-
day diabetic male-derived microsomal lipids (N-deethylase activity).....................130
40. The effects of incorporating male-specific cytochrome P-450 isozyme into
vesicles prepared from mixture of phospholipid and neutral lipid derived 
from control; 3-day and 21-day diabetic male-derived microsomal lipids (N- 
deethylase activity).......................................................................................................... 131
41. Phospholipid composition of liver microsomes in control, 3-day and 2 1-day 
diabetic rats......................................................................................................................134
42. Microsomal phospholipid fatty acid composition in control; 3-day- and 21-day 
diabetic rats. Fatty acid composition was determined by gas chromatography as 
described in Materials and Methods section (2.18.). Control (n = 3); 3-day (n =
3) and 21-day diabetic (n = 3)........................................................................... 136
XIX
Abbreviations:
A M P...................................... Adenosine-ST^ monophosphate
CD.......................................... Carbon monoxide
DAPC.....................................Diarachidoylphosphatidylcholine
DBPC.....................................Dibehenoylphosphatidylcholine
DCPC.....................................Dicaproylphosphatidylcholine
DEAE-cellulose..................... Diethylaminoethyl-cellulose
DLPC.....................................Dilauroylphosphatidylcholine
D LPE...................................... Dilauroylphosphatidylethanolamine
DOPC.....................................Dioleoylphosphatidylcholine
DSPC ..................................Distearoylphosphatidylcholine
DTT........................................Dithiothreitol
FAD........................................Ravin adenine dinucleotide
FM N ...................................... Ravin mononucleotide
H b ...........................................Haemoglubin
HTP........................................Hydroxylapatite
NADPH................................ Nicotinamide adenine dinucleotide phosphate (reduced)
NL...........................................Neutral lipid
P C ...........................................Phosphatidylcholine
P E ...........................................Phosphatidylethanolamine
PEG........................................Polyethyleneglycol
PI ...........................................Phophatidylinositol
P L ...........................................Phospholipid
PMSF..................................... Phenylmethanesulfonyl fluoride
PS ....................................... Phosphatidylserine
TEMED.................................. NjNjN'N'-tetramethylenediamine
XX
INTRODUCTION
1 .1 .  HISTORICAL BACKGROUND.
The studies of Brodie et al. (1955) revealed the existence of an enzymatic system 
in the endoplasmic reticulum of the liver capable of converting drugs into more polar 
products by the use of the cofactor, NADPH, and it was established that the reaction can 
only proceed in the presence of molecular oxygen. Garfinkel (1958) and Klingenberg 
(1958) detected a CO-binding pigment in liver microsomes of pigs and rats respectively, 
which was shown to be reducible by either NADPH or dithionite. Omura and Sato 
(1964a,b) revealed the haemoprotein nature of the CO-binding pigment and its 
identification as a b-type cytochrome with a typical Soret band of the CO-complex at 
450nm which made the authors designate it cytochrome P-450. The first step in the 
reaction cycle was determined as formation of an enzyme-substrate complex, the spectral 
characteristics of which depend on the substrate used (Narasimhulu et al., 1965; Remmer 
et al., 1966; Schenkman et al., 1967). Substrates, which are supposed to bind to a polar 
amino acid residue at the active site and are hydroxylated, induced a blue shift of the Soret 
band with absorption bands at 385-390 nm as maximum and 425-435 nm as minimum in 
the difference spectrum (type I). The other compounds which are assumed to be bound 
directly to the heme iron induce a red shift thus leading to an absorption maximum at 425- 
435 nm and a minimum at 390-410 in a difference spectrum which is denoted as a type II 
spectrum (Schenkman et al., 1967). Estabrook et al. (1963) demonstrated that cytochrome 
P-450 in the bovine adrenal mitochondrial system is indeed the terminal oxidase of the 
monooxygenase system. Somewhat later, in 1969, this result was confirmed for the 
enzyme system in the endoplasmic reticulum of mammalian liver by Diehl et al. (1969). It 
was simultaneously shown by Katagiri et al. (1968), Lu et al. (1969b) and Gunsalus and 
Sligar (1978) that the monooxygenase system is composed of a certain number of 
essential components. All of these systems work as electron transferring chains 
transporting the electrons from the cofactor, nicotinamide adenine dinucleotide phosphate
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(NADPH), via an FAD/FMN-containing flavoprotein as electron transmitter to 
cytochrome P-450 as the terminal oxidase acting as electron acceptor.
1 .2 .  THE STRUCTURE OF THE ENDOPLASMIC RETICULUM.
Most eukariotic cells are traversed by a membrane and tubular network which 
represent a basophilic component of the cytoplasm known as chromophilic substance or 
ergastoplasm. From its localisation and form it was called endoplasmic reticulum by 
Porter (1953). In 1954, Palade and Porter showed that it consisted of rough and smooth 
membranes. The particles attached to the rough membranes were named as ribosomes 
by Roberts (1958) (about 60% of the endoplasmic reticulum has been shown to be 
composed of ribonucleic acid) (Porter, 1953). That part of the endoplasmic reticulum 
which is involved in protein biosynthesis and occupied by ribosomes appears as rough 
membranes but in the peripheral part of the cell the ribosomes disappear and the 
endoplasmic reticulum morphologically appears as smooth membranes (Ruckpaul and 
Bernhardt, 1984). After homogenisation and differential centrifugation of cells a special 
fraction consisting of small particles, which were called microsomes because of their 
small size, was formed. Palade and Siekevitz (1956), by means of electron microscopy, 
showed that this microsomal fraction originates from endoplasmic reticulum. Because of 
the transversal rupture of the endoplasmic reticulum, microsomes have the same 
inside/outside orientation. Therefore they can be regarded as the biochemical equivalent 
of the endoplasmic reticulum and it seems reasonable to assume that the microsomes 
reflect functionally physiological conditions (DePierre and Dallner 1975; Dallner and 
Emester 1968). The main constituents of the endoplasmic reticulum of hepatocytes - 
protein and lipids- are contained in lg  wet weight of liver in an amount of 40-50 mg 
protein and about 15mg phospholipid, meaning that the membrane of the endoplasmic 
reticulum consists of 60-70% protein and 30-40% phospholipid by weight. Based on a 
molecular weight of 800 for a typical phospholipid and 50,000 as the average molecular
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weight of a microsomal protein, DePierre and Emster (1977) roughly calculated that 
there are approximately 27-42 phospholipid molecules per protein molecule in the 
endoplasmic reticulum. Besides the monooxygenase system with cytochrome P-450 as a 
terminal oxidase the endoplasmic reticulum contains another electron transport system 
with cytochrome b$ and an NADH-dependent reductase which apparently is involved in 
some hydroxylating reactions. Shimakata et al. (1971) have shown cytochrome b5 to be 
the intermediate electron carrier in the microsomal NADH-dependent stearyl-Co-A 
desaturase system.
1 .3 .  THE FUNCTION OF THE MIXED FUNCTION OXIDASE SYSTEM.
In 1968 Lu and Coon showed that the hepatic monooxygenase in the membrane 
of the endoplasmic reticulum is composed of three essential componentsrcytochrome P- 
450, NADPH-cytochrome P-450 reductase and a heat-stable lipid factor, later 
discovered to be phosphatidylcholine (Strobel et al., 1970), which can be reconstituted 
to an enzymatically active enzyme system. Due to the membrane-bound state and the 
presence of many other proteins in the endoplasmic reticulum, the purification of the 
monooxygenase system was rather difficult to achieve. The monooxygenase system can 
biotransform a variety of substrates, both endogenous and exogenous (Figure 1.1.). 
Due to the broad reaction specificity, many lipophilic drugs and xenobiotics are 
hydroxylated to more polar products making them more readily excreted than stored.
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FIGURE 1.1.
The mixed function oxidase system found in microsomes (endoplasmic 
reticulum) performs many different functionalisation reactions (summarized in figure
1.1.). An expamle of each reaction is given below.
1. AROMATIC HYROXYLATION
d r  h  CH3 r  HI. / C2H5
NH-CO-CH2-N. « f ^ - N H - C O - C H 2 - N .„ - —- IX « ■OHThe 3-hydroxylation of lignocaine
2. ALIPHATIC HYDROXYLATION
1
N
0
N
a
H
C2H5
CH-CH2-CH-CH3 l 1
CH3 OH
3. EPOXEDATION
The side-chain hydroxylation of pentobarbital.
The formation of benzo(a)pyrene-4,5-epoxide
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FIGURE 1.1. (continued).
4. N-DEALKYLATION
H
+ HCHO
Cl
The N-demethylation of diazepam
5 .0-DEALKYLATION
O
acetophenetidin
O
II
n h -c -c h 3
+ CH3CHO
HO
p-hydroxyacetanilid 
The O-de-ethylation of acetophenetidin
6. S-DEALKYLATION 
CH3
s SH
N
>
N
N
^  + HCHO
The S-demethylation of S-methylthiopurine.
7. OXIDATIVE DEAMINATION
/  \ CH2-CH-NH2 
\ = /  CH3^ n  \-—.v v
The oxidative deamination of amphetamine.
^  CH2-C-CH3 + n h 3
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FIGURE 1.1. (continued).
8. N-OXIDATION
CH3
The N-oxidation of 3-methylpyridine.
9. S-OXIDATION
(CH2)3
N(CH3)2
(CH2)3
N(CH3)2
The S-oxidation of chlorpromazine.
10. PHOS PHOTHIONATE OXIDATION
o 2n - p  V - o - p =s  
— /  o c 2h5
o 2n-T up
\ = /  o c 2h5
The oxidation of parathion
11. DEHALOGENATION
H
CF3-C-Br
Cl
c f 3-c h 2 o h c f3-c o o h
The oxidative dehalogenation of halothane.
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1 .4 .  COMPONENTS OF THE MIXED FUNCTION OXIDASE 
SYSTEM.
1 .4 .1 .  Cytochrome P-450.
Cytochrome P-450 refers to a class of protoporphyrin IX-containing 
haemoproteins which show an unusual absorbing peak at 450nm when carbon 
monoxide is bound to the reduced form. Originally characterized by Omura and Sato 
(1964a,b), the enzyme was subsequently shown by Cooper et al. (1965) to participate in 
mixed function oxidation reactions. It does not appear to conform to the cytochrome b5-
type structural model. Rather, it is more intimately associated with the microsomal 
membrane, and no hydrophilic domain is released upon proteolysis. Proteolysis (as well 
as other harsh treatments i.e. a wide variety of detergents eg sodium deoxycholate and 
lysolecithin) can result in a conversion of cytochrome P-450 to a nonfunctional form 
termed cytochrome P-420. In a critical analysis of the manner in which these treatments 
convert cytochrome P-450 to cytochrome P-420, Imai and Sato (1967) concluded that 
the ultimate effect was to disrupt the association between haemoprotein and microsomal 
lipid. Using the combined approaches of proteolytic destruction of the native heme 
absorbance and derivitization with diazobenzene sulfonate, DePierre and Emster (1980) 
have demonstrated that, like the other microsomal components, cytochrome P-450 is at 
least partially exposed to the cytoplasmic side of the membrane. At least twenty different 
forms of the cytochrome have been purified from detergent solubilization of microsomal 
membranes, and most, if not all, appear to be separate gene products (Waxman 1988). 
Apparent molecular weights (by SDS-PAGE) are in the 50,000-to 55,000-dalton range. 
The haemoprotein is present in very high concentrations in the microsomal membrane, 
and upon induction with phenobarbital, can comprise up to 15 to 20% of the microsomal 
protein. In its isolated form the protein self-associates to an aggregate of 500,000 
daltons or more, and the size of the aggregate can be decreased by phospholipid 
(Guengerich and Holladay, 1979).
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1 .4 .1 .1 .  Multiplicity of Cytochrome P-450.
The existence of more than one liver microsomal drug-metabolising enzyme in 
different animal species was first postulated more than 28 years ago. An early study of 
Conney et al. (1959) suggested, not only that the drug metabolising enzymes of various 
species differ but that the liver of a single species contains several enzyme forms that 
catalyse the same reaction. Conney et al. (1959) found that the administration of 
benzo(a)pyrene to rats markedly increased the microsomal metabolism of substrates such 
as benzo(a)pyrene, acetanilide, zoxazolamine and 3-methyl-4-monomethylamino-benzene 
yet decreased the metabolism of meperidine and benadryl and had no effect on the 
metabolism of chlorpromazine. Since these initial observations, studies on the nature of the 
drug metabolising enzyme system have concentrated on the liver microsomal 
haemoprotein, cytochrome P-450. In 1965 Cooper et al., demonstrated that cytochrome P- 
450 is the terminal oxidase of the liver microsomal drug-metabolising enzyme system. Imai 
and Sato (1974) and Van der Hoeven et al. (1974) independently reported the successful 
purification and characterisation of hepatic microsomal P-450 from PB-treated rabbits to a 
gel-electrophoretically homogeneous state. Since then the data accumulated over the past 
years from studies with microsomes as well as purified cytochrome P-450 isozymes and 
the purification of cytochrome P-450's from a variety of induced and non-induced species 
supports the concept of multiple forms of cytochrome P-450. The use of different inducers 
to manipulate the biochemical and biophysical properties of the microsomal hydroxylation 
system has played a major role in establishing the existence of multiple forms of 
cytochrome P-450 i.e. liver microsomes prepared from phenobarbital (PB)-treated rats 
were shown to differ with respect to substrate specificity and the absorption maxima of 
their reduced difference spectra from liver microsomes prepared from 3- 
methylcholanthrene (3MC)-treated rats (Alvares et al., 1967;Sladek and Mannering, 1966; 
1969a; Mannering, 1971; Thomas et al.,1976). Also immunological properties can be 
studied by the use of antibodies prepared against various purified cytochrome P-450
9
preparations which generally show high specificity and thus provide another means for 
distinguishing multiple forms of cytochrome P-450 i.e. antibodies produced against rat 
cytochrome P-450a, P-450b, P-450c (Haugen et al., 1977; Botelho et al., 1979) or B 
fractions of PB- and 3-MC-treated rats (Guengerich 1978) were highly specific.
The ultimate proof of different primary structures for different species of 
cytochrome P-450 will be a comparison of the total amino acid sequence of each isozyme. 
Partial sequences of rat P-450a, rat P-450b and rat P-450c forms are available (Haugen et 
al., 1977; Botelho et al., 1979) and the sequence of the first 19 amino acids on the N- 
terminal end of the three forms are quite different. All forms contain a high percentage of 
hydrophobic amino acids, the N- and C-terminal respectively are, methionine and 
methionine for P-450a, glutamic acid and serine for P-450b, and isoleucine and leucine 
for rat P-450c (Botelho et al., 1979; Haugen et al., 1977). Waxman and Walsh (1982), 
however, demonstrated that the P-450 PB-4 and P-450 PB-5 have identical primary 
structures for their first 31 and probably 34 amino acid residues. Most of these results, 
therefore provide further support for the multiplicity of cytochromes P-450 and suggest 
that most of the cytochromes P-450 are separate gene products rather than posttranslational 
modifications of a common precursor.
Over the last 2 decades workers in the field have used a variety of different 
nomenclatures for an increasing number of forms of P-450 isolated in their laboratories. 
This plethora of names has become more and more confusing. To rectify this problem a 
nomenclature for P-450 gene superfamily is proposed (Nebert et al., 1987) based on 
evolution. Recommendations include Roman numerals for distinct gene families, capital 
letters for subfamilies, and Arabic numerals for individual genes. An updating of this list, 
which presently includes 65 entries, will be required every 1-2 years. As segment of 
orthologous gene is presently uncertain in some cases-between widely diverged and 
especially in the P-450 II family due to large number of genes. For more details see Nebert 
et al., (1987).
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1 .4 .1 .2 .  Regioselectivity and Stereoselectivity of Steroid Hormone 
H ydroxylation.
Many of the cytochromes P-450 metabolise the commonly studied compounds 
(i.e. 7-ethoxycoumarin, ethylmorphine, benzo(a)pyrene) with similar efficiencies and 
overlapping site specificities, making it difficult to uniquely characterise individual P- 
450 forms solely using these compounds as a substrate (Waxman 1988). In contrast, 
steroid hormones are frequently oxygenated by cytochrome P-450 enzymes with a high 
degree of specificity. Steroid hormones have proven most useful as substrates for 
distinguishing these multiple cytochrome P-450 forms (Sheets and Estabrook 1985) 
owing to the unique and characteristic metabolite profiles obtained (figure 1.2.) i.e. 
experiments carried out using electrophoretically homogeneous rat hepatic cytochrome 
P-450 form 2c (Waxman 1984) established that this enzyme can hydroxylate 4- 
androstene-3,17-dione from the alpha face on either the B-ring (yielding 7a-O H - 
androstenedione) or the D-ring (yielding 16aOH-androstenedione (for review see 
Waxman 1988)).
FIGURE 1.2.
Phase one Hepatic Microsomal Metabolism of 4-Androstene-3,17-Dione.
O
3(oc,P)
oxred.
O
6
5(ot,p) 
red
HO
H
Isozym e Product Selectivity
6p-hydroxylase 6(3-hydroxy (androstenedione) female < male
7a-hydroxylase 7a-hydroxy (androstenedione) female = male
16a-hydroxylase 16a-hydroxy (androstenedione) female < male
16a-Ohase7a-Ohase6 P-Ohase
OH
OH
OH
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1 .4 .2 .  NADPH-Cytochrome C (P-450) Reductase.
This flavoprotein was initially isolated and characterized by proteolytic treatment 
of microsomes. Williams and Kamin (1962) isolated and Kamin et al. (1966) 
characterized a 71000-dalton form which contained two flavins per molecule. The 
flavins were subsequently identified as flavin adenine dinucleotide (FAD) and flavin 
mononucleotide (FMN), (Iyanagi and Mason, 1973). In the native protein, the two 
flavins perform separate catalytic functions, (Vermillion et al., 1981); the flavin adenine 
dinucleotide (FAD) interacts with and accepts electrons from NADPH and donates them 
internally to the flavin mononucleotide (FMN). The latter then transfers electrons to the 
native electron acceptor, cytochrome P-450. The proteolytic form of the enzyme is 
monomeric and soluble in aqueous solutions, (Williams and Kamin, 1962; Kamin et al.,
1966). This form is no longer capable of binding to microsomes, and does not function 
in the reduction of cytochrome P-450. The functional reductase was subsequently 
purified following detergent extraction of the microsomal membrane, (Dignam and 
Strobel, 1977; Vermillion and Coon, 1974). This form of the reductase had a molecular 
weight of 77, 000 with about 50 additional amino acids. With these additional residues, 
the isolated reductase aggregated to form a hexamer and could bind to both microsomes 
and artificial phospholipid membranes, (Gum and Strobel, 1979). The purified, 
functional form of the reductase required added phospholipid to support reduction of 
cytochrome P-450 and the associated oxidative reactions, (Miwa and Cho, 1976). 
Typsinization of the holoprotein allowed isolation of both the hydrophilic domain and a 
small hydrophobic peptide with a molecular weight of about 6000, (Black and Coon, 
1982; Gum and Strobel, 1981). The sequence of the hydrophobic portion has been 
determined, (Black and Coon, 1982) and contains a long region of hydrophobic 
residues which promote interaction with the hydrophobic membrane. This peptide
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sequence has also been proposed to function specifically in the interaction of the 
reductase with cytochrome P-450, (Black et al., 1979).
1 .4 .3 .  Microsomal Lipid.
Microsomal membranes are composed of a mixture of neutral lipid and 
phospholipid, with a large proportion of unsaturated fatty acyl residues, and cholesterol, 
(Dallner and Emster, 1968). The observations by Komberg and McConnell (1971) 
suggested that the membranes are fluid, allowing rapid lateral diffusion in the plane of 
the membrane, and that the membrane proteins are often inserted into and through the 
lipid bilayer, resulting in the Singer and Nicholson (1972) "fluid mosaic model" (figure
1.3.). Within this model, the functional role of lipids is related to their ability to self- 
assemble into bilayer structures on hydration, thus providing a permeability barrier as 
well as a matrix with which functional membrane proteins can be associated. Lipids in 
bilayers may undergo a temperature-dependent phase separation which produces patches 
of membrane with differing composition (Quinn, 1981).
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FIGURE 1.3.
A refined mosaic model of a biological membrane.
Protein
Taken from Phospholipids and Cellular Regulation. 
Volume I, ed. Kuo, J. F. (1985)
1 .5 . Examination of lipid in detail
1 .5 .1 . Membrane Asymmetry.
Lipid phase transitions and lateral motions could occur in one or both layers of 
the bilayer. The composition of the two membrane bilayers appears to be very different 
but there is some movement of lipids between the outer and the inner layers of the 
membrane, usually referred to as "flip-flop". This transbilayer exchange has been 
reported to be as much as four times greater in biological membranes (Rothman and 
Kennedy, 1977) than in artificial bilayers (Roseman et al., 1975). Studies with 
phospholipase C have indicated that two-thirds of the phosphatidylethanolamine of rat 
liver endoplasmic reticulum is located in the inner leaflet of the membrane bilayer 
(Hutson and Higgins, 1982). They also suggest that phosphatidylethanolamine is 
synthesised at the cytoplasmic leaflet of the endoplasmic reticulum and subsequently 
transferred across the membrane to the cisternal leaflet of the bilayer. Valtersson et al. 
(1986) suggested that the phosphatidylethanolamine in microsomes is distributed in a 
non random fashion, and they demonstrated the existence of two pools of 
phosphatidylethanolamine. The two pools showed differences in fatty acid composition 
as well as in their sites of attachment. Phosphatidylcholine synthesised by the choline 
phosphotransferase pathway is preferentially located in the outer leaflet of the 
microsomal membrane (Higgins, 1979). In contrast, during synthesis of 
phosphatidylcholine by methylation of phosphatidylethanolamine, the first methylation 
step apparently occurs at the inner surface of the membrane and translocation of partly 
methylated intermediates across the membrane bilayer takes place so that 
phosphatidylcholine exists on both sides of the membrane (Higgins, 1981).
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1. 5. 2. Membrane Fluidity.
Although several enzymes have specific phospholipid requirements for 
biological activity, it has been considered more likely that the role of membrane lipids is 
to provide an environment of proper viscosity and surface ionic milieu for optimal 
enzyme function (Thompson, 1973). The fluid mosaic model (figure 1.3.) of membrane 
structure (Singer and Nicholson, 1972) has provided a valuable model for protein-lipid 
interactions within the membrane. Studies of movement within membranes have 
suggested that phospholipids diffuse in the membrane at rates of approximately 10'^ to 
10-7 cm2/sec, (Stier and Sackman, 1973). It is well known that the artificial bilayers 
made of pure lipids of the same type found in membranes will undergo a transition from 
a relatively fluid state (generally termed the liquid crystalline phase) to a more rigid state 
(the gel phase) when the temperature is lowered to a characteristic point (Cullis et al.,
1985). The membrane may also undergo transition from a bilayer form into a hexagonal 
phase (Thompson, 1973).
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1 .5 .3 . Model Membranes.
Due to the heterogeneous composition and the complexity of biomembranes for 
biochemical and biophysical studies, model membranes are often used which contain 
only one or a few essential components. The aim of such studies on model membranes 
is to find general principles according to which membranes are organized and thus to 
draw conclusions on biological membranes. The basis for such studies is the capability 
of phospholipids to arrange themselves as multiwalled rather than as single-walled 
vesicles. Many properties (e.g. permeability for ions and water, response to Ca2+, 
incorporation of proteins) of bilayers resemble those of biomembranes. For biochemical 
and biophysical studies two types of bilayers can be used (I) multibilayer dispersions, 
which are formed spontaneously whenever phospholipids are dispersed in an aqueous 
medium, (II) homogeneous, small single-walled bilayer as vesicles which are readily 
obtained under appropriate conditions such as sonication. The formation of either 
multilayer or bilayer dispersions not only depends on the external physical conditions 
but also on the nature of the acyl residues.
Dispersion of lipids in water.
The simplest model system is obtained by depositing the lipid of interest as a 
film by evaporating from chloroform. The lipid is subsequently hydrated by mechanical 
agitation in the presence of aqueous buffer. Lipids that adopted the hexagonal Hn phase
are usually much more difficult to disperse in water and form fine particulate 
suspensions. Water/Lipid dispersions are useful for studies on the structural preferences 
of lipids.
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Small unilamellar vesicles:
These systems provide a more representative model system than the hexagonal 
H jj which do not exhibit a well-defined permeability barrier between external and
internal environments. These vesicles can include reconstituted proteins if an 
understanding of lipid-protein interactions or the influence of a given lipid on protein 
function is required.These vesicles can be achieved by sonication (Huang, 1969).
Large unilamellar vesicles;
Large unilamellar vesicles can be achieved by detergent solubilisation followed 
by dialysis or gel filtration to remove the detergent, thus it produces vesicles which 
range in size from 50 to 200 nm diameter (Cullis et al., 1985; Schmitz, 1986).
1 .5 .4 .  Properties of individual lipid species.
Phosphatidylcholine:
At temperatures below the gel to liquid crystal transition temperature all species 
of PC adopt a lamellar gel phase where the acyl chains assume an all-trans 
configuration. Above the transition temperature the configurition is also lamellar but 
liquid crystalline where the acyl chains are disordered (Cullis et al., 1985).
Sphingomyelin:
Sphingomyelin adopts only the lamellar organisation over a wide range of 
temperatures and hydration (Cullis et al.,1985).
Phosphatidylethanolamine (PE) spontaneously adopts the hexagonal Hjj phase 
structure in the presence of excess aqueous buffer at physiological temperatures. 
However unsaturated PE undergoes a transition between the lamellar and the hexagonal 
H jj phases with increasing temperature which, depending on the hydration, ionic 
strength and acyl chain unsaturation, can adopt both lamellar and hexagonal Hjj 
configurations (Cullis et al., 1985).
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Mixtures of phosphatidylcholine and phosphatidylethanolamine:
Phosphatidylcholine can stabilise the unsaturated PE into a lamellar configuration 
in a manner which is sensitive to the acyl chain unsaturation of the lipid, the temperature 
and the ratio of PC to PE (Cullis et al., 1985).
1 .5 .5 .  Influence of Cholesterol on Membrane Structure
Changes in the cholesterol content of the native membrane can cause alterations 
in its physico-chemical properties (e.g. fluidity, permeability, cell fusion properties) 
(Inoue, 1974; Block et al., 1977). The normal content of cholesterol in the liver and 
hepatic microsomes varies considerably (Bernhardt and Ruckpaul, 1981). Besides 
phospholipid-induced modification of the function of the monooxygenase system, there 
is an increasing amount of evidence that the incorporation of cholesterol also affects the 
drug metabolising enzyme activity (Bernhardt and Ruckpaul, 1981; Skett and Cuthill, 
1986). It has been shown that cholesterol may induce incorporation of proteins into 
vesicles (Scotto and Zakim 1986, Scotto et al., 1987).The codeine N-demethylation is 
inhibited in guinea pigs fed for 72 day on cholesterol rich diet but when the rats are fed 
on the same diet for 137 day the codeine N-demethylation increases Tsia et al., (1977). 
On the other hand, the activity of NADPH cytochrome P-450 reductase in rats was not 
altered by the cholesterol rich diet (Lang et al., 1976) which indicates that either 
cytochrome P-450 or the interaction between the cytochrome P-450 and the reductase 
are influenced by the cholesterol.
2 0
1 .6 . LIPID INVOLVEMENT IN MICROSOMAL HYDROXYLATION.
In 1969 Lu and coworkers (Lu et al., 1969b) reported that one of the three 
components of their resolved and reconstituted fatty acid hydroxylation system was a 
heat stable factor. The same fraction was later found to also be required for the maximal 
hydroxylation of steroids, carcinogens and many drugs (Lu et al., 1969a; Lu et al., 
1970; Lu et al., 1971; Lu et al., 1972). This factor was subsequently found to be 
phospholipid and phosphatidylcholine was found to be the most effective in 
reconstituting the enzyme system (Strobel et al., 1970). The result of phospholipase C 
treatment also indicated the essential role of the phospholipid in microsomal oxidation 
(Chaplin and Mannering, 1970; Eling and Di Augustine, 1971). This treatment removed 
approximately 70% of the total phospholipids, which led to a decrease in the metabolism 
of type I compounds and essentially eliminated the binding of type I compounds to 
cytochrome P-450. However the role of the phospholipids in drug hydroxylation was 
questioned by Cater et al. (1972) who found that the metabolism of type I compounds, 
inhibited by the deoxycholate which was still present in the reconstituted system of Lu 
and Coon (1968), could be overcome by the addition of phosphatidylcholine. Since the 
reconstituted system of Lu et al. (1969) still contained deoxycholate, it has been 
suggested that the role of lipid could be that of relieving the inhibition caused by the 
detergent. As for the phospholipase C treatment, Cater et al. (1972) found that the 
decrease in the aminopyrine demethylation after the phospholipase C treatment could not 
be restored completely by the addition of phosphatidylcholine. They suggested that fatty 
acids released by an endogenous acylhydrolase were responsible for the decrease in 
aniline hydroxylation, since fatty acids are also substrates for the cytochrome P-450 
system, and because defatted serum albumin prevented this inhibition. Based on these 
studies they concluded that the liver microsomal cytochrome P-450-linked hydroxylation 
system is not phospholipid dependent. To resolve this controversy Vore et al. (1974) 
were able to remove lipids from microsomes without significantly affecting the other
21
components of the system. The enzymatic activity of the extracted microsomes, as 
measured by their ability to hydroxylate 3,4-benzpyrene, was 30-50% of the control 
activity. However, addition of a total lipid extract or synthetic phosphatidylcholine to the 
extracted microsomes fully restored the activity. These results are consistent with the 
idea that lipid is an essential part of the microsomal hydroxylation system and that its 
function is not related to the use of detergents.
1 .6 .1 .  Role of Phospholipid.
Several reports describing alterations of drug metabolism dependent on 
nutritional status, under physiological and pathological conditions which cause 
alterations in phospholipid composition, have been presented (Rumack et al., 1973; 
Paine and McLean, 1973; Laitinen et al., 1975; Hammer and Wills, 1978; Feuer et al., 
1980). There are two different ways to modify the phospholipid structure (i) by changes 
in the fatty acid residues or (ii) by substituting the head group. In 1972, Norred and 
Wade demonstrated that a total fat deficiency in the diet caused a decrease in the activities 
of hydroxylation and glucuronidation of foreign compounds in microsomes. It was 
suggested that the fatty acid composition of a given phospholipid molecule exerts a
signal function directing the lipid to its final intramembranous location (Valtersson et al.,
1986). However Wade et al. (1978) showed that if the diet was supplemented with 3% 
com oil, which increases the amount of linoleic (18:2) and arachidonic acid (20:4) in the 
phospholipid of hepatic microsomes, the ethylmorphine demethylase (Norred and 
Wade, 1972) increased. Fasting of rats leads to an overall increase of saturation of fatty 
acids in hepatic lipids which causes a decrease in the activity of 4-nitroanisole O- 
demethylation. Several authors (Ingelman-Sundberg and Glaumann, 1977; Ingelman- 
Sundberg et al., 1980) have demonstrated that the efficiency of phospholipids to 
enhance the monooxygenase activity increases with their acidity. The changes in the 
phospholipid concentration or composition could affect the functioning of the 
microsomal enzyme systems by a variety of mechanisms and thus affect the metabolism
2 2
of fatty acids, steroids, xenobiotics and carcinogens and such a change occurs during 
development. Feuer et al. (1980) demonstrated that at birth (in rats) there is a significant 
increase in the fluidity of the microsomal membrane, which correlates both with the 
membrane cholesterol content and unsaturation of the phospholipids. They also noted 
that the fatty acids become more unsaturated in the fetal to adult progression. In 1980, 
Dhami et al., noted that pregnancy causes a similar change in the lipid composition. 
Diet, as noted above, also causes changes in the phospholipid composition which in turn 
can affect the activity of the microsomal drug metabolising enzymes. Wills (1980) has 
demonstrated that the activity of benzo(a)pyrene metabolism was directly proportional to 
the fraction of unsaturated fatty acids in the membrane phospholipids. Microsomal 
phospholipids have been found to consist of about 55% phosphatidylcholine, 20-25% 
phosphatidylethanolamine, 5-10% phosphatidylserine, 5-10% phosphatidylinositol, and 
4-7% sphingomyelin (DePierre and Dallner 1975). The fatty acid moieties of these 
phospholipids are mainly palmitic (16:0), palmitoleic (16:1), stearic (18:0), oleic (18:1), 
linoleic (18:2), arachidonic (20:4), and decosahexaenoic acid (22:6) species (Lee and 
Snyder 1973). In the endoplasmic reticulum the cytochrome P-450 and NADPH 
cytochrome P-450 reductase are embedded in a bilayer of membrane lipids with protein 
regions sticking out of the lipid (figure 1.3.). Delipidated proteins are incapable of 
performing hydroxylation reactions, but they can be reconstituted to an enzymatically 
active monooxygenase in the presence of phospholipid (Strobel et al., 1970; Van Der 
Hoeven et al., 1974).The early work on the mixed function oxidase system in the liver 
indicated that the lipid was the third essential component (Lu and Coon, 1968). Work 
with phospholipase C also indicated the essential role of phospholipids in microsomal 
oxidation (Chaplin and Mannering, 1970; Eling and Di Augstine, 1971). The 
requirement for lipid was further refined when dilauroylphosphatidylcholine (DLPC) 
was found to stimulate drug metabolism in a reconstituted system (Miwa and Lu, 1981). 
In contrast to earlier experiment with partially purified cytochrome P-450 (Lu et al.,
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1970) it was proved that the binding of benzphetamine to cytochrome P-450LM2 
increased about 5-fold in the presence of dilauroylphosphatidylcholine (Coon et al., 
1976; Dawson et al., 1978; French et al., 1980). Although Parke (1981) suggested that 
this was an oversimplification of the endoplasmic reticulum and misrepresented the 
physiological situation as DLPC does not exist in vivo. Taniguchi et al. (1984) has 
suggested that protein insertion and interaction is affected by this artificial phospholipid 
as compared to the natural lipids. Indeed, Ingelman-Sundberg et al. (1980) have 
demonstrated that phosphatidylcholine (PC) can inhibit the activity of cytochrome P-450 
LM2 and that this inhibition can be overcome by microsomal lipids. The idea is still 
prevalent, however, that the microsomal phospholipids are simply structural 
components to hold the enzymes in place.This view is challenged by findings of 
correlations between changes in lipid composition and drug metabolism. Decreased drug 
metabolism is seen in pregnancy in the rat (Neakand Parke, 1973) and this correlates 
with altered phospholipid content (Dhami et al., 1980). Similarly sex differences in drug 
metabolism have been shown to correlate to sex-dependent lipid differences (Belina et 
al., 1975). The binding of the substrate is paralleled by a shift to the high spin state, 
which can also be produced by phospholipid forming type I difference spectra (Tsong 
and Yang, 1978; Chiang and Coon, 1979; French et al., 1980). Whitmer et al. (1986) 
have suggested that the lipid composition and vesicle properties of the native membranes 
may modulate substrate disposition and bio transformation in hepatocytes, indeed they 
demonstrated that the lipid composition of membranes incorporating bilirubin appears to 
modulate the rate of glucuronidation and the relative rates of bilirubin mono- and 
diglucuronide formation. Spectrophotometric titrations and steady state kinetics have 
shown that the interaction between cytochrome P-450 reductase and cytochrome P-450 
LM2 shifts the equilibrium of P-450 LM2 to the high spin state and that, in the presence 
of the phospholipid, the affinity of the cytochrome P-450 reductase for cytochrome P- 
450 is further increased (French et al., 1980). It has been shown that the reduction of
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cytochrome P-450 by the cytochrome P-450 reductase as well as the relaxation rate of 
conformational changes of cytochrome P-450, are greatly enhanced by 
phosphatidylcholines with different fatty acid residues or a mixture of phospholipids 
(Taniguchi et al., 1979; Tsong and Yang, 1978; Yang and Tsong, 1980). Other reports 
(Haaparanta et al., 1980; Yang and Tsong, 1980) have demonstrated that the 
phospholipid-protein interaction is dependent on the fatty acid side chain of the 
phospholipid.
Phospholipids mav function in at least 3 different wavs:
1. Phospholipid mediated interactions between cytochrome P-450 and its 
corresponding reductase thus constituting a catalytically active arrangement.
2. Phospholipids modulate the electron transfer.
3. Phospholipids stabilise and/or induce a functionally active conformation of 
cytochrome P-450.
25
1 . 6 .2 . Role of the Fatty Acids.
The chain length and the degree of saturation of the fatty acid residues of the 
respective phospholipids determine the physical properties of the membrane, such as 
fluidity, and in this way modulate the activities of the membrane bound enzymes.The 
existence of two hydrocarbon chains per head group in the phospholipid helps the 
formation of bilayers whereas lipids which contain only one acyl chain, 
lysophospholipids, are unable to form bilayers and can even destroy bilayer structures 
(Cullis et al., 1985). The nature of the fatty acids can regulate oxidative drug metabolism 
in the liver endoplasmic reticulum (Rowe and Wills, 1976; Lambert and Wills, 1977a, 
b). In 1980, Wills demonstrated that the dietary lipid alters the rate of oxidative 
metabolism by modifications of the fatty acid composition of the endoplasmic reticulum, 
he suggested that the polyunsaturated fatty acids are important as a constituent of the 
membrane phospholipids, in holding the cytochrome P-450 in an active conformation in 
the membrane thus enhancing its efficiency. Maintaining rats on purified synthetic diets 
with decreased fat content markedly lowers cytochrome P-450 concentration and 
hydroxylating enzyme activity in liver microsomal fraction when compared to rats fed on 
stock pellets. When both groups are treated with phenobarbitone the difference is even 
greater, the purified fat free diets allowing only 50% of the cytochrome P-450 
concentrations of the controls. However the addition of herring oil, containing linoleic 
acid to the diets allows induction of the cytochrome P-450 to take place (Mar shall and 
McLean, 1971).
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1 .7 . TOTAL DEPENDENCE ON THE THREE ESSENTIAL COMPONENTS.
Since 1972 many studies have been carried out to isolate and investigate each 
component of the microsomal hydroxylation system individually.In the early 1970's 
Levin et al. (1974) and Coon et al. (1972) isolated cytochrome P-450 essentially free 
from reductase and phospholipids and reductase free from cytochrome P-450 and 
phospholipids. Levin et al. (1974) demonstrated a complete dependence on the three 
components (cytochrome P-450, NADPH-cytochrome P-450 reductase and 
phospholipid), for the hydroxylation of a variety of substrates. Early work in this 
laboratory has shown that all three components of the mixed function oxidase system are 
required for the full expression of sex dependent drug and steroid metabolism (Barr and 
Skett, 1984). They concluded that there is no one essential component of the 
microsomal drug hydroxylation system that can be ascribed with the responsibility of 
expressing sex differences in rat hepatic microsomal metabolism. Barr and Skett 
suggested that the choice of membrane in reconstitution studies of the system may be 
crucial to the quantitative and qualitative results obtained using partially pure and 
extensively purified cytochrome P-450 preparations. A role for the microsomal 
membrane lipids was postulated in the maintenance of sex differences in drug and 
steroid metabolism. This work showed a very complex interaction of proteins and lipids 
and proved difficult to interpret due to the three possible variables (Ban*, 1985).
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1 .8 . M ECHANISM  OF INTERACTION BETW EEN PHOSPHOLIPIDS 
AND THE PROTEIN COMPONENTS OF THE P-450 DEPENDENT 
M ONOOXYGENASE.
Since Lu et al. (1969a) succeeded in the solubilization of the rabbit liver 
microsomal mixed-function oxidase it has been well established that lipids are essential 
for its hydroxylating activity. The reconstituted system, consisting of the terminal 
oxidase cytochrome P-450, NADPH-cytochrome C (P-450) reductase and a heat-stable, 
organic solvent extractable factor, which later could be identified as phospholipid 
(Strobel et al.,1970), was found to catalyze fatty acid co-hydroxylation (Lu et al., 
1969b) and also the hydroxylation of hydrocarbons and the demethylation of drugs (Lu 
et al., 1969a). Neutral fats proved ineffective for reconstituting an active system but 
synthetic phosphatidylcholine was found as active as the crude extract. Extending these 
results, Strobel et al. (1970) observed that the proportion of reduced cytochrome P-450 
increased on addition of phospholipids to the assay mixture and that there existed a 
correlation between the extent of reduction and the lipid concentration. This relation has 
been quantitated with respect to hydroxylating activity by Ingelman-Sundberg and 
Glaumann (1977). All these data suggested that the most relevant function of 
phospholipids with respect to the substrate metabolism was in electron transfer 
processes. A lot of experimental data supported this working concept without solving 
the question of the mechanism of interaction. Ingelman-Sundberg (1977) demonstrated 
that phospholipids facilitate the NADPH-dependent, but also the sodium periodate 
supported, 6p-hydroxylation of androstenedione by a stabilization and/or induction of 
an active conformation of cytochrome P-450. He found that, in sodium periodate- 
supported 6p-hydroxylation of androstenedione, renaturable cytochrome P-450 was 
saturated with about 10 nmoles of phosphatidylcholine per nmole cytochrome P-450, 
whereas in NADPH-supported reactions saturation only occurs when a 
phosphatidylcholine/cytochrome P-450 ratio of 1000 was reached thus indicating
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different requirements for phospholipids in the two types of reaction (peroxidatic or 
monooxygenatic).
A similar requirement for phospholipids was also found for other cytochrome P- 
450 dependent activities. Williamson and O'Donnell (1969) demonstrated that 
phospholipids can stabilize cytochrome P-450, thereby preventing decomposition to the 
inactive P-420 and enhancing the rate of deoxycorticosterone lip-hydroxylation. 
Hydroxylation of testosterone in the 6p-, 7a- or 16 a-positions was also shown to 
depend highly on the presence of phospholipids in the assay system, as does the 3,4- 
benzpyrene hydroxylation (Lu and Levin, 1974). The relative unspecificity of the 
phospholipid/protein interaction is further supported by the well known fact that in 
reconstitution experiments cross substitutions, including phospholipids as well as 
reductase, are possible over a wide phylogenetic range (e.g. yeast-mammalian 
components) (Duppel et al., 1973; Duppell and Ullrich 1976). These results provide 
evidence for the functional importance of phospholipids. A role of the phospholipid 
component in substrate binding and control of substrate specificity was suggested by Lu 
et al. (1969a, b) who also reported on the influence of phospholipids on hydroxylation 
of benzphetamine and laurate (Lu et al., 1970) but could not detect any influence on the 
spectral binding constants of these two substrates. It was considered unlikely that the 
phospholipids are required for the binding of a substrate to cytochrome P-450 (Levin et 
al., 1974). Ristau et al. (1978) suggested that the phospholipids increase the affinity of 
cytochrome P-450 to bind substrates. DePierre and Emster (1975) demonstrated that 
laurate and unsaturated fatty acids are able to compete with type I substrates for the 
binding sites thereby inhibiting the metabolism of type I compounds. No such effect 
was observed with aniline (a type II substrate). On the other hand, Haaparanta et al. 
(1980) demonstrated that the acidic phospholipids are more active than neutral ones in 
cytochrome P-450 LM2-catalysed O-demethylation of 7-ethoxycoumarin and 
hydroxylation of benzo(a)pyrene. Strobel et al. (1970) have reported that the lipid
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component is essential for the electron transfer from NADPH to cytochrome P-450. One 
can conclude from these studies that the phospholipid, due to its highly ordered bilayer 
structure, not only mediates a functional linkage between proteins by its amphipathic 
environment but, rather more importantly, orientates the proteins in a specific manner 
within the bilayer. Therefore the phospholipid function in mediating the electron transfer 
is an indirect one and indicates protein-protein interactions involved therein. Negatively 
charged phospholipids may be responsible for recognition and regulation processed by 
charge compensation, which include the possibility to regulate enzymatic activity by 
metabolic processes (Ingelman-Sundberg et al., 1980).
1 .9 . MECHANISM OF MIXED FUNCTION OXIDATION.
Phospholipid appears to be crucial to membrane activities requiring two or more 
protein components. For example, cytochrome c reduction can be reconstituted by 
recombining the two proteins (cytochrome P-450 and NADPH-cytochrome C (P-450) 
reductase) in the presence of phospholipid. Furthermore, acetone treatment of 
microsomes (which extracts phospholipids) was found to abolish the NADPH- 
cytochrome c reductase activity, but not the NADH-K3Fe(CN)6 reductase activity,
indicating that phospholipid is required for the transfer of electrons from the flavoprotein 
to the cytochrome. This activity could be restored by the addition of a mixture of 
phosphatidylcholine and lysophosphatidylcholine to the delipidated preparation. These 
data thus indicated that the enzyme system described above requires the protein 
components plus microsomal lipid (Jones et al., 1969). Cytochrome P-450-dependent 
systems catalyze the oxidation of a variety of relatively hydrophobic compounds of both 
endogenous and exogenous origin. These include steroids, fatty acids, a large number 
of drugs and carcinogens. A typical hydroxylation reaction is shown below (Omura et 
al., 1967).
3 0
2H+ +R-H + 0 2 + 2e" -> R-OH + H20
The aliphatic or aromatic substrate (R-H) is hydroxylated, requiring molecular 
oxygen plus two electrons. One atom of oxygen is inserted into the substrate (Coon et 
al., 1973a,b), while a second is incorporated into water. The system can also catalyze 
epoxidations, N-oxidations, sulfoxidations, peroxidations, and N-, S-, and O- 
dealkylations. There are a moderately large number of microsomal cytochromes P-450, 
each apparendy with its own range of substrate specificities. In general, each of these 
microsomal cytochromes tends to be rather nonspecific, in contrast to some of the 
mitochondrial cytochromes P-450. The catalytic cycle for a generalised cytochrome P- 
450, a modification of that originally proposed by Estabrook et al. (1970), is shown in 
figure 1.4. (Lambeth 1985). Substrate binding to the oxidized (ferric heme) enzyme is 
followed by reduction to the ferrous heme enzyme. Oxygen becomes bound to the 
ferrous enzyme, and a second electron is donated to the system, resulting in the 
production of a powerful oxidising species at the active site which then hydroxylates the 
bound substrate. For more details about the proposals for the nature of the 
hydroxylating species see review by White and Coon, (1980). The electrons can be 
donated to the cytochrome by the flavoprotein NADPH-cytochrome P-450 reductase. In 
cytochrome P-450-containing reconstituted systems, this reductase, in the presence of 
phospholipid, can provide electrons for hydroxylating activity (Omura et al., 1966; Lu 
and Coon, 1968). Based upon a synergestic effect of NADPH and NADH in 
microsomes, Hildebrandt and Estabrook, (1971), proposed that the second electron in 
the catalytic cycle (figure 1.4.) can be provided by cytochrome b^. In support of this
proposal, Sugiyama et al. (1980) have purified a cytochrome P-450 from microsomes 
which shows an absolute activity requirement for both the NADPH-specific flavoprotein 
and the NADH-specific cytochrome b5 system.
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Figure 1.4.
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1 .9 .1 .  Site of Lipid Function.
Lu et al. (1969b) have suggested that the phosphatidylcholine does not serve as a 
substrate when added to cytochrome P-450 and it does not cause any spectral changes.
It has no effect on the dissociation constant of the cytochrome P-450-benzphetamine 
complex (Lu et al., 1970) or the cytochrome P-450-laurate complex (Lu et al., 1969b).It 
is unlikely that the phospholipid is required for the binding of substrate to cytochrome 
P-450 since the partially purified cytochrome P-450 has less than 1 nmole phospholipid 
per nmole P-450 (Levin et al., 1974). It still gives type I and II binding spectra with a 
variety of substrates (Strobel et al., 1970). Coon et al. (1973b) have reported that the 
lipid component is essential for electron transfer from NADPH to cytochrome P-450 
(figure 1.4.). Since the phosphatidylcholine is obviously not an electron carrier, the 
mode of action is still unknown. Lu and Levin (1974) speculated that the phospholipid 
may function in some manner to facilitate the transfer of electrons from the reductase to 
cytochrome P-450.
1 .1 0 . SEX DIFFERENCES IN HEPATIC DRUG METABOLISM.
The action of a variety of drugs are more pronounced and persist longer in the 
female than the male rat (Kato,1974). The main mechanism of such sex differences is the 
differences in the activity of microsomal drug metabolising enzymes in rat liver (Conney et 
al., 1965; Kato and Gillette, 1965; Kato et al., 1962). Although the drug-metabolising 
enzymes from rat liver microsomes metabolise a variety of drugs, Kato and Gillette (1965) 
showed that the magnitude of sex differences is dependent on the substrates and metabolic 
pathways, i.e., the N-demethylation of aminopyrine and the aliphatic hydroxylation of 
hexobarbital are 3.5-fold higher in male rats than in females, whereas there is little or no sex 
differences in the hydroxylation of aniline. Bjorkhem and coworkers, (1974; 1976) and 
Kato and Takahishi (1968) showed that there is a slight sex differences in the NADPH
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cytochrome C (P-450) reductase activity and cytochrome P-450 content of rat liver 
microsomes. It is generally thought that if differences in reductase activity do exist they are 
of secondary importance to the difference seen in cytochrome P-450 (Lu and West, 1980). 
Early work in this laboratory has shown that sex-specific NADPH cytochrome C (P-450) 
reductase is required for the full expression of sex-dependent drug and steroid metabolism 
(Barr and Skett, 1984). It has been suggested that androgen may induce some species of 
cytochrome P-450 capable of metabolising rapidly a variety of drugs, which show clear sex 
differences in their metabolism (Kato and Onoda 1970). Androgens were found to be 
involved in the regulation of sexually differentiated drug and steroid metabolism when Yates 
and associates (1958) found that castration of male rats reduced the activity of these 
enzymes towards the female level of metabolism. Androgenic control of metabolism has 
been reported using a number of substrates e.g. ethylmorphine N-demethylase (Castro & 
Gillette, 1967), hexobarbitone (Conney et al., 1965). Two sexually differentiated forms of 
cytochrome P-450 have been purified to homogeneity from untreated male and female rats 
respectively; 16oc-hydroxylase (Morgan et al., 1985), and 15P-hydroxylase (MacGeoch et 
al., 1984). Of all the cytochrome P-450-dependent activities of rat liver microsomes that 
show sex differences, the steroid 16a-hydroxylase has been the most thoroughly 
characterised in terms of its hormonal regulation (Skett, 1977; Skett et al., 1979; Colby, 
1980; Morgan et al., 1985) although the 15p-hydroxylase is also under hormonal regulation 
(MacGeoch et al., 1984). Almost all cytochrome P-450-catalysed reactions have been found 
to be more efficient in male than in female rat liver except the 15p-hydroxylase activity 
which was found to be present at high level in female microsomes and undetectable in the 
male and immature female (Gustafsson and Ingelman-Sundberg, 1974). Sex differences in 
the metabolism of steroids have also been well documented (Yates et al., 1958, Conney et 
al., 1965, Einarsson et al., 1973). Similarly sex differences in drug metabolism have been 
shown to correlate to sex-dependent lipid differences (Belina et al., 1975). Preliminary 
work has indicated that the lipid environment may affect the activity of these sex-dependent
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enzymes and lead to a disappearance of the sex differences (Barr, 1985). It is well known 
that cytochrome P-450 requires phospholipids for activity (Lu et al., 1970; Strobel et al., 
1970), and phospholipids affect the substrate binding of cytochrome P-450 (Chaplin and 
Mannering, 1970; Estabrook et al., 1971) and the interaction with NADPH-cytochrome P- 
450 reductase (Autor et al., 1973). Thus, the lipid component of liver microsomes can be 
regarded as a determinant of the activity of cytochrome P-450> ' .
Generally, males exhibit higher oxidative metabolic activities than females. The 
hepatic metabolism of drugs and xenobiotics (e.g. ethylmorphine (Castro, and Gillette,
1967), aniline, (El Defrawy El Masry et al., 1974), 7-hydroxycoumarin, (Kamataki et al., 
1980), lignocaine and imipramine (Skett et al., 1980)), as well as steroid hormones, 
(Gustafsson (1973); Gustafsson and Eriksson (1971)) in the rat, have been shown to be 
sex-differentiated (Gustafsson and Ingelman-Sundberg, 1975). Lignocaine is a substrate 
which has been shown to possess sex differences in metabolism; it exhibits a male-specific 
N-deethylation and a sexually independent 3-hydroxylation, (figure 1.5., von Bahr et al., 
1977). It, thus, is ideal for the study of the maintenance of sex differences in drug 
metabolism as there is an inbuilt control activity for direct comparison. The use of 
lignocaine as a substrate in this project was suggested by the continuing research in this 
department into the hormonal control of drug metabolism, (Skett and Gustafsson, 1979; 
Gustafsson et al., 1983; Skett and Young, 1982; Skett and Weir, 1983; Skett et al., 1984; 
Skett and Joels, 1985; Skett and Barr, 1985) which shows that, the rate of N-deethylation 
was faster in the male microsomes than the female microsomes, whereas the rate of the 3- 
hydroxylation activity was similar in both sexes.
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FIGURE 1.5.
The phase one hepatic microsomal metabolism of lignocaine.
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1 .1 1 . EFFECT OF STREPTOZOTOCIN-INDUCED DIABETES
MELLITUS ON HEPATIC DRUG METABOLISM IN RAT.
j
Insulin-dependent diabetes induced by either alloxan or streptozotocin alters drug 
metabolism in rat liver (Dixon et al., 1961; Dixon et al., 1963; Reinke et al., 1978; Past 
and Cook, 1982). Learning et al. (1982) showed that conversion of 
dehydroepiandrosterone to androst-4-ene-3,17-dione and testosterone was enhanced in 
streptozotocin-treated animals, the same treatment can cause an increase in oestradiol 
metabolism. Cholesterol 7 a-hydroxylase activity is enhanced by STZ treatment 
(Subbiah and Yunker, 1984), on the other hand 5 a-reductase is unaffected by the same 
treatment (Warren et al., 1983). Steroid and drug metabolism by the rat liver is known 
to be sex-dependent (Kato, 1974; Gustafsson et al., 1980; Colby, 1980) and the effect 
of diabetes on hepatic metabolism of type I substrate such as aminopyrine and 
ethylmorphine (Schenkman et al., 1980) is also sex dependent (Kato and Gillette, 1965; 
Reinke et al., 1978; Faas and Carter, 1980). The effects of diabetes mellitus have been 
shown to be sex-dependent with regard to drug metabolism (Dixon et al., 1961; Kato 
and Gillette, 1965; Skett and Joels, 1984). In 1986, Skett demonstrated the effect of 
STZ-induced diabetes mellitus on 4-androstene-3,17-dione metabolism using male 
animals and showed that the 7a-hydroxylase activity was increased but the 6£- and 
16a-hydroxylases were decreased and 5a-reductase was unaffected. Female animals 
were unaffected by the same treatment. Skett (1986) indicated that the effects seen in the 
male rats were always sex-dependent, i.e. only the male-specific activities were 
decreased and only in the male ra t
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1 . 12 .  MICROSOMAL PHOSPHOLIPID COMPOSITION IN THE 
STREPTOZOTOCIN DIABETIC RAT.
Rat liver microsomal fatty acid composition and fatty acid desaturation were 
studied in streptozotocin diabetic rats (Faas and Carter, 1980; 1983; Holman et al., 1983) 
and it was found that diabetes changes the fatty acid composition of rat liver microsomal 
phospholipid. It was demonstrated that fatty acids such as linoleic and docosahexaenoic 
acids were increased whereas palmitoleic, oleic and arachidonic acids decreased in the 
major microsomal phospholipids (Faas and Carter, 1980; 1983). However, Faas and 
Carter in 1983 suggested that most of these changes in fatty acid composition in the 
diabetic rat are caused by the diminished fatty acid desaturase activities, since the fatty 
acid composition can be overcorrected by insulin therapy with the exception of the 
diminished arachidonic acid which was further decreased following insulin therapy. 
Several authors (Nelson, 1980; Mathur et al., 1983) have demonstrated that the 
phospholipid fatty acid composition plays an important role in the membrane fluidity and 
in the enzyme activities.
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1 .1 3 . PURPOSE OF PROPOSED STUDY:
These may be summarised as follows:
1. To confirm the existence of sex differences in rat hepatic microsomal metabolism of 
lignocaine (Skett & Young, 1980).
2. To purify the essential components of the microsomal mixed function oxidase system 
from male and female rats and reconstitute a functionally active drug hydroxylation 
system.
3. To reconstitute the system in such a way as to investigate the role of cytochrome P-450 
and microsomal lipid in the expression of sex differences.
4. To separate and analyse the microsomal lipids and use the separated fractions to 
reconstitute the enzyme activities to ascertain the role of sex dependent lipids in the 
modulation of microsomal enzyme activity.
5. To separate and analyse the microsomal lipids and use the separated fractions to 
reconstitute the enzyme activities to ascertain the exact nature of the protein-lipid 
interaction.
6. To separate and analyse the microsomal lipids from both male and female rats to 
establish whether the male microsomal lipid and the female microsomal lipid differ in 
their composition.
7. To investigate the effect of using lipids with different acyl chain (saturation and length) 
on the microsomal enzyme activity.
8. To study the effect of pathological conditions (eg diabetics) on the microsomal enzyme 
activity by modifying the microsomal lipid composition.
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MATERIALS A N D  METHODS
2 .1 .  GENERAL MATERIALS.
The materials used during the course of this study and their respective 
suppliers are described in the following section. All other chemicals were of analytical 
grade purity.
2 .1 .1 .  Autoradiography Materials.
X-ray Film X-Omat S (France), X-ray Developer D-19, X-ray Fixer FX-40 
were supplied by Kodak (U.K.) Ltd., London.
2 .1 .2 .  Chromatography.
Bio-Gel P-30 and Hydroxylapatite (Bio-Gel HTP) were obtained from Bio-Rad 
Laboratories, California, USA.; Sephadex G-50 purchased from Sigma Chemical Co. 
Ltd., Poole, Dorset, U.K.; DEAE-Cellulose DE52 purchased from Whatman 
International Ltd, England and 2'5'-ADP Sepharose 4B obtained from Pharmacia Fine 
Chemicals, Sweden.
2 .1 .3 .  Electrophoretic Materials.
Acrylamide, 2-mercaptoethanol, Coomassie Brilliant Blue R-250, N, N'- 
methylene bis acrylamide, N, N, N’N'-tetramethylenediamine (TEMED) and 
ammonium persulphate were obtained from Sigma Chemical Co. Ltd., Poole, Dorset, 
U.K
2 .1 .4 .  R adioisotopes.
[Carbonyl-14C]-lignocaine and 4-[4-14C]-Androstene-3,17-dione purchased 
from Amersham International, Amersham, Bucks.
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2 .1 .5 . Fine Chemicals.
Dithiothreitol (DTT), Sucrose, Potassium chloride, di-Potassium hydrogen 
orthophosphate, Potassium di-hydrogen orthophosphate purchased from Koch Light 
Laboratory, Colnbrook. Ammonium Molybdate, Cholic Acid (Sodium Salt) and 
NADPH were obtained from Sigma, Chemical C o ,. Ltd., U.K. EDTA was purchased 
from Hopkins and Williams and glycerol was from May and Baker. Emulgen 913 was 
the kind gift of Dr G. Gibson. Ecoscint was supplied by National Diagnostics, 
Manville, New Jersey. The kit for measurement of serum glucose was purchased from 
Sigma Chemical Co. Ltd., Poole, Dorset, U.K.
2 .1 .6 .  Lipids and Fatty Acids.
L, a-dilauroylphosphatidylethanolamine, L, a-dilauroylphosphatidylcholine, L, 
a-dioleoylphosphatidylcholine, L, a-dicaproylphosphatidylcholine, L, a-dibehenoyl- 
phospha-tidylcholine, L, a-diarachidoylphosphatidylcholine, L, a-distearoylphospha- 
tidylcholine, arachidonic acid, palmitic acid, heneicosanoic acid and oleic acid, supplied 
by Sigma Chemical Co. Ltd., Poole, D orset, U.K.
2 .1 .7 .  Proteins.
Cytochrome C, Bovine serum albumin (BSA), Albumin bovine 67000; Egg 
Albumin 45000; Pepsin 34700 and Trypsin 24000 were supplied by Sigma, 
Chemical C o ,. Ltd., U.K.
2 .1 .8 .  Substrates.
Lignocaine was kindly donated by Astra Lakemedel AB, Sodertalje, Sweden. 4- 
androstene-3,17-dione and streptozotocin were purchased from Sigma Chemical Co. 
Ltd., Poole, Dorset, U.K.
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2 .2 .  EXPERIMENTAL ANIMALS.
All rats used throughout the study were mature Wistar stock bred in the 
departmental animal house (males 300-350 g and females 225-250g body weight). They 
were kept in a controlled environment; temperature 19±1°C, 12 hours light (0700- 
1900), 12 hours dark (1900-0700), with free access to drink (tap water) and food (CRM 
Nuts, Labsure, Croydon, U.K.).
2 .3 . PREPARATION OF MICROSOMES.
2 .3 .1 .  Preparation of Post-Mitochondrial Supernatant.
Animals were killed by C 02 asphyxiation followed by cervical dislocation. The
livers were removed immediately and cooled in ice cold 0.25 M sucrose. The livers were 
rinsed in 0.25 M sucrose, dried with blotting paper and weighed. All subsequent steps 
were carried out at 4°C. The livers were then roughly chopped using scissors in four 
volumes of 0.25 M sucrose (4mls buffer to 1 gm wet weight of liver). The liver was 
homogenised in the same buffer using a Potter-Elvehjem homogeniser with loose-fitting 
Teflon pestle with a clearance of 0.40-0.45 mm and driven at 10, 000 rpm by a TRI-R 
STIR-R motor, model S63C (Rockville Centre, New York). 10 complete strokes were 
used to homogenize the liver by this method. The homogenate was centrifuged in an 
MSE HI-SPIN 21 centrifuge using a type 143 Rotor with an average centrifugal force of 
13, 000 x g for 20 minutes. This step is considered to remove cell nuclei, mitochondria 
and large fragments of cellular debris. The supernatant of this spin was decanted and 
kept, the pellet being discarded. The preparation thus produced was the 
postmitochondrial supernatant.
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2 .3 .2 .  Preparation of Microsomes by Ultracentrifugation.
The microsomal fraction of the liver was prepared by ultracentrifugation as 
described by Berg and Gustafsson, (1973). Postmitochondrial supernatant was 
dispensed into 5/8"x3" cellulose nitrate tubes (Beckman Instruments Inc., Palo Alto, 
California) which were then tightly capped. Twelve of these tubes were inserted into a 
Beckman 70Ti Rotor (in a Beckman Model L8-55M refrigerated ultracentrifuge) and 
spun at 105, 000 x g for 1 hour at 4°C. After the spin the supernatant (cytosol) was 
discarded, the pellet (microsomes) was treated as described below.
2 .3 .3 .  Removal of Haemoglobin From Microsomes.
Removal of haemoglobin from microsomes was by the method of Mihara and 
Sato (1978). One pellet was resuspended in 6 mis of buffer containing 10 mM EDTA 
and 1.15 % (w/v) KC1.
Resuspension was carried out using the Potter-Elvehjem homogenizer, three 
strokes were sufficient to return the microsomes to suspension. The suspension was 
then centrifuged at 105, 000 x g for 1 hour at 4°C as described above and the 
supernatant was discarded. The pellet containing the washed microsomes was 
subsequently used as detailed below.
2 .3 .4 .  Solubilisation of Microsomes.
Haemoglobin-free microsomes, were resuspended in 10 volumes of buffer 
(containing 20% glycerol, to prevent conversion to the inactive P-420 form, ImM 
EDTA to inhibit lipid peroxidation, 1 mM dithiothreitol to keep sulphydryl groups in the 
reduced state in 0.1 M potassium phosphate buffer at pH 7.25) at a protein concentration 
of approximately 10 mg/ml. The microsomal membrane proteins were solubilised by the 
careful addition of 10% (w/v) sodium cholate solution in a dropwise manner to the 
washed microsomal suspension while stirring the mixture on ice and under a constant
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flow of oxygen-free nitrogen to prevent haem destruction arising from lipid 
peroxidation.
The sodium cholate was added to a final concentration of 1.8% (w/v) and the 
mixture was left stirring for a further 30 minutes. The solubilised preparation was 
centrifuged at 105,000 X g for 60 minutes at 4°C (in a Beckman Model L8-55M 
refrigerated ultracentrifuge) to remove unsolubilised material. The supernatant is referred 
to as the solubilised microsomes.
2 .3 .5 .  Concentration of Solubilised Microsomes.
Concentration of the mixed function oxidase enzymes in solubilised microsomes 
was carried out by the addition of solid ammonium sulphate to 80% saturation, the 
mixture was left on ice for 30 minutes and then centrifuged at 2, 500 x g for 10 minutes 
and the plug produced at the top was removed carefully and resuspended in 1 ml of 
0.1M potassium phosphate buffer at pH 7.25 containing 20% glycerol, 1 mM EDTA, 1 
mM dithiothreitol and 1.8% sodium cholate.
2 .3 .6 .  Delipidation of Concentrated Solubilised Microsomes.
5g of Bio-Rad P-30 was suspended in 200 ml of elution buffer containing 0.1M 
potassium phosphate pH 7.25, 20% glycerol, 1 mM EDTA, and 0.7% sodium cholate 
and left in a cold room for 24-48 h. The packing of the column was carried out in the 
cold room and equilibrated using the elution buffer. The solubilised preparation was 
delipidated by applying a 1 ml sample (to which sucrose had been added to increase the 
density) to the Bio-Gel P-30 column (1.5 x 50 cm) and eluting with 0.1M potassium 
phosphate buffer at pH 7.25 containing 20% glycerol, 1 mM EDTA, and 0.7% sodium 
cholate at a flow rate of 0.1 ml/min. Delipidated samples could be detected easily since 
they were yellowish in colour. Samples were normally combined and assayed for 
microsomal protein, lipid phosphorus and subsequently used directly for reconstitution.
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2 .4 .  CYTOCHROME P-450 ISOZYME 2C PREPARATION.
2 .4 .1 .  Preparation of DE52 Column.
DE52 (DEAE-cellulose) was purchased from Whatman international Ltd., 
Maidsone, Kent, England. The first stage in the preparation of the gel for ion- exchange 
chromatography purposes is to remove the fines. Fines are small fibres which, if not 
removed, block the flow of buffer through the column. The fines were removed by 
mixing approximately 53g of the cellulose gently in concentrated potassium phosphate 
buffer (0.2 M) and allowing the mixture to settle for 2-3 minutes About 15-30 ml of the 
buffer were used for every gram of dry cellulose powder and the pH of the buffer was 
adjusted to 7.4 using the acidic or basic components of the buffer mixture. The fines 
remaining in the supernatant above the slurry were carefully poured away and 600 ml of 
the same buffer was added to the cellulose. The suspension was transferred to a 
measuring cylinder, the volume of the gel was noted and the mixture was made up to
1.5 volume . The column was set up vertically in an area free of draughts, direct 
sunlight, and other heat sources and the stirred slurry was poured into the column. It is 
essential that, from the moment of pouring the slurry into the column to the stage of 
having a settled column bed of gel, the operations are carried out as quickly as possible 
otherwise convection currents will form in the slurry which cause a very slow flow rate, 
peaks overlap and incomplete separation.
The packing of the column was carried out at room temperature and equilibrated 
using the starting buffer (containing 10 mM potassium phosphate pH 7.4, 20% (v/v) 
glycerol, 0.5% sodium cholate, 0.2% Emulgen 913 and 0.1 mM EDTA).
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2 .4 .2 .  Preparation of Solubilised Microsomes.
Male rats were killed and the microsomal fraction of the liver prepared by the 
ultracentrifugation method as described in the section 2.2.2. Haemoglobin was removed 
from the microsomes as described above in section 2.2.3. and the pellet was 
resuspended in buffer (containing 20% glycerol, ImM EDTA in 0.13M potassium 
phosphate buffer at pH 7.4) at a protein concentration of approximately 10 mg/ml. The 
microsomal membrane proteins were solubilised by the careful addition of 10% (w/v) 
sodium cholate solution in a dropwise manner to the washed microsomal suspension 
while stirring the mixture on ice under a constant flow of oxygen-free nitrogen. The 
sodium cholate was added to a final concentration of 2.3 % (w/v) and the mixture was 
left stirring for a further 40 minutes. The solubilised preparation was centrifuged at 
105,000 x g for 60 minutes at 4°C in a Beckman L8-55M ultracentrifuge to remove 
unsolubilised material. The supernatant is referred to as the solubilised preparation.
2 .4 .3 .  Polyethyleneglycol (PEG) 6000 Fractionation.
The solubilised preparation (168 ml) was fractionated by the careful addition of 
30 ml 50% PEG 6000 in a dropwise manner while stirring the mixture on ice over a 10 
minute period, and the mixture was centrifuged at 20,000 x g for 25 minute in a MSE HI- 
SPIN 21 centrifuge. The pellet was discarded and 11.5 ml of 50% PEG 6000 were added 
slowly to the supernatant, stirred for 10 min and centrifuged at 20,000 x g at 4°C for 12 
minutes. The pellet was again discarded. Finally 61.5 ml of 50% PEG 6000 were added 
in a dropwise manner to the supernatant, the mixture was stirred for 10 minutes then 
centrifuged at 20,000 x g for 12 minutes. The pellets were resuspended to a volume of 
60 ml in buffer A (containing 10 mM potassium phosphate pH 7.4, 20% glycerol, 0.5% 
sodium cholate, 0.2% Emulgen 913 and O.lmM EDTA). The preparation was dialysed 
overnight at 4°C against 1 litre of lOmM potassium phosphate pH 7.4 buffer 
(containing, 20% glycerol, 0.5% sodium cholate, 0.2% Emulgen 913 and O.lmM 
EDTA).
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2 .4 .4 .  DE52 Column.
The male-specific isozyme of cytochrome P-450 was prepared from the PEG 
6000 fraction by the method of Waxman, (1984). The fraction was applied to a column 
of Whatman DE52 resin (1.5 X 50 cm prepared as described in section 2.4.1.) at a flow 
rate of 30 ml/hr. The column was washed with 60 ml of buffer A (lOmM potassium 
phosphate pH 7.4 containing, 20% glycerol, 0.5% sodium cholate, 0.2% Emulgen 913 
and 0.1 mM EDTA) to ensure the quantitative transfer of the protein to the column and 
then eluted with 500 ml of buffer A + 20 mM KC1. At this point two yellow bands at 50 
to 70 % of the way down the column and a red band (containing cytochrome b5) at the
top could be seen. Fractions of < 10 ml were collected and monitored at 417 and 295 
nm. Fractions with an A417:295 > 1 were collected.
2 .4 .5 .  Hydroxylapatite Column.
Fractions collected from the DE52 column were analysed by SDS-PAGE gel 
electrophoresis (see section 2.15) and homogeneous fractions were combined and 
dialysed overnight at 4°C against more than 10 volumes of buffer B, containing 10 mM 
potassium phosphate pH 7.4, 20% glycerol, 0.2% Emulgen 913 and 0.2 mM EDTA. 
The fractions were subsequently applied to a hydroxylapatite (Bio-Rad HTP purchased 
from Bio-Rad Laboratories California, USA) column (1.5x3 cm), equilibrated in the 
same buffer at a flow rate of 15 ml/hr and run at room temperature (Waxman and Walsh, 
1983). The hydroxylapatite column was washed with 50 ml of buffer B+35 mM 
potassium phosphate followed by 40 ml buffer B+45 mM potassium phosphate and 40
ml of buffer B+70 mM potassium phosphate. Finally the isozyme was eluted with 120
ml buffer B+120 mM potassium phosphate.Pooled fractions of cytochrome P-450 were 
dialysed overnight against 1 litre of 50 mM potassium phosphate pH 7.4 buffer 
containing 20% glycerol and 0.1 mM EDTA and stored at -20°C in the dark under a 
nitrogen atmosphere.
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2 .4 .6 .  Detergent Removal.
Detergent was removed from the male-specific cytochrome P-450 isozyme 
preparation by absorption onto a hyroxylapatite (1 x 1.5 cm) column and eluting with 
0.2 M potassium phosphate buffer at pH 7.4 containing 20% glycerol, 1 mM EDTA, 
and 0.7% sodium cholate (buffer C) at a flow rate of 15 ml/hr as described by Cheng 
and Schenkman, (1982). Samples were dialysed against 2 x 20 volume of buffer C 
containing 10 mM potassium phosphate pH 7.4, 20% glycerol, 0.5% sodium cholate 
and then applied to a hydroxylapatite column (1 x 1.5 cm) which had been equilibrated 
in the same buffer. Removal of detergent (detected by monitoring the eluent at 280 nm) 
was accomplished by washing with buffer C until the absorption of the eluant at 280 nm 
was equivalent to that of buffer C. The cytochrome P-450 isozyme was eluted as a 
relatively sharp band using 0.5 M potassium phosphate buffer pH 7.4 containing 20% 
glycerol and 0.1 mM EDTA. The preparation was finally dialysed against 100 volume of 
50 mM potassium phosphate buffer pH 7.4 containing 20% glycerol and 0.1 mM EDTA 
and stored in small fractions in the dark under nitrogen at -20°C. Thawing and 
refreezing of the fractions was avoided as much as possible.
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2 .5 .  NADPH CYTOCHROME C(P-450) REDUCTASE PREPARATION.
NADPH Cytochrome C (P-450) reductase was prepared by the method 
described by Shephard et.al (1983). Male mature Wistar rats were fed a 0.1% (w/v) 
solution of sodium phenobarbital instead of tap water for 7 days. Total microsomal 
vesicles were isolated as described above (section 2.2.2.), the microsomal membrane 
pellet was resuspended at a final protein concentration of about 20 mg/ml in a 10 mM 
potassium phosphate buffer pH 7.25 (containing 20% glycerol, 1 mM dithiothreitol, 1 
mM EDTA 2 p.M flavin mononucleotide), and solubilised as described above (section
2.2.4.).
2 .5 .1 .  Purification Procedure.
Solubilised membrane vesicles (350 ml), at a protein concentration of 1.5 
mg/ml, were loaded (at 15 ml/h) onto a column (1.5 X 3 cm) of 2 ', 5'-ADP sepharose 
4B (Pharmacia Fine Chemicals AB, Uppsala, Sweden) which had been equilibrated at
o
4 C with 100 ml of a buffer containing 10 mM potassium phosphate, pH 7.25, 20% 
glycerol, and 1 mM EDTA. After loading the sample the column was washed 
extensively with the same buffer and eluted by washing firstly with 250 ml of a solution 
containing 0.3 M potassium phosphate pH 7.7, 20% glycerol, 0.1 mM EDTA, 0.1% 
Lubrol PX, and then 350 ml of a solution containing 30 mM potassium phosphate, pH
7.7, 0.1 mM EDTA, 20% (v/v) glycerol, 0.15% (w/v) sodium deoxycholate. During 
this washing procedure, the colour of the column turned from dirty brown to bright 
yellow.The enzyme was subsequently eluted at a flow rate of 30 ml/hr with a solution 
containing 30 mM potassium phosphate pH 7.7, 0.1 mM EDTA, 20% (v/v) glycerol, 
0.15% (w/v) sodium deoxycholate, 5 mM 2’-AMP, and 0.4 mM PMSF 
(phenylmethanesulfonyl fluoride). Fractions with an A455:380 ratio > 1 were pooled 
together.
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The enzyme eluted in a volume of approximately 15 ml and was dialysed for 48 
hours against 100 volume of 30 mM potassium phosphate, pH 7.7, 0.1 mM EDTA, 
20% glycerol. The dialysis buffer was changed once. Protein purity was analysed by 
SDS-PAGE as described by Laemmli (1970) and in section 2.15. The enzyme was 
stored in aliquots in the presence of 0.4 mM PMSF (phenylmethanesulfonyl fluoride) in
o
small fractions in the dark under nitrogen at -20 C. Thawing and refreezing of the 
fractions was avoided as much as possible.
2.6. ULTRAFILTRATION OF THE PURIFIED M ICROSOM AL PROTEIN.
Purified preparations were routinely concentrated to obtain the protein at useable 
stock concentrations. A clean membrane with a molecular weight exclusion cut off 20, 
000, which had been moistened in water, was placed in an ultrafiltration cell (Micro 
Filtration System, California). The cell was attached to a cylinder of nitrogen via high 
pressure tubing. The protein solution was poured into the chamber and concentrated 
under 30PSI pressure.
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2 .7 .  EXTRACTION OF WHOLE MICROSOMAL LIPID.
Total microsomal lipid was extracted by a two step procedure (Folch et al. 
(1957); Bligh and Dyer, (1959) as detailed by Overturf and Dyer, (1969).
One gram of liver was homogenised with 10 ml of methanol for 1 minute, then 
20 ml of chloroform was added and the process continued for a further 2 minutes. The 
mixture was filtered and the solid residue resuspended in chloroform-methanol (2:1 v/v, 
30 ml) and homogenised for 3 minutes. After filtering, the solid was washed once more 
with chloroform (20 ml) and once with methanol (10 ml). The combined filtrates were 
transferred to a measuring cylinder and to the filtrate was added one quarter of the total 
volume of 0.88% potassium chloride in water. The mixture was shaken thoroughly and 
allowed to settle. The upper layer was removed by aspiration and to the lower layer was 
added one quarter of the volume of water-methanol (1:1) and the washing procedure 
repeated. The lower phase, containing the purified lipid, was transferred to a dry 
evaporating cylinder and connected to a Buchi Rotavapor-R. The solvent was partially 
evaporated off under vacuum in a water bath at 30° C. When the solution was 
concentrated to 10 ml, a 0.5 ml aliquot were removed and placed in a previously 
weighed test-tube. The solvent was completely evaporated off under nitrogen at 30°C. 
The lipid mixture was stored in the dark at -20°C in chloroform at a concentration of 10 
mg/ml under a nitrogen atmosphere.
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2 .8 .  FRACTIONATION OF LIPIDS ON SILICA GEL.
The lipid mixture was fractionated as described by Rouser et al. (1970)
2 .8 .1 .  Column Preparation.
A slurry was prepared of 15-20 g silica gel 60 (70-200 mesh, Merck F 254) 
(preheated at 120°C for 2 h before use) in about 30-50 ml chloroform and poured into a 
1x30 cm glass chromatography tube. The solvent level was allowed to drop to the top of 
the silica gel, and the bed was washed with 2 vols. of chloroform.
2 .8 .2 .  Application of the Sample and Elution of the Column.
A solution of 200-250 mg of total lipids in 5 ml of chloroform was placed gendy 
on the top of the column and allowed to run into the column. Chloroform (1-2 ml) was 
then added to ensure quantitative transfer of the lipid mixture to the column. The elution 
of the column was carried out with chloroform (10 column volumes) to elute neutral 
lipids; and methanol (10 column volumes) to elute phospholipids. The total volume of 
each solvent was collected for monitoring by TLC and phosphorus content
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2 .9 .  SEPARATION OF PHOSPHOLIPIDS BY THIN LAYER
CHROM ATOGRAPHY.
The phospholipid fractions prepared as in section 2.7 were separated by a 
modification of the method of Yavin and Zutra, (1977). For this technique three organic 
solvent mixture were prepared:
A) chloroform:methanol:40% aqueous methylamine (13:6:1.5) (v/v/v).
B) diethylether:acetic acid (glacial) (19:1) (v/v).
C) chloroform:acetone:methanol:acetic acid (glacial):distilled H2O
(10:4:2:3:1) (v/v/v/v/v).
All three organic solvent mixtures were freshly prepared.
Lipids were dissolved in 0.1 ml of chloroform:methanol (9:1, v/v) and 
spotted on silica-gel t.l.c. plates (10 cm x 10 cm) (Silica Gel 60, thin layer 
chromatography plate (Merck F254)) for two dimensional separation of phospholipids. 
The glass chromatographic chambers were equilibrated with the solvent mixtures 
(approximately 200 mis in total) 2 hrs before commencing the separation. Phospholipid 
samples were applied at the lower left hand comer (2 cm in), using a 10 |il disposable 
micro-pipette and the solvent dried in a stream of warm air. A total of 8 plates could be 
run in one batch. After a period of approximately 25 minutes in solvent A, by which 
time the solvent front was within 1 cm of the edge of the plate, the plates were removed 
and dried in a stream of warm air for 10-15 min. Each plate was then exposed to the 
fumes of a concentrated solution of HC1 for approximately 5 min, then cool air for an 
additional 5 min. The plates were then placed in solvent B running in the second 
dimension (origin at lower comer), for a period of 10-15 min. The plates were 
subsequently dried for 5-10 min in a stream of cool air before placing in solvent C in the 
same dimension as that immediately above. A period of approximately 25 min was 
needed to allow the solvent front to reach within 1 cm of the edge of the plate. At this
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point the plates were removed from the solvent and allowed to dry thoroughly in a 
stream of cool air. After drying the plates, the phospholipids were visualised by placing 
the plates in an iodine vapour tank. The spots corresponding to PE 
(phosphatidylethanolamine); PC (phosphatidylcholine); PI (phosphatidylinositol) and 
PS (phosphatidylserine) (see figure 2.1.) were scraped into test tubes and the 
phospholipids were extracted with 3-4 portions (5 ml) of chloroform. Water was 
removed by the use of anhydrous sodium sulphate. The extracts of phospholipids were 
evaporated to dryness in a stream of nitrogen in weighing flasks, and weighed. 
Phosphorus content was determined in each fraction as described in section 2.13.2. The 
purified, separated phospholipids were stored in the dark at -20°C under a nitrogen 
atmosphere.
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FIGURE 2.1.
Schematic representation of phospholipid separation by two-dimensional thin 
layer chromatography.
2 .10 . RECONSTITUTION OF MIXED FUNCTION OXIDASE.
2 .1 0 .1 .  Sephadex G-50 Column Preparation.
The reconstitution of a functional drug metabolising system was carried out by 
the method of Ingelman-Sundberg and Glaumann (1977). This technique of cholate-gel 
filtration makes use of a Sephadex G-50 (particle size 50-150|im) column. The column 
(1 x15  cm) was equilibrated in 50 mM Tris HC1 pH 7.4 containing 50 mM NaCl and 
0.2 mM EDTA. Before being used, the column was precoated with a solution of protein 
and lipid as described below. The precoating solution was composed of 20 mg total 
microsomal phospholipid in 2 ml of equilibrating buffer (10% (w/v) cholate added till 
solution clear) and 10 mg of bovine serum albumin was added to the lipid solution. This 
solution was applied to the column and the eluate collected. The absorbance of the eluate 
at 280 nm was compared to a similar solution containing only lipids. The process was 
repeated until the absorbance of the lipid-only solution was greater than the absorbance 
of the lipid-protein eluate solution.
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2 .1 0 .2 .  Reconstitution Using Delipidated Microsomes.
0.1 ml of the lipid solution, containing 1 mg of lipid, was taken and the 
chloroform was evaporated off at 45°C, under a stream of nitrogen. The lipid was 
resuspended by sonication in 0.1 ml of buffer containing 0.1M potassium phosphate 
at pH 7.25, 20% glycerol, 1 mM EDTA, and 1.8% sodium cholate. 0.5 ml of 
delipidated microsomes (prepared as in section 2.3.6.) contain 1 nmole cytochrome 
P-450 was added to the lipid suspension, mixed gently and left to stand on ice for 30 
minutes. The delipidated microsomes/lipid mixture was applied to a Sephadex G-50 
column (1 x 1 5  cm) and eluted with a buffer containing 10 mM Tris HC1 (pH 7.4),
50 mM NaCl and 0.2 mM EDTA. The void volume was collected and used as the 
reconstituted metabolic system. [This technique allowed the small detergent molecules 
to be held back in the column while allowing incorporation of the enzymes into 
phospholipid vesicles which form as the cholate is removed].
2 .1 0 .3 . Reconstitution Using Purified Enzymes.
0.1 ml of the lipid solution, containing 1 mg of lipid, was taken and the 
chloroform was evaporated off at 45°C, under a stream of nitrogen. The lipid was 
resuspended by sonication in 0.1 ml of buffer containing 50 mM potassium phosphate 
pH 7.4, 20% glycerol and 0.1 mM EDTA. A 0.5 ml aliquot contain lnmole of purified 
cytochrome P-450 (prepared as in section 2.4.) was added to the lipid suspension, 
followed by 8 units of NADPH cytochrome P-450 reductase (prepared as in section
2.5.), mixed gently and left to stand on ice for 30 minutes. The mixture was applied to a 
Sephadex G-50 column (1 x 15 cm) and eluted with a buffer containing 10 mM Tris 
HC1 (pH 7.4), 50 mM NaCl and 0.2 mM EDTA. The void volume was collected and 
used as the reconstituted metabolic system. It should be noted here that, in the 
determination of the activity of the reconstituted system, the order of reforming the 
vesicles is very important. To achieve maximal activity, it is essential that the three 
components (cytochrome P-450, reductase and phospholipid) are mixed before applying
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to the Sephadex G50 column. The results are most consistent and maximal activity was 
achieved when the procedure was carried out in this manner. However we have tried to 
add the reductase after reforming the vesicles since it was free from detergent but the 
result obtained from this and the non-vesicle preparation was less than 50% of the 
microsomal activity. Poor performance of non-vesicle preparations has been reported by 
Haaparanta et al. (1980).
2 .1 1 . METABOLISM OF LIGNOCAINE BY THE RECONSTITUTED 
ENZYME SYSTEM.
2 .1 1 .1 . Incubation Conditions.
The metabolising activity of the reconstituted system was measured by following 
the metabolism of 14C-lignocaine. An appropriate volume of the reconstituted system, 
containing 0.1 nmole cytochrome P-450 was added to 30 pi of 14C-lignocaine 
(containing O.lpCi; 100 |ig) and 1 mg of NADPH (at a concentration of 10 mg/ml) and 
the mixture was incubated at 37 °C in a shaking water bath for 60 minutes. The reaction 
was stopped by the addition of 4 drops of 10 M NaOH. The NaOH raised the pH of the 
reaction mixture to about 14 which not only denatured the enzymes present but caused 
the lignocaine to become unionised and, therefore, more readily extracted into 
chloroform.
2 .1 1 .2 . Separation and Identification of the Lignocaine Metabolites.
After termination, 5 mis of chloroform was added to the mixture and shaken for 
20 minutes in a rotary shaker to allow the metabolites to be extracted into the organic 
phase. The organic layer was removed and the procedure was repeated twice. The 
organic extracts were recombined and evaporated to dryness under a stream of nitrogen 
at 40 C. The metabolites and unchanged substrate were redissolved in 5 drops of 
chloroform by sonication for 30 seconds. The metabolites were spotted onto a thin layer
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chromatography plate (silica gel, Merck F254) and run once in a solvent system 
consisting of chloroform/methanol (9:1). After separation, the radioactive bands were 
located by autoradiography in which X-ray film was cut to the same size as the TLC 
plate and placed on the top of the TLC plate and left in a dark box for 5-7 day after 
which the films were processed and developed and the radioactive metabolites were 
traced. The appropriate areas were scrapped into scintillation fluid (6 mis of Ecoscint 
from National Diagnostics, New Jersey) and the radioactivity quantitated by liquid 
scintillation counting using a Packard Tri-Carb liquid scintillation analyser (MODEL 
2000 CA). Metabolites have been identified by their thin-layer and gas chromatographic 
behaviour and mass spectrographic profile in comparison to authentic standards, Skett et 
al. (1980).
CALCULATIONS OF RESULTS :-
S x £21 x -  x -  x IQQQ = nmoles produced/min/nmole cytochrome P-450 
Ct t n MW
S = amount of substrate added (100 |ig)
n = nmole of cytochrome P-450 (0.1 nmole)
t = incubation time in minutes (60 minutes)
Ct = total cpm
Cm = metabolites cpm
MW = substrate molecular weight (271)
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2 . 1 2 .  M ETABO LISM  OF 4-A N D R O STE N E-3.17-D IO N E BY TH E  
RECONSTITUTED ENZYM E SYSTEM .
2 .1 2 .1 .  Incubation Conditions.
The metabolising activity of the reconstituted system was measured by 
following the metabolism of 14C-4-androstene-3,17-dione . An appropriate volume of 
the reconstituted system (containing 0.1 nmole cytochrome P-450) was added to 50 p.1 
of 14C-4-androstene-3,17-dione (containing O.ljiCi; 100 Jig) and 0.1 mg of NADPH (at 
a concentration of 10 mg/ml) and the mixture was incubated at 37°C in a shaking water 
bath for 20 minutes. The reaction was stopped by the addition of 1 ml 0.9% NaCl and 5 
ml chloroform: methanol (2:1).
2 .1 2 .2 . Separation and Identification of the 4-Androstene-3,17- 
dione Metabolites.
After termination, the mixture was shaken for 20 minutes in a rotary shaker to 
allow the metabolites to be extracted into the organic phase. The organic (bottom) layer
o
was removed. The extract was then evaporated to dryness at 30 C under a stream of 
nitrogen. The metabolites and unchanged substrate were redissolved in 5 drops of 
chloroform by sonication for 30 seconds. The metabolites were spotted onto a thin layer 
chromatography plate (silica gel, Merck F254) and run twice in a solvent system 
consisting of chloroform : ethylacetate (4:1) as a mobile phase. After separation, the 
radioactive bands were located by autoradiography as described in section 2.11.2. after 
which the radioactive metabolites were traced, the appropriate areas were scrapped into 
scintillation fluid (6 mis of Ecoscint from National Diagnostics, New Jersey) and the 
radioactivity quantitated by liquid scintillation counting using a Packard Tri-Carb liquid 
scintillation analyser (MODEL 2000 CA). Identification of the metabolites employed 
authentic standards as described by Berg and Gustafsson, (1973).
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CALCULATIONS OF RESULTS :-
S x £*2 x -  x -  x = nmoles produced/min/nmole cytochrome P-450 
Ct t n MW
S = amount of substrate added (100 |ig)
n = nmole of cytochrome P-450 (0.1 nmole)
t = incubation time in minutes < 20min
Ct = total cpm
Cm = metabolites cpm
MW = substrate molecular weight (280)
2 .1 3 . SPECTROPHOTOM ETRIC TECHNIQUES.
All spectrophotometric techniques were performed on a Shimadzu UV/240 
spectrophotometer.
2 .1 3 .1 . Cytochrom e P-450.
Cytochrome P-450 was routinely measured as the reduced carbon monoxide 
(CO) difference spectrum as described by Omura and Sato, (1964a,b). Microsomes 
were put into two plastic cuvettes (Elkay Products, Mass, USA), 1 ml aliquot in each. A 
base line spectrum was drawn between 400 nm and 500 nm. To each cuvette few crystals 
sodium dithionite were added and the content of the sample cuvette was gassed gently 
with CO for 30 seconds. The difference spectrum between the two cuvettes was then 
recorded between 400 nm and 500 nm. The change in absorbance at 450 nm, relative to 
baseline was then converted to a concentration of cytochrome P-450 using the extinction 
coefficient of 91 mM' 1 cm'1.
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2 .1 3 .2 .  NADPH Cytochrome C (P-450) Reductase.
NADPH Cytochrome C (P-450) reductase activity was routinely measured by 
the method of Philips and Langdon (1962). This assay makes use of the increase in the 
absorbance at 550 nm of the artificial electron acceptor, cytochrome C, when reduced. 
5 mis of 0.1M phosphate buffer (pH 7.4) and 0.5 ml of the sample solution was added 
to 0.5 ml of cytochrome C solution (3.7 mg/ml) in distilled water. The mixture was split 
into two 3 mis cuvettes and 10 |il of 10 mM NADPH solution was added to the test 
cuvette. The change of absorbance at 550 nm was recorded against a blank with the 
same contents as above except that distilled water was added instead of NADPH. The 
concentration of NADPH-Cytochrome C (P-450)-reductase was determined using the 
molar extinction coefficient of 19.1 mM' 1 cm '1. The activity of the reductase is 
expressed in units (a unit of reductase is define as the amount of enzyme which will 
reduce 1 pinole of cytochrome C per minute at 20°C).
2 .1 3 .3 . Cytochrome b5
Cytochrom e b5 was measured by the method of Estabrook and
Weningloer(1978). Two cuvettes were set up containing identical microsomal or vesicle
samples. The test cuvette was treated with 5 mg of sodium dithionite and the difference
spectrum was recorded between 400 nm and 500 nm. The change in absorbance at 423 
nm was used to determine the concentration of cytochrome b5 using the extinction
coefficient of 121 mM'1 cm'1.
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2 .14 . OTHER ASSAYS.
2 .1 4 .1 .  Protein Assay.
Protein concentrations were routinely measured by the method of Lowry 
et al. (1951). For this method three solutions were prepared.
A) 4% (w/v) Sodium carbonate in 0.1M NaOH.
B) 1% (w/v) Potassium disodium tartrate.
C) 0.5% (w/v) Hydrated copper sulphate.
A mixture of these three solutions was prepared freshly before every protein 
determination by mixing 50 parts of A. with 1 part of B. and 1 part of C. An aliquot of 
the protein suspension containing approximately 100 jig of protein was diluted to 1 ml 
with distilled water and added to 2 mis of the reagent mixture. The solution was mixed 
and left to stand for 10 minutes at room temperature. 0.3 ml of Folin Ciocalteu reagent 
(1M) was added, mixed thoroughly and left to stand at room temperature for 30 minutes 
before determining the optical density at 750 nm on a Shimadzu UV-240 
spectrophotometer. Protein standards were prepared from a stock solution of bovine 
serum albumin (200 |ig/ml).
2 .1 4 .2 . Phosphorus Assay.
A phosphorus assay was used to determine the phospholipid content of the 
microsomal samples and the technique employed was a modification of the method of 
Rouser et al (1970). Extraction of phospholipid was carried out by the addition of 2 ml 
of chloroform/methanol (2:1) and 0.4 ml of 0.9% sodium chloride solution to 100 pi of 
the microsomal fraction. The mixture was centrifuged gently (1, 500 x g for 2 minutes) 
and the organic layer was removed. To 100 p.1 of the organic layer was added 0.65 ml 
perchloric acid and the mixture was heated in an oven at 200 °C for 20 minutes in sealed 
tubes. This allows the phosphorus in the phospholipids to be converted to phosphates.
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The tubes were cooled and the following solutions were added rapidly, accurately and 
with mixing in the correct order :- 
2.8 ml distilled water 
1 ml of 1.25% ammonium molybdate 
0.5 ml of 10% ascorbic acid
The tubes were then heated in a boiling water bath for 5 minutes after which time 
the absorbance was read at 810 nm on a Shimadzu UV-240 spectrophotometer. A 
standard curve was obtained using known phosphate concentrations. It should be noted 
that all glassware (pipettes, flasks, tubes, etc.) must be washed with chromic acid- 
sulphuric acid (Vogel, 1956) before use, then rinsed with distilled water followed by 
methanol and chloroform, and used immediately; test tubes, particularly, should not be 
stored before use. Failure to follow these instructions results in development of an 
anomalous deep blue colour.
2 .1 5 . SDS-PAGE GEL ELECTROPHORESIS.
2 .1 5 .1 . Separation of Proteins by Gel Electrophoresis.
SDS gels were prepared and samples subjected to electrophoresis by the method 
of Laemmli (1970). The dimension of the gel plates was 16 x 16 cm to fit in the 
apparatus, and the thickness of the gels was 1.5 mm. The lower separation gels 
contained 10% acrylamide and the ratio of acrylamide to methylene-bis-acrylamide was
36.5 to 1. The concentration of the other components present in the separation gel was 
as follows:0.375M Tris-HCl (pH 8.8), 0.1% (w/v) SDS, 0.03 % (v/v)TEMED and 
0.1% (w/v) ammonium persulphate. The upper stacking gels contained 5% (w/v) 
acrylamide, 0.13% (w/v) methylene-bis-acrylamide 0.12 M Tris-HCl (pH 6.8), 0.1% 
(w/v) SDS, 0.03 % (v/v)TEMED and 0.2% (w/v) ammonium persulphate. Samples 
were mixed with 0.5 volumes of buffer containing 0.025 M Tris-HCl (pH 6.8), 4.5 % 
(w/v) SDS, 45% (v/v) glycerol, 10 % (v/v) 2-mercaptoethanol and 0.002% (w/v)
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bromophenol blue. The maximum amount of protein in each sample was 8 Jig and the 
volume applied was never larger than 20 pi. The protein samples were completely 
reduced and denatured by heating at 100°C for 2 minutes. The electrophoresis buffer 
contained 0.025 M Tris, 0.192 M glycine and 0.1 % (w/v) SDS at pH 8.3. The samples 
were subjected to electrophoresis towards the anode at 200V for about 3 hours until the 
Bromophenol Blue dye marker was about 1 cm from the bottom of the gel. The gels 
were then processed as described below. Molecular weights of proteins were determined 
using standards supplied by Sigma Chemical Co. Ltd., Poole, Dorset, U .K .. Standard 
proteins used were, Albumin bovine 67000; Egg Albumin 45000; Pepsin 34700; 
Trypsin 24000.
2 .1 5 .2 . Processing of Gels.
2 .1 5 .2 .1 . Staining of the Gels with Coomassie Brilliant Blue.
Gels were stained for 2-3 hrs at room temperature in 0.1% (w/v) Coomassie 
Brilliant Blue R-250 (purchased from BDH Chemicals, Poole, Dorest, U.K.) in 
methanol, acetic acid and water (5:1:1). Gels were destained for about 24 hrs at room 
temperature using a solution containing methanol, acetic acid and water (8:1:1) with 
several changes of solution. The gel was placed on a piece of absorbent paper slightly 
larger than the gel itself and covered with nonporous Cling Film plastic film, trapped air 
bubbles were released. The construction was placed on the gel dryer base and covered 
over with the sheet of silicon rubber and vacuum was applied for 10 minutes after which 
heat (60°C) was applied for 2h to draw all layers together. After the gel was completely 
dry it was photographed.
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2 .1 5 .2 .3 .  Silver Staining.
When the Coomassie Brilliant Blue staining method described above revealed 
that insufficient protein was present for adequate visualization in this way, the same gels 
were restained using the Bio-Rad silver stain (Bio-Rad Laboratories, California, USA). 
This method is said to be 10-50 fold more sensitive than staining with Coomassie 
Brilliant Blue R-250. The Bio-Rad silver stain is derived from the method of Oakley et 
al. (1980). A silver solution is prepared just prior to use by rapidly mixing 0.8 g silver 
nitrate in 4 ml water and 21 ml of 0.36% sodium hydroxide and 1.4 ml concentrated 
NH3 solution. If any particles are left, concentrated NH3 solution is added dropwise 
until they disappear. The developer solution is prepared by adding to 2.5 ml of 1% citric 
acid, 0.25 ml 37% formaldehyde and making the mixture up to 500 ml with distilled 
water. Staining was performed in a glass vessel. Gels, 1.5 cm thick, were rinsed 
quickly in water and kept in 50% (v/v) methanol for 20 minutes then washed with water 
for at least 10 minutes. Gels were incubated in the silver solution for 15 minutes, and 
then in the developer solution for about 10 minutes and then stopped with 25% 
photographic fixer (250 ml) for 1 minute. Between these steps the gels were washed 
with water. Following development the gels were dried as described in section
2.15.2.1. and were photographed.
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2 .1 6 . PREPARATION OF PHOSPHOLIPID FATTY ACID METHYL 
EST ER S.
The fatty acids methyl esters were prepared by a modification of the 
method of Kates, (1964). For this technique four solutions were prepared :
A) Methanolic (90%) sodium hydroxide (0.3M), [dilute 10 ml of 3M aqueous NaOH to 
100 ml methanol ].
B) Potassium hydroxide (33%; 6M), [16.5 g KOH pellets dissolved to 50 ml in water].
C) Phenolphthalein indicator (1%), [dissolve lg of phenolphthalein to 100 ml in 90% 
ethanol].
D) Hydrochloric acid (6M), [dilute 50 ml of concentrated. HC1 with water to 100 ml ].
A 0.5ml aliquot (containing 15-30 mg) of phospholipid as prepared by the 
method described in section 2.8., was placed in a side-arm flask, solvent was removed 
using a stream of nitrogen at 30°C. 5 ml of methanolic NaOH was added and the 
mixture was refluxed for 1-2 h. A few drops of phenolphthalein indicator were added 
and nonsaponifiables were extracted with 3-4 portions (5 ml) of petroleum ether (b.p. 
30-60 °C). The alcoholic phase was acidifying with 0.3 ml of 6 M HC1 to pH 2 and free 
fatty acids were extracted with 3-4 portions (5 ml) of petroleum ether (b.p. 30-60°C). 
The extracts of fatty acids were evaporated to dryness in a stream of nitrogen in 
weighing flasks, and weighed. The free fatty acids were refluxed for l-2h in 4.5 ml of 
methanolic-HCl and extracted with 3-4 portions (5 ml) of petroleum ether (b.p. 30- 
60°C). Water was removed from the extracts by the addition of 2g anhydrous sodium 
sulphate, the extracts of fatty acid methyl esters were evaporated to dryness under a 
stream of nitrogen in weighing flasks, weighed and stored at -20°C in the dark under a 
nitrogen atmosphere.
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2 .17 . GAS CHROMATOGRAPHY.
Samples of fatty acid methyl esters were prepared for GC analysis as described 
in section (2.6.). A solution of the sample (containing 1 mg of phospholipid) in 
chloroform was placed in a tube and the solvent was evaporated to dryness under a 
stream of nitrogen at 40°C. The residue was redissolved in toluene (100 jig/lOp.1) and 1 
p.1 of sample was injected with a microsyringe onto the column. The methyl- esters were 
analysed on a 1% OV-1 (fused silica) column, film thickness 250 nm and 12 meter 
length, using a. PERKIN-ELMER 8420 CAPILLARY GAS CHROMATOGRAPH 
with FED detector and SGE unijector split mode at 190°C (isothermal) for 30 minutes.
We are  grate/ut to !Martin T lcA voy ,  Department 
of  fitocfiemtstry, University oj Glasgow for  assistance 
w i t h  the  GC a n a ly s i s  of f a t t y  a c id  m e th y l  esters.
2 .1 8 . STATISTICS.
Statistical significance was tested using Student's t-test for unpaired samples. 
Results were expressed as mean ± s.d. and the level of significance set at p < 0.05. 
Where appropriate Duncan's Multiple Range Test was used and the level of significance 
set at p < 0.05.
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RESULTS
3 .1 . M ICROSOM AL RESULTS.
The aim of this experiment was to verify the activity of the rat microsomes 
before the solubilisation stage and to confirm the previously reported existence of sex 
differences in microsomal metabolism of lignocaine (Skett and Gustafsson, 1979; Skett 
and Young, 1982; Skett and Weir, 1983; Skett et al., 1984; Skett and Joels, 1985). The 
microsomes used were prepared by ultracentrifugation (Materials and Methods 2.3.2.) 
and the incubation and detection of metabolites was performed as described in Materials 
and Methods 2.12.2. The results are expressed as the mean ± s.d. of six values. Figure
3.1. shows the production of the N-deethylated and 3-hydroxylated derivatives of 
lignocaine (figure 1.5.). As is seen N-deethylation rate is greater in the microsomes 
prepared from male animals than microsomes prepared from female animals. Statistical 
analysis of the results indicate that the N-deethylation route is significantly different (p < 
0.001) whereas the 3-hydroxylation route is not found to exhibit a sex difference in 
metabolism.
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FIGURE 3.1.
Sex differences in the metabolism of lignocaine using haemoglobin- 
free microsomes from mature male and female rat liver.
N-DEETHYLATION
3-HYDROXYLATION
Results are expressed as mean ± s.d. of six values. 
** = p < 0.001 compared to female values.
7 2
■  MALE MICROSOMES 
□  FEMALE MICROSOMES
3 . 1 . 1 .  Measurements of the Components of Rat Liver Microsomes.
The components as prepared from male liver are shown in Table 3.1. and the 
same components isolated from female liver are shown in Table 3.2. It is seen from the 
two tables that the cytochrome P-450, NADPH cytochrome P-450 reductase and the 
microsomal lipid, were measured at each stage towards the reconstitution of the 
functional drug metabolising system. It can be seen from Table 3.1. and Table 3.2. that 
the ratios of cytochrome P-450 to NADPH cytochrome P-450 reductase vary slightly 
from step to step as the preparation procedure progresses. However the NADPH 
cytochrome P-450-reductase activity in the incubation was similar in comparison groups 
but varied somewhat between experiments. This applied to both male and female derived 
proteins. It should be noted that the cytochrome b5 in the reconstituted hydroxylation
system could not be determined due to high turbidity after the removal of the detergent 
and because of the small volume of the vesicle preparation. In order to measure the 
cytochrome P-450 content the assay procedure should be done as quickly as possible 
because of protein precipitation and thus the measurement of cytochrome b5 in the
vesicle preparation was ignored.
73
TABLE 3.1.
The contents of the drug metabolising system from mature male Wistar rats. 
These results are from a typical experiment.
Step Lipid
pmoles/ml
Cyt.P-450
nmoles/ml
Reductase
unit/ml
Cyt.b5
nmoles/ml
Cyt. P-450/ 
Reductase
Cyt.P-450/
Cyt.b5
Microsomes 6.0 5.2 9.7 1.15 0.62
Hb-free Microsomes - 5.0 5.1 10 1.08 0.50
Solubilised 4.8 5.2 7.5 0.92 0.64
Cone. Sol. Microsomes 750 15.0 16.0 24.0 0.94 0.63
Delipidated 15 3.0 3.7 4.9 0.81 0.61
Vesicles - 0.38 0.53
*
N.D- 0.72 -
*
= Not Determined.
Step Reductase
nmoles/ml
Cyt.P-450/
Reductase
Microsomes 130 0.04
Hb-free Microsomes 127.5 0.04
Solubilised 130 0.04
Cone. Sol. Microsomes 400 0.04
Delipidated 92.5 0.03
Vesicles 13.25 0.03
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TABLE 3.2.
The contents of the drug metabolising system from mature female Wistar rats. 
These results are from a typical experiment.
Step Lipid
jimoles/ml
Cyt. P-450 
nmoles/ml
Reductase
unit/ml
CyLb5
nmoles/ml
CytP-450/
reductase
Cyt.P-450/
Cyt.b^
Microsomes - 4.5 3.9 8.8 1.10 0.50
Hb-free Microsomes _ 4.0 4.1 8.5 0.97 0.49
Solubilised 3.8 4.0 8.0 0.95 0.47
Cone. Sol.Microsomes 540 11.1 14.2 21.0 0.90 0.51
Delipidated 9 1.5 2.8 2.9 0.86 0.51
Vesicles - 0.25 0.33 N.D.* 0.75 -
* = Not Determined.
Step Reductase
nmoles/ml
Cyt.P-450/
Reductase
Microsomes 97.5 0.04
Hb-free Microsomes 102.5 0.04
Solubilised 100 0.04
Cone. Sol. Microsomes 355 0.03
Delipidated 70 0.02
Vesicles 8.25 0.03
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3 . 1 . 2 .  Determination of Optimum ProteinrLipid Ratio for Reconstitution.
As is seen in figure 3.2., the addition of delipidated microsomes containing 0.1 
nmole cytochrome P-450 to 100 nmoles of lipid (in this case microsomal lipid obtained 
from the male rat) gave the maximum enzyme activity, indicating that, this is the optimal 
amount of lipid to use for the reconstitution. A similar result was seen for all lipids used. 
The amount of lipid added is more than was removed by the delipidation procedure and 
accounts for over 97% of the lipid in the final preparation. The above ratio of protein to 
lipid was therefore used for the rest of the study.
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FIGURE 3.2.
Determination of Optimum Protein:Lipid Ratio for Reconstitution. Using 
microsomal lipid and delipidated microsomes derived from male rat liver. 0.1 nmole 
cytochrome P-450 was used in each reconstitution.
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Based on a molecular weight of a typical phospholipid of 800,1 mg of microsomal 
phospholipid equivelant to 1.25 nmole therefore the ratio of microsomal phosphlipid to 
microsomal phosphlipid is 12.5nmole
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3 .2 . THE EFFECT OF ADDED LIPID COMPOSITION ON LIGNOCAINE 
METABOLISM BY DELIPIDATED MICROSOMES FROM MALE 
AND FEMALE LIVER.
These experiments were designed to investigate the influence of added lipid 
composition on the activity of cytochrome P-450 in a delipidated microsomal preparation 
to metabolise lignocaine. For this purpose the lipids were extracted from male and 
female rat liver microsomes using the method of Overturf & Dyer (Materials and 
Methods, 2.7.) and their effects compared to the effects of commonly used artificial 
lipids i.e. dilauroylphosphatidylcholine (DLPC) and dilauroylphosphatidylethanolamine 
(DLPE). The results obtained from the enzyme assays allowed the calculation of the 
lignocaine N-deethylase and 3-hydroxylase enzyme activities. The effects of 
incorporating the delipidated enzymes derived from the male and female liver into 
vesicles prepared from dilauroylphosphatidylcholine (DLPC) and dilauroylphos- 
phatidylethanolamine (DLPE)/DLPC mixture (3:1 w/w) are shown in figures 3.3. and
3.4., respectively. It is seen that DLPE had no effect on the enzymes isolated from 
female liver (figure 3.3.) but significantly increased the N-deethylating activity of the 
enzymes isolated from the male animal (figure 3.4.), without having any effect on the 3- 
hydroxylating activity. Figure 3.5. and 3.6., show the effects of incorporating enzymes 
derived from male and female liver respectively into vesicles prepared from DLPC and 
male-derived microsomal lipids. It is seen that the N-deethylating activity of the enzymes 
is higher in microsomal lipids than in DLPC but the 3-hydroxylating activity is 
unaffected by the nature of the lipid. This is equally the case for enzymes derived from
male and female animals.
Figure 3.7. shows that the enzymes derived from male rats showed a lower N- 
deethylating activity in female-derived lipids while the 3-hydroxylating activity of the 
same preparation was not significantly affected. The enzymes derived from the female
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showed a decreased N-deethylating activity in female derived lipids but 3-hydroxylating 
activity was unaffected by the female-microsomal lipid (figure 3.8.). It is also noted that 
N-deethylating activity was higher in the male-derived vesicles than the female derived 
vesicles whereas the 3-hydroxylating activity was similar. This result agrees with the 
sex differences seen in the rat (figure 3.1.).
A summary of the results obtained using the delipidated microsomal 
preparation is given in Table 3.3.
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FIGURE 3.3.
The effect of incorporating enzymes derived from female rat liver into vesicles
prepared from dilauroylphosphatidylcholine (DLPC) and dilauroylphosphatidylethanolamine
(DLPE)/ DLPC mixture (1:3 w/w) on metabolism of lignocaine.
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Results are expressed as mean ± s.d. of six values.
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FIGURE 3.4.
The effect of incorporating enzymes derived from male rat liver into vesicles prepared
from dilauroylphosphatidylcholine (DLPC) and dilauroylphosphatidylethanolamine (DLPE)/
DLPC mixture (1:3 w/w) on metabolism of lignocaine.
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3-HYDROXYLASE
Results are expressed as mean ± s.d. of six values. 
* = p < 0.01 compared to DLPC.
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FIGURE 3.5.
The effect of incorporating enzymes derived from male rat liver into
dilauroylphosphatidylcholine (DLPC) and male microsomal lipid on metabolism of
lignocaine.
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Results are expressed as mean ± s.d. of six values. 
**= p < 0.001 compared to DLPC.
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FIGURE 3.6.
The effect of incorporating enzymes derived from female rat liver into
dilauroylphosphatidylcholine (DLPC) and male microsomal lipid on
metabolism of lignocaine.
■  Male Microsomal Lipid 
□  DLPC
Results expressed as mean + s.d. of six values. 
**= p < 0.001 compared to DLPC.
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FIGURE 3.7.
The effect of incorporating enzymes derived from male rat liver into microsomal 
lipids derived from male and female rat liver on metabolism of lignocaine.
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Results expressed as mean ± s.d. of six values.
**= p < 0.001 compared to female microsomal lipid.
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FIGURE 3.8.
The effect of incorporating enzymes derived from female rat liver into 
microsomal lipids derived from male and female rat liver on metabolism of 
lignocaine.
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Results expressed mean ± s.d. of six values.
**= p < 0.001 compared to female microsomal lipid.
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Tab I .5.
A summary of the results obtained using the delipidated microsomal preparation.
M icrosouies Derived From N-Deethylase 3-H ydroxylase
M a l e 1.98 ± 0.17** 0.49 ± 0.03
' F e m a l e 0.97 ± 0.21 . 0.48 ± 0.08 .
Enzyme derived from 1 Lipid N-Deethylase 3-Hydroxylase
Female DLPC 0.98 ± 0.09 0.48 ± 0.05
Female j DLPC/DLPE 0.92 ±0.10 0.47 ± 0.04
Male DLPC
....... .... ....1............... ' ”
1.48 ± 0.17* 0.48 1  0.01
Male DLPC/DLPE : 1.72 ± 0.02 0.47 1  0.03
Male DLPC 1.45 ± 0.04** 0.48 1  0.03 I
Male male 2 .3110.14 0.49 10.01 |
Female DLPC 0.90 + 0.07** 0.48 1  0.01
Female male 1.68 10.09 0.47 10.06
Male male 1.89 1 0.03 0.50 1 0.02
Male female 0.97 1 0.08** 0.48 1  0.02
Female male 1.22 ± 0.03 _0.48. ± 0.05
Female female 0.89 + 0.08** J).47.1.0.04
Results expressed as nmoles product formed/min/nmole cytochrome P-450 and 
as mean 1  s.d. of at least six values.
**=p < 0.001; * = p < 0.01 compared to respective control.
DLPC=dilauroylphosphatidylcholine; DfcPE = dilauroylphosphatidylethanolamine.
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3 .3 . THE EFFECT OF ADDED LIPID COMPOSITION ON
LIGNOCAINE METABOLISM BY THE MALE-SPECIFIC 
ISOZYME OF CYTOCHROME P-450, LIGNOCAINE N- 
DEETHYLASE.
3 .3 .1 .  Purification and Characterization of the Male-Specific Isozyme of 
Cytochrom e P-450, Lignocaine N-deethylase.
A summary of the purification of the cytochrome P-450 isozyme lignocaine N- 
deethylase, from liver microsomes of untreated male rats is shown in Table 3.4. The 
procedure developed for the purification is based on the methods used by Waxman 
(1984). The fraction precipitated by the use of 10-13% polyethyleneglycol 6000 had a 
specific content of 3.3 nmoles cytochrome P-450/mg protein. However if, in the final 
precipitating stage, the polyethyleneglycol was increased to 16%, an enhanced specific 
content of cytochrome P-450 (up to 6 nmoles cytochrome P-450/mg protein) was seen 
and this represented 89.7% of the original microsomal cytochrome P-450. In contrast to 
the earlier study of Waxman (1984), cytochrome P-450 eluted from the DE52 column as 
two distinct peaks (figure 3.9.). Both peaks (F I, F II) were eluted by buffer A, 
containing 10 mM potassium phosphate pH 7.4, 20% glycerol, 0.5% sodium cholate, 
0.2% Emulgen, 0.1 mM EDTA and 20 mM potassium chloride. Fraction FII showed a 
high contamination with other proteins as analysed by SDS-PAGE (figure 3.10.), 
whereas fraction F I  was enriched in a single band corresponding to cytochrome P-450 
(figure 3.10.).
Cytochrome P-450 was recovered from the DE52 column with a specific content 
of 9 nmoles cytochrome P-450/mg protein representing 10 fold purification at this stage. 
After dialysis the fraction (F I) was applied to a hydroxylapatite column and eluted in a 
stepwise manner with 35 mM-120 mM concentration of potassium phosphate buffer as 
described in Materials and Methods 2.4.5. The cytochrome P-450 eluted with the 120 
mM fraction. The final recovery of the isozyme, after the separation and the removal of
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the detergent using very small hydroxylapatite columns (1 ml bed volume) as described 
in Materials and Methods 2.4.6., was 0.32% of the initial microsomal cytochrome P- 
450. The specific content was 12.8 nmoles cytochrome P-450/mg protein. Figure 3.10. 
shows an SDS-PAGE of the electrophoretically homogeneous cytochrome P-450 
isozyme produced, indicating a molecular weight of approximately 52000. The protein 
was homogeneous as assayed by SDS-PAGE. The isozyme gave an absorbance 
maximum for the reduced CO-difference spectrum at 448.8 nm with no traces of 
cytochrome P-420.
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FIGURE 3.9.
DE52 column profiles of partially purified male-specific cytochrome P-450 
isozyme from male rat. The P-450 peaks eluted from the DE52 column with 10 mM 
potassium phosphate buffer pH 7.4 containing 20% glycerol, 0.5% Na cholate, 0.2% 
Emulgen 913,0.1 mM EDTA and 20 mM KC1. The fraction size was 8 ml.
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FIGURE 3.10.
SDS-PAGE of purified cytochrome P-450 isozyme from adult untreated male. 
The samples were analysed as described in Materials and Methods, 2.15., shown are: 
A, purified NADPH-cytochrome P-450-reductase; B, microsomes from untreated male 
rats; C, DE52 (FI) column eluate; D, HTP column eluate; E, standards (see Materials 
and Methods, 2.15.); . Gels were Stained with Coomassie Brilliant Blue.
A B C D E
3  4 . 7 K  
2 4 K
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TABLE 3.4.
Purification of the male specific cytochrome P-450 isozyme, lignocaine N- 
deethylase from untreated male liver microsomes.
Step Protein
mg
P-450
nmoles
Specific Content 
nmoles/mg protein
Yield
%
Microsomes 2951 2810 0.95 100
solubilised microsomes 2184 2520 1.15 89
PEG 6000 fractionation 360 2160 6.0 77
DE52 Column 4.2 40 9.4 1.42
HTP Column (1) 0.85 9.8 11.5 0.35
HTP Column (2) 0.71 9.1 12.8 0.32
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3 . 3 . 2 .  Purification of NADPH-Cytochrome P-450-Reductase.
A summary of the purification of NADPH-cytochrome P-450-reductase is given 
in Table 3.4. The enzyme was purified using a 2’5’-ADP Sepharose 4B column as 
described in the Materials and Methods 2.5. The use of deoxycholate as the detergent in 
the buffer permitted subsequent removal of detergent by extensive dialysis. PMSF was 
used to elute the column and used in the storage buffer to prevent apparent proteolysis 
which occurred in its absence. The purified preparation of reductase was homogeneous 
as examined by SDS-PAGE gel electrophoresis and exhibited a subunit molecular 
weight of approximately 72000 (figure 3.10.). The preparation was detected 
spectrophotometrically and found to have an A455:A380 ratio of > 1. The enzyme was 
recovered from the column with a yield of 70% and a catalysing activity of 104 units/mg 
protein (a unit of reductase is defined as the amount of enzyme which reduced l|imole 
of cytochrome C per minute at 20 °C) and was free of other contaminants.
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TABLE 3.5.
Purification of NADPH-cytochrome P-450-reductase from male 
sodium phenobarbital treated rats.
Step Protein Specific Content Reductase Fold Purification Yield
mg unit/mg protein %
Microsomes 1250 0.064 1 100
Sol. Microsomes 1210 0.17 1.1 115
2'5’ ADP Sepharose 2.3 104 80 70
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3 . 3 . 3 .  The Metabolism of Lignocaine and Androst-4-ene-3,17-dione by 
the Purified Cytochrome P-450 Fractions.
Figure 3.11. shows the metabolism of androst-4-ene-3,17-dione in a 
reconstituted microsomal drug metabolising system containing NADPH cytochrome C 
(P-450) reductase, cytochrome P-450 (fraction FII) and microsomal lipid. It is seen that 
the androst-4-ene-3,17-dione was poorly metabolized to the 6P~, 7a -  and 1 6 a- 
hydroxylated derivatives by cytochrome P-450 (fraction FII) and thus fraction FII was 
both inefficient and nonselective in catalysing the metabolism of androst-4-ene-3,17- 
dione. Figure 3.12. shows the metabolism of lignocaine in a reconstituted microsomal 
drug metabolising system containing NADPH cytochrome C (P-450) reductase, 
cytochrome P-450 isozyme (fraction FH) and microsomal lipid. It is seen that fraction 
FII was very poor at catalysing the metabolism of lignocaine and produced both the N- 
deethylated and 3-hydroxylated metabolites. Due to the poor non-selective metabolism 
shown by fraction FH and its low purity no further purification was carried out and it 
was eliminated from the study. On the other hand the cytochrome P-450 FI fraction 
metabolises androst-4-ene-3,17-dione with a high effectiveness and regioselectivity 
(figure 3.13.). The catalytic activity of cytochrome P-450 (fraction FI) on androst-4- 
ene-3,17-dione agrees with those for the isozyme 2c of Waxman, (1984) and RLM5 of 
Morgan et al. (1985). However we have not detected any 6p-, and 7a-hydroxylase 
activity in the fraction as reported by Morgan et al. (1985). Figure 3.14. shows the 
activity of this isozyme (fraction FI) on N-deethylation of lignocaine. It is seen that the 
N-deethylase activity of fraction FI was the same as the unsolubilised microsomes but 
no 3-hydroxylase activity was detected. Accordingly a further purification on a 
hydroxylapatite column was carried out for this fraction, which apparently contains the 
purified lignocaine N-deethylase activity.
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FIG U RE 3.11.
The metabolism of androst-4-ene-3,17-dione in a reconstituted system 
containing NADPH cytochrome C (P-450) reductase, cytochrome P-450 (fraction HI) 
and microsomal lipid. All components derived from male rat liver microsomes.
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Results are expressed as mean ± s.d. of six values.
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FIGURE 3.12.
The metabolism of lignocaine in a reconstituted system containing NADPH
cytochrome C (P-450) reductase, cytochrome P-450 (fraction FII) and microsomal lipid.
All components derived from male rat liver microsomes.
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Results are expressed as mean ± s.d. of six values.
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FIGURE 3.13.
The metabolism of androst-4-ene-3,17-dione in a reconstituted system
containing NADPH cytochrome C (P-450) reductase, cytochrome P-450 (fraction FI)
and microsomal lipid. All components derived from male rat liver microsomes.
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Results are expressed as mean ± s.d. of six values.
FIGURE 3.14.
The metabolism of lignocaine in a reconstituted system containing NADPH
cytochrome C (P-450) reductase, cytochrome P-450 (fraction FI) and microsomal lipid.
All components derived from male rat liver microsomes.
N-deethylase
Results are expressed as mean ± s.d. of six values.
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3 .3 .4 .  R econstitution Using the M ale-Specific Cytochrom e P-450 
Isozym e.
It is seen (figure 3.15.) that when the male-specific isozyme of cytochrome P- 
450 is incorporated into a membrane consisting of dilauroylphosphatidylcholine (DLPC) 
and dilauroylphosphatidylethanolamine (DLPE) mixture (3:1 w/w) there is an increase in 
the ability of the enzyme to N-deethylate lignocaine compared to when the isozyme is 
incorporated into DLPC. These data are consistent with those obtained using delipidated 
microsomes (figure 3.4.). It is not clear why the ability of the enzyme to N-deethylate 
lignocaine seen here is slightly less than the ability of the delipidated microsomes, but 
the 3-hydroxylase activity was not detected. Figure 3.16. shows the effect of 
incorporating the male-specific isozyme into vesicles prepared from hepatic microsomal 
lipids derived from male and female rats. The vesicles prepared from female-derived 
lipids gave a lower N-deethylase activity than those prepared from male-derived lipid. 
This is also similar to the results using delipidated microsomes (figure 3.7.). Figure 
3.17. shows the effect of incorporating the enzymes into vesicles prepared from male- 
or female-microsomal lipid, DLPC, and DLPC/DLPE mixtures. In all experiments it 
was seen that male m icrosom al lipids are more effic ien t than 
dilauroylphosphatidylcholine (DLPC) in reconstituting N-deethylase activity and male- 
derived lipids gave a higher activity than dilauroylphosphatidylethanolamine 
(DLPE)/DLPC mixtures or female-derived lipids.
The results of the experiments incorporating the male-specific cytochrome P-450 
isozyme into vesicles prepared from DLPC; DLPC/DLPE mixtures and total microsomal 
lipids are summarised in Table 3.6.
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FIGURE 3.15.
The effect of incorporating the male-specific cytochrome P-450 isozyme into vesicles
prepared from dilauroylphosphatidylcholine (DLPC) and dilauroylphosphatidylethanolamine
(DLPE)/DLPC mixture (1:3 w/w) on metabolism of lignocaine.
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Results are expressed as mean ± s.d. of six values. 
* = p < 0.01 compared to the DLPC.
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FIGURE 3.16.
The effect of incorporating the male-specific cytochrome P-450 into vesicles
prepared from microsomal lipids derived from male and female livers on the metabolism
of lignocaine.
■  MALE 
□  FEMALE
Results expressed mean ± s.d. of six values. 
** = p < 0.001 compared to the female.
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FIGURE 3.17.
The effect of incorporating the male-specific cytochrome P-450 isozyme into 
vesicles prepared from DLPC or male- and female-derived microsomal lipids.
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Results are expressed as mean ± s.d. of six values. 
** = p < 0.001; * = < 0.01 as compared to DLPC.
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Table 3.6.
Summary of the results obtained from incorporating the male-specific 
cytochrome P-450 into vesicles prepared from DLPC; DLPE/DLPC mixtures and total 
microsomal lipids.
Lipid N -deethylase
DLPC/DLPE 1.39 ± 0.17*
DLPC 0.97 ±0.11
Male 2.31 ±0.03**
Female 1.61 ± 0.07
Male 2.32 ± 0.15
Female 1.63 ±0.13*
DLPC 0.99 ± 0.20**
Results are expressed as nmoles product formed/min/nmole cytochrome P-450 
and as mean ± s.d. of at six values.
** =p < 0.001; *=p < 0.01 compared to respective controls.
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3 .4 .  T H E  E F F E C T  O F D IFFE R E N T  FR A C T IO N S OF L IP ID
EX TRA CTED  FRO M  M ALE AND FEM A LE RATS ON TH E
M ETA B O LISM  O F LIG N O CA IN E BY A R EC O N STITU TED
ENZYM E SYSTEM.
From the previous set of experiments, it seems possible that the sex differences 
seen in lignocaine-metabolising activity might be related to the microsomal lipid 
composition. We have demonstrated that changes in the drug metabolising activities can 
be brought about by alterations in the lipid composition. We decided, therefore, to 
investigate whether the activity of the microsomal lipid is related to certain fractions of 
the microsomal lipid extracted from male and female rats. Microsomal lipids were 
extracted from male and female rat livers as described in Materials and Methods (2.7.) 
and phospholipid and neutral lipid fractions separated using silica gel column 
chromatography as described in Materials and Methods (2.8.). The various lipid 
fractions were used to reconstitute the enzyme activities in delipidated microsomal 
preparations (section 2.3.6.). Figure 3.18. shows the effects of incorporating male- 
derived enzymes into vesicles prepared from phospholipid (PL) and neutral lipid 
(NL)/PL mixture derived from male and female livers. It is seen that the enzymes 
derived from male rats showed a lower N-deethylating activity in female-derived 
phospholipid and phospholipid/neutral lipid fraction than in the respective male-derived 
lipids. For the male-derived lipid fractions, the mixture of PL and NL gave a greater 
enzyme activity than PL alone but this was not the case for the female-derived lipids. 
Neutral lipids alone do not form vesicles and thus no result was obtained for NL alone. 
The 3-hydroxylating activity of both the male- and female-derived enzyme preparation 
was not significantly affected by any lipid fraction (figure 3.19. and 3.21.). Figure 
3.20. shows the effect of incorporating female enzymes into vesicles prepared from 
phospholipid (PL) and phospholipid/neutral lipid (NL/PL) mixture derived from male 
and fem ale livers. It is seen that the enzymes derived from the female showed a
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decreased N-deethylating activity in female derived lipids when compared to the male 
derived lipid fractions. From the two experiments It is interesting to note that the N- 
deethylating activity was higher in the male-derived vesicles than the female derived 
vesicles whereas the 3-hydroxylating activity was similar in all cases.
A summary of the results obtained using different fractions of lipids extracted 
from male and female by reconstituted the delipidated microsomal preparation is given in 
Table 3.7.
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FIG U R E 3.18.
The effects on lignocaine N-deethylase activity of incorporating male protein into 
vesicles prepared from male- and female-derived microsomal lipid fractions.
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Results are expressed as mean ± s.d. of six values.
** = p < 0.001 compared to female (PL/NL) and female (PL); * = p < 0.05 
compared to female (PL).
PL = phospholipid; NL = neutral lipid
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FIGURE 3.19.
The effects on lignocaine 3-hydroxylase activity of incorporating male protein 
into vesicles prepared from male- and female-derived microsomal lipid fractions.
0 .6  n
0.5 -
0.4 -
0.3 -
0.2  -
0.1 -
0.0
3-7{ydroxyla tio ri
pm Ph
Results are expressed as mean ± s.d. of six values. 
PL = phospholipid; NL = neutral lipid
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FIGURE 3.20.
The effects on lignocaine N-deethylase activity of incorporating female protein
into vesicles prepared from male- and female-derived microsomal lipid fractions.
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Results are expressed as mean ± s.d. of six values.
t=p < 0.01 compared to female (PL/NL) and male (PL); *= p < 0.05 compared to female (PL). 
PL=phospholipid; NL = neutral lipid.
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FIGURE 3.21.
The effects on lignocaine 3-hydroxylase activity of incorporating female protein 
into vesicles prepared from male- and female-derived microsomal lipid fractions.
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Results are expressed as mean ± s.d. of six values. 
PL = phospholipid; NL = neutral lipid
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TABLE 3.7.
A summary of the results obtained from the incorporation of the 
delipidated microsomal preparation into vesicles prepared from lipid fractions 
extracted from male and female rat livers.
Lipid Enzym es N-deethylase 3-hydroxylase
Male (PL) male 1.42 ± 0.02** 0.50 ± 0.03
Male (PL/NL) male 1.86 ± 0.02 0.48 ± 0.05
Female (PL) male 1.2 ± 0.01* 0.49 ± 0.02
Female (PL/NL) male 1.3 ± 0.07 0.51 ± 0.02
Male (PL) female 1.19 ±0.04* 0.50 ± 0.02
Male (PL/NL) female 1.4 ±0.04 0.48 ± 0.05
Female (PL) female 1.04 ± 0.02* 0.48 ± 0.06
Female (PL/NL) female 1.1 ± 0.04 0.47 ± 0.01
Results expressed as nmoles product formed/min/nmole cytochrome P- 
450 and as mean ± s.d. of at least six values.
**=p < 0.001; f  = p < 0.01; *= p < 0.05 as compared to respective female values. 
PL = phospholipid; NL = neutral lipid
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3 .4 .1 . Resolution of the Microsomal Phospholipid Composition in the Rat
Liver.
Figure 3.22. shows the phospholipid composition of liver microsomes in male 
and female rats. The individual phospholipids from liver microsomes were separated by 
TLC as described in Materials and Methods (2.9.). The phospholipids were separated 
in to  the ir m ajor ind iv idual fractions, phosphatidy lcho line  (PC), 
phosphatidylethanolamine (PE), phosphatidylserine (PS), and phosphatidylinositol (PI). 
Phosphorus content was determined in all fractions as described in Materials and 
Methods, (2.15.2.). It is seen that the microsomal phospholipid phosphorus was 
significantly higher in the male than the female animals. Among individual microsomal 
phospholipids, phosphatidylcholine and phosphatidylethanolamine were significantly 
higher in the male than the female rats. However phosphatidylinositol and 
phosphatidylserine were similar in both sexes.
I l l
FIGURE 3.22.
Microsomal phospholipid composition in the liver of male and female rats. 
Fractions analysed were phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylinositol (PI) and phosphatidylserine (PS).
■  Male 
□  Female
* = p < 0.001; t  = P < 0.05 compared to female value.
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3 . 4 . 2 .  Resolution of the Fatty Acid Composition of Microsom al
Phospholipid in the Male and Female Rat Liv er .
Microsomal phospholipid fatty acid composition assays were carried out as 
described previously in Materials and Methods (2.16.). Figure 3.23. shows the result of 
the fatty acid analysis of the microsomal phospholipid extracts. Of the fatty acids seen, 
there were no sex differences in palmitoleate (C16.j) or palmitate (C16.0). However the 
stearate (C18.0) was significantly higher in female (25±1%) microsomal phospholipid
fraction than the male (1Q±2%) microsomal phospholipid fraction. The livers of females 
had (6±2%) half as much arachidonate (C2Q.4) as in the male (12±2%). Also linoleate 
(Ci8*2)was considerably higher in the male than the female There was little difference in 
oleate (C18.j) content. It should be noted that the total unsaturated fatty acid content of 
male (48%) livers was considerably higher than that of females (37%).
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FIGURE 3.23.
Microsomal phospholipid fatty acid composition in male and female liver. Fatty 
acid composition was determined by gas chromatography as described in Materials and 
Methods section (2.18.). Male (n = 5) and female (n = 5).
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* = p < 0.05; §= p < 0.001; t  = p < 0.01 compared to male value.
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3 . 4 . 3 .  The Effect of the Fatty Acid Acyl Chain of Phosphatidylcholine 
on the Metabolism of Lignocaine by a Reconstituted Drug 
Metabolising Enzyme System.
Delipidated solubilised microsomes prepared from male mature Wistar rats were 
used in these studies and were incorporated into vesicles prepared from various PCs 
(phosphatidylcholine) containing fatty acids of differing acyl chain 
[dicaproylphosphatidylcholine (6:0); dilauroylphosphatidylcholine (12:0); distearoyl- 
p h o sp h a tid y lch o lin e  (18:0); d ibehenoy lphospha tidy lcho line  (2 2 :0 ); 
dioleoylphosphatidylcholine (18:1) and diarachidoylphosphatidylcholine (20:4) ]. All of 
the PCs were found to restore the N-deethylase activity of the cytochrome P-450 to 
differing extents (Figure 3.24.). Figure 3.24. shows the activity of different PCs (as a 
function of the fatty acid chain length and degree of unsaturation) in reconstituting male 
microsomes. Phosphatidylcholines having longer acyl chains were more efficient and 
the unsaturated PC (18:1) reconstituted the enzyme activity better than did the saturated 
PC of the same length (18:0). Diarachidoyl (20:4) PC gave the highest enzyme activity. 
However, figure 3.25. shows that the 3-hydroxylating activity is unaffected by the fatty 
acid chain length or the number of double bonds except when the chain length is reduced 
to 6 carbon atoms (DCPC).
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FIGURE 3.24.
The effect on activity of lignocaine N-deethylase of incorporating enzymes
derived from male rat liver into vesicles prepared from phosphatidylcholines having
different acyl chains.
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FIGURE 3.25.
The effect on activity of lignocaine 3-hydroxylase of incorporating 
enzymes derived from male rat liver into vesicles prepared from 
phosphatidylcholines having different acyl chains.
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see figure 3.24.
For DAPC, DOPC, DBPC, DSPC, DLPC, DCPC abbreviations see figure 
3.24.
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3 . 5 .  THE EFFECT OF DIABETES MELLITUS INDUCED BY 
STREPTOZOTOCIN ON THE METABOLISM OF LIGNOCAINE 
BY THE RAT LIVER.
3 . 5 . 1 .  Changes Produced by Streptozotocin-Induced Diabetes in 
R ats.
The injection of a single dose of 60 mg of streptozotocin/kg body weight to rats 
produced a constant hyperglycemia after 24 hrs. On the day of treatment the body 
weights of animals in the three experimental groups did not differ significantly but 
during the remainder of the experiment the diabetic rats lost weight compared to the 
controls (Table 3.8.) although they were exposed to the same amount of food and drink. 
Livers from diabetic rats were significantly lighter than those from controls when 
expressed as g/100 g body weight (Table 3.8.). The liver weights of the 21-day diabetic 
rats were lower than the livers of 3-day diabetic rats, but these values were about the 
same when expressed relative to the body weights (Table 3.8.).
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TABLE 3.8.
Changes in body and liver weights in normal and streptozotocin-diabetic rats
Treatment Body weight 
before treatment (g)
Body weight 
after treatment (g)
Liver weight 
(g)
Liver wt/  
body wt x 100
Serum glucose 
(mM)
Control 340 ± 22 340 ± 22 15.8 ± 1.8 4.8 ± 0.74 5.9 ± 0.7
3-day diabetics 352 ± 25.8 330 ± 20 11.8 ± 2.4 3.5 ± 0.43 19 ± 2.5
21-day diabetics 344 ± 16 277 ± 26 10.1 ± 1.3 3.6 ±  0.8 16.3 ± 3.3
Results expressed as absolute weights or g / 100 g body weight.
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3.5.2. The Effect of Lipid Fractions Extracted from Streptozotocin- 
Diabetic Rat Liver on the Metabolism of Lignocaine by a 
Reconstituted Drug Metabolising System.
Figure 3.26. shows the effect of incorporating delipidated microsomal protein 
derived from male rat liver into vesicles prepared from microsomal lipid derived from 
control, 3-day and 21-day diabetic rats on the metabolism of lignocaine to its N- 
deethylated metabolite. It is seen that the microsomal lipid extracted from diabetic rats 
gave a significantly lower N-deethylase activity as compared to the control. It should be 
noted that the inhibition was greater in the microsomal lipid derived from 21-day diabetic 
rats. As is seen in figure 3.27. there is no effect of lipids extracted from diabetic rat 
livers on the 3-hydroxylation of lignocaine. Figure 3.28. shows the effect of preparing 
vesicles from the phospholipid fraction derived from control, 3-day and 21-day diabetic 
rats on the metabolism of lignocaine to its N-deethylated metabolite. It is seen that the 
phospholipids derived from diabetic rat liver were significantly worse in reconstituting 
the metabolising system. Again phospholipids derived from 21-day diabetic rats gave 
the lowest N-deethylase activity. Figure 3.29. shows there is no effect on lignocaine 3- 
hydroxylase of phospholipids derived from diabetic rats. Figure 3.30. shows the effect 
of incorporating male-derived, delipidated microsomal enzymes into vesicles prepared 
from a mixture of neutral lipid and phospholipid derived from control, 3-day and 21-day 
diabetic rats. It is seen that the N-deethylase activity was altered by the use of the lipid 
fractions derived from diabetic rats in the same manner as seen for the total microsomal 
lipid. The addition of the neutral lipid fraction to the phospholipid fraction gave a higher 
N-deethylase activity in all experiments performed. As with other fractions tested, no 
effect of the neutral lipid/phospholipid mixture was seen on lignocaine 3-hydroxylase
activity (figure 3.31.).
A summary of the effect of lipid fractions from diabetic rat livers on
lignocaine metabolism is given in Table 3.9.
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FIGURE 3.26.
The effect on lignocaine N-deethylase activity of incorporating male-derived
delipidated microsomal protein into vesicles prepared from the microsomal lipids derived
from control; 3-day and 21-day diabetic rat livers.
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Results are expressed as mean ± s.d. of six values. 
**= p < 0.001; * = p < 0.01 as compared to control.
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FIGURE 3.27.
The effect on lignocaine 3-hydroxylase activity of incorporating male-derived
delipidated microsomal protein into vesicles prepared from the microsomal lipids derived
from control; 3-day and 21-day diabetic rat livers.
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Results are expressed as mean ± s.d. of six values.
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FIGURE 3.28.
The effect on lignocaine N-deethylase activity of incorporating male-derived
delipidated microsomal protein into vesicles prepared from the microsomal phospholipid
derived from control; 3-day and 21-day diabetic rat livers.
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Results are expressed as mean ± s.d. of six values. 
t=  p < 0.05; ** = < 0.001 as compared to control.
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FIGURE 3.29.
The effect on lignocaine 3-hydroxylase activity of incorporating male-derived
delipidated microsomal protein into vesicles prepared from the microsomal phospholipid
derived from control; 3-day and 21-day diabetic rat livers.
0.4 -i
0
LT)TT1
Ph
& 0 .3 -
0 .2 -
•rdsPt
n
£
0.1  -
0.0
Z -Jfydro 'xyta tio ri
■  Male Control 
ED 3-4ay 
□  21-day
Results are expressed as mean ± s.d. of six values.
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FIGURE 3.30.
The effect on lignocaine N-deethylase activity of incorporating male-derived
delipidated microsomal protein into vesicles prepared from the mixture of phospholipid
and neutral lipid derived from control; 3-day and 21-day diabetic rat livers.
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Results are expressed as mean ± s.d. of six values. 
*= p < 0.01; **= p < 0.001 as compared to control.
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FIGURE 3.31.
The effect on lignocaine 3-hydroxylase activity of incorporating male-derived
delipidated microsomal protein into vesicles prepared from the mixture of phospholipid
and neutral lipid derived from control; 3-day and 21-day diabetic rat livers.
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TABLE 3.9.
The effects of incorporation of male delipidated proteins into vesicles 
prepared from control; 3-day and 21-day diabetic male microsomal lipid.
Lipid derived from N -deethylase 3-hydroxylase
W h o l e  l i p i d
Control 1.8 ± 0.13 0.31 ± 0.02
3-day diabetic 1.2 ± 0.15* 0.33 ± 0.01
21-day diabetic 0.9 ± 0.06** 0.28 ± 0.05
P h o s p h o l i p i d
Control 1.45 ± 0.05 0.32 ± 0.01
3-day diabetic 1.2 ± 0.081 0.29 ± 0.04
21-day diabetic 0.7 ± 0.03** 0.29 ± 0.02
N e u t r a l  1 i p i d / P h o s p h o 1 i p i d
Control 1.8 ± 0.12 0.31 ± 0.01
3-day diabetic 1.2 ± 0.0.25* 0.30 ± 0.02
21-day diabetic 0.8 ± 0.03** 0.28 ± 0.03
Results are expressed as nmoles product formed/min/nmole cytochrome P-450 
and as mean ± s.d. of six values.
** = p < 0.001; * = < 0 .0 1 ;t = P<  0.05 as compared to respective controls.
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3 . 5 . 3 .  The Effect of Lipid Fractions Extracted from the Streptozotocin- 
Diabetic Rat on the Metabolism of Lignocaine by a Male-Specific 
Isozym e of Cytochrome P-450 in a R econstituted Drug 
M etabolising System.
Figure 3.32. shows the effects of incorporating the male-specific cytochrome P- 
450 isozyme into vesicles prepared from control; 3-day and 21-day diabetic male- 
derived microsomal lipids. It is seen that there is an inhibition of the N-deethylation of 
lignocaine when the enzyme is incorporated into microsomal lipid derived from 3-day 
diabetic animals, the inhibition was even greater when the same enzyme was 
incorporated into 21-day diabetic microsomal lipid. Figure 3.33. shows the effect of 
incorporating the enzymes into vesicles prepared from hepatic microsomal phospholipid 
derived from male 3-day and 21-day diabetic animals. The vesicles prepared from the 3- 
day diabetic-derived phospholipid gave a lower N-deethylase activity than those 
prepared from the phospholipid derived from the control male. Phospholipid vesicles 
prepared from 21-day diabetic animals were very poor in reconstituting the N- 
deethylating activity of the isozyme. Figure 3.34. shows the effects of preparing 
vesicles from phospholipid/ neutral lipid mixtures from male, 3-day and 21 day diabetic 
rats. Both diabetic fractions gave lower N-deethylase activity when compared to the 
control activity. In all cases, the 3-hydroxylase activity of the isozyme could not be 
detected.
A summary of the effects of lipids derived from diabetic rat livers on 
the N-deethylation activity of a male-specific isozyme on cytochrome P-450 
is given in Table 3.10.
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FIGURE 3.32.
The effects of incorporating male-specific cytochrome P-450 isozyme into 
vesicles prepared from control; 3-day and 21-day diabetic male-derived microsomal 
lipids (N-deethylase activity).
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Results are expressed as mean ± s.d. of six values. 
* = p < 0.01; ** = P < 0.001 as compared to control.
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FIGURE 3.33.
The effects of incorporating male-specific cytochrome P-450 isozyme into 
vesicles prepared from phospholipid derived from control; 3- and 21-day diabetic 
rats.(N-deethylase activity).
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Results are expressed as mean ± s.d. of six values. 
* as p < 0.01; ** = P < 0.001 as compared to control.
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FIGURE 3.34.
The effects of incorporating male-specific cytochrome P-450 isozyme into
vesicles prepared from mixture of phospholipid and neutral lipid derived from control;
3-day and 21-day diabetic male rats (N-deethylase activity).
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Results are expressed as mean ± s.d. of six values. 
** = P < 0.001 compared to respective control.
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TABLE 3.10.
The effect of lipids derived from diabetic rat livers on the N-deethylating activity of a
male-specific isozyme of cytochrome P-450.
Lipid derived from N -deethylation
Who e lipid
Control 2.3 ± 0.30
3-day diabetic 1.2 ±0.13*
21-day diabetic 0.9 ±0.1**
Phosp lo lip id
Control 1.45 ±0.1
3-day diabetic 1.2 ± 0.06*
21-day diabetic 0.8 ± 0.04**
N eutral lipid/PhosphoIipid
Control 1.8 ±0.15
3-day diabetic 1.2 ± 0.08**
21-day diabetic 0.8 ± 0.15**
Results are expressed as nmoles product formed/min/nmole cytochrome P-450 and as 
mean ± s.d. of at least six values.
** = p < 0.001; * = p < 0.01 as compared to respective controls.
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3 .5 .4 .  Resolution of the Microsomal Phospholipid Composition of 
Streptozotocin Treated Rats.
Figure 3.35. shows the phospholipid composition of liver microsomes in control 
and streptozotocin treated rats. The individual phospholipids from liver microsomes 
were separated by TLC and lipid phosphorus measured as described in the Materials and 
Methods 2.17. It is seen that the microsomal phospholipid phosphorus was 8% lower in 
the 3-day diabetic animals compared to controls. The phospholipids were separated into 
their major individual fractions i.e. phosphatidylcholine (PC), phosphatidylethanolamine 
(PE) phosphatidylserine (PS), and phosphatidylinositol (PI). Control microsomal 
phospholipid contained 57% phosphatidylcholine, 25% phosphatidylethanolamine, 10% 
phosphatidylinositol and 4% phosphatidylserine. There were significant changes in the 
amount of phosphatidylcholine, phosphatidylethanolamine in the 3-day diabetic rats. It 
is seen that the microsomal phospholipid phosphorus was decreased 40% in the 21-day 
diabetic animals compared to controls. There were significant changes in the 21-day 
diabetic microsomal phospholipid components appearing as a 34% decrease in 
phosphatidylcholine content, 25% decrease of the phosphatidylethanolamine content but 
no significant change in the phosphatidylinositol and phosphatidylserine content
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FIGURE 3.35.
Phospholipid composition of liver microsomes in control, 3-day
and 21-day diabetic rats.
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phosphatidylserine (PS) and phosphatidylinositol (PI).
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3 .5 .5 .  Fatty Acid Composition of the Microsomal Phospholipid in
Streptozotocin Treated Rats.
Figure 3.36. shows the fatty acid composition of microsomal phospholipid in 
the control; 3-day diabetic and 21-day diabetic rats. Liver microsomal phospholipid fatty 
acid composition is altered in the diabetic rats with significantly increased proportions of 
stearate (C18.0) and linoleate (C18.2) and dramatically decreased proportions of 
arachidonate (C204) ^  palmitoleate all of these changes are seen clearly in the
21-day diabetic animals. In 3-day diabetic animals there was no difference seen with 
respect to. stearate (C18.0) palmitoleate (C16.j) and oleate (C18<1). No differences were 
seen in the palmitate (C16.q) in all three fractions.
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FIGURE 3.36.
Microsomal phospholipid fatty acid composition in control; 3-day- and 21-day 
diabetic rats. Fatty acid composition was determined by gas chromatography as 
described in Materials and Methods section (2.18.). Control (n = 3); 3-day (n = 3) and 
21-day diabetic (n = 3).
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4 .1 .  THE SUBSTRATE.
The use of lignocaine as a substrate was suggested by the continuing research in 
this department into the hormonal control of drug metabolism, (Skett and Gustafsson 
1979; Skett and Young 1982; Skett and Weir 1983; Skett et al., 1984; Skett and Joels 
1985; Skett and Barr 1985). Lignocaine is a substrate which has been shown to possess 
sex differences in metabolism; it exhibits a male-specific N-deethylation and a sexually 
independent 3-hydroxylation (von Bahr et al., 1977). It, thus, is ideal for the study of 
the maintenance of sex differences in drug metabolism as there is an inbuilt control 
activity for direct comparison. To reinforce the use of lignocaine, the microsomal 
metabolism was determined using microsomes prepared as described in Materials and 
Methods 2.3.2. before the solubilisation process and with the concentrations of 
substrate and cofactors to be used in the later experiments. The incubation, separation 
and identification of metabolites was by the modified method of Skett et al., 1980 
(Materials and Methods 2.12.). The results obtained are in agreement with the 
previously published reports on lignocaine (Skett and Young 1982). These results 
confirmed the finding that, the rate of N-deethylation was faster in the male microsomes 
than the female microsomes, whereas the rate of the 3-hydroxylation activity was similar 
in both sexes.
4 .2 .  T H E  E F F E C T  OF ADDED L IP ID  C O M P O S IT IO N  ON
LIGNOCAINE METABOLISM BY DELIPIDATED MICROSOMES
FROM  MALE AND FEMALE LIVER.
The methods employed in this study i.e., the delipidation of solubilised 
microsomal proteins and subsequent reconstitution with lipids of known origin, gave a 
method for studying in isolation the role of lipids in the control of drug metabolism. 
After optimal reconstitution (lmg. lipid to 0.1 nmole cytochrome P-450) the added 
lipids accounted for over 97% of the total lipid fraction and the ratio of other
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components was little changed from the original microsomal suspension (Table 3.1 and 
3.2). In this study it is seen that, for the assay conditions used, a sex difference in 
metabolism is seen for the microsomal preparation (figure 3.1.) and that incorporation of 
microsomal enzymes into a membrane containing DLPC and DLPE in the proportions 
found in the microsomes (3:l(w/w) DLPC:DLPE), (DePierre and Emster, 1975) gave 
an increased N-deethylating activity from the male derived enzymes (figure 3.4.) but no 
significant change in the female-derived enzymes (figure 3.3.) or the 3-hydroxylase 
activity measured in the male derived enzyme preparation (figure 3.3. and 3.4.). There 
is, thus, both a sex-and pathway-dependent effect of DLPE. An effect of incorporation 
of PE is well documented: Ingelman-Sundberg and Glaumann (1980) working with the 
rabbit cytochrome P-450 LM2, showed that PE was better than PC in maintaining 7- 
ethoxycoumarin O-dealkylation. These authors suggested that this effect was due to a 
charge difference between the different lipids (Haaparanta et al., 1980). It is interesting 
to note that the only effect seen of DLPE was in the male-derived system with the male- 
specific enzyme (the N-deethylase) (Skett et al., 1980). This indicates that the male- 
specific enzymes are more susceptible to alteration of lipid composition. This could be 
due to a sex-specific enzyme in the male being dependent on membrane charge or 
membrane fluidity, both of which are altered by the incorporation of DLPE (Ingelman- 
Sundberg et al., 1981; Strobel et al., 1970). The existence of a sex-specific cytochrome 
P-450 species in the male has been reported (Waxman 1984; Morgan et al., 1985).
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Another possible explanation is an interaction with other proteins contained in the 
protein fraction of the microsomes. The most likely candidate is cytochrome which is
present in the incubations and can influence metabolism catalysed by cytochrome P-450 
(Ingelman-Sundberg and Glaumann, 1980). This possible influence of cytochrome b^
would need to be followed up using purified preparations of cytochrome P-450 and 
cytochrome b5.
In this study it was seen that the microsomal lipid was more effective than DLPC 
in reconstituting N-deethylase activity in both male- (figure 3.5.) and female-derived 
(figure 3.6.) enzyme preparations but, as before, 3-hydroxylase activity was unaffected. 
This agrees with earlier work with partially purified enzymes (J. Barr, Ph.D. Thesis, 
University of Glasgow, 1985) and with previous findings with rabbit cytochrome P-450 
LM2 (Ingelman-Sundberg et al., 1981). Dilauroylphosphatidylcholine (DLPC), was 
found to stimulate drug metabolism in a reconstituted enzyme system (Miwa and Lu, 
1981), although Parke (1981) suggested that this is an oversimplification of the in vivo 
situation as DLPC does not exist in microsomes and Taniguchi et al. (1984) have 
suggested that the enzyme insertion and interactions are affected differently when DLPC 
is used rather than vesicles prepared from natural phospholipid. The male-derived 
enzymes show a decreased N-deethylase activity in female-derived lipids but 3- 
hydroxylase activity is not significantly affected (figure 3.7.). This is similar to the 
effect seen by Barr and Skett (1984) using partially purified cytochrome P-450 and 
reductase preparations. As in the previous experiment, only the sex-dependent (male- 
specific) enzyme is affected using the female-derived lipids. It is noted that the sex 
difference seen for the N-deethylase in the microsomal preparation used (figure 3.7.) is 
only fully expressed if the correct lipid preparation is used i.e., male enzymes and male 
lipid mixture compared to the female reconstitution (figure 3.8.).
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The microsomal lipids, as prepared, contain a complex mixture of phospholipids 
as well as triglycerides and cholesterol. Any of these components could account for the 
differences seen. Indeed, cholesterol has been reported to affect' the metabolism of 
drugs when incorporated into DLPC vesicles (Skett and Cuthill 1986). Sex differences 
also exist in the proportions and fatty acid composition of the hepatic microsomal 
phospholipid (Belina et.al. 1975) and these differences could lead to the effects seen.
In summary, the N-deethylation of lignocaine catalysed by delipidated 
microsomal proteins from male and female rat liver is greater when reconstituted in 
microsomal lipid than in DLPC. The 3-hydroxylation of lignocaine is unaffected by this 
treatment. The above effect is mimicked by incorporation of DLPE into the DLPC 
vesicles with male- but not the female-derived enzymes. Microsomal lipids derived from 
the male were more effective than female-derived lipids in reconstituting enzyme 
activities with both male-and female-derived enzymes. In addition, the sex-dependence 
of the metabolism of lignocaine was maintained in the reconstituted system, indicating 
that this is a suitable system for investigating the role of lipids in maintaining sex- 
specific drug metabolism.
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4 .3 .  PU RIFICA TIO N  AND CH A RA CTERIZA TIO N  OF TH E MALE- 
SPEC IFIC  ISOZYM E OF CYTOCHROM E P-450, LIGNOCAINE 
N -D EETH Y LA SE.
Cytochrome P-450 in liver microsomes plays a major role in the oxidation of a 
wide variety of exogenous and endogenous compounds. The existence of two sex- 
dependent forms of cytochrome P-450 were first demonstrated by Kato and Kamataki
(1982) and Kamataki et al. (1982) and they have been designated cytochrome P-450- 
male and cytochrome P-450-female. The male form was shown to metabolise 7- 
propoxycoumarin, aniline, aminopyrine and benzphetamine better than the female. The 
cytochrome P-450-male did not show any 6(3—hydroxylase activity. Sex-related 
differences of cytochrome P-450-dependent oxidations of many drugs and steroid 
hormones in rat liver microsomes have been well documented (Kato and Onoda, 1970; 
Kato, 1974; Colby, 1980; Gustafsson et al., 1980) (see Introduction 1.3.) and several 
forms of cytochrome P-450 have been shown to participate in the hydroxylation of 
testosterone with different regio- and stereoselectivities (Ryan et al., 1984a;; Cheng and 
Schenkman 1983; Waxman 1988).
In this study the purification of the male-specific cytochrome P-450 isozyme was 
performed by the technique suggested by Waxman and Walsh (1983) (Materials and 
Methods 2.4.5.). The percentage recovery of the cytochrome P-450 shown in Table
3.4. is in full agreement with other workers who suggest that the content of this isozyme 
in the microsomes is less than 1% (Morgan et al., 1985; Waxman 1984). The isozyme 
of cytochrome P-450 which has been isolated from male rat liver was homogeneous (at 
least 95% in a single protein band) as assayed by SDS-PAGE. The isozyme has a 
minimum molecular weight of approximately 52000 and a specific content of 12.8 
nmoles cytochrome P-450/mg protein. The protein was found to have a specific activity 
for the 16 a-hydroxylation of 4-androstene-3,17-dione of 10 nmoles/min/nmole 
cytochrome P-450. These data suggest that the isozyme under study is the male specific
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isozyme 2c of Waxman (1984) and RLM5 of Morgan et al. (1985). The results obtained 
by Waxman (1984) suggest that this isozyme can perform 6p-hydroxylation and 7 a -  
hydroxylation which was not detected by us. A possible explanation for these 
differences lies in the difference in the reconstitution methods or the change of lipids 
from DLPC to total natural microsomal lipids. A change in the metabolic profile of 
steroid (testosterone) hydroxylation has been reported using partially purified 
cytochrome P-450, where DLPC was replaced by microsomal lipids but 6 p — 
hydroxylation was unaffected (Shiverick and Neims 1979). Ryan et al. (1984b) 
suggested that it would seem that the metabolism of steroids by the cytochrome P-450 
linked hydroxylation system is regiospecific, but this may also be regulated by the 
membrane used in reconstitution studies and not only by the species of cytochrome P- 
450 present. The isozyme was found to have the highest lignocaine N-deethylase 
activity. We, thus, consider that this enzyme is responsible for the N-deethylation of 
lignocaine seen in microsomes. However, it cannot be considered as the P-450 species 
involved in the 3-hydroxylation of lignocaine since this is not produced by this isozyme 
in these reconstitution experiments.
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4 . 3 . 1 .  The Effect of Vesicle Lipid Composition on the Metabolism
of Lignocaine by a Male-Specific Isozyme of Cytochrome P-450,
Lignocaine N-Deethylase.
Kamataki et al. (1980) suggested that the terminal oxidase, cytochrome P-450, 
would be responsible for the expression of all sex differences. The data presented in this 
section does not agree with those workers (for review, see Lu and West, 1980; Skett, 
1987) who attribute any sex difference exhibited in microsomal metabolism only to 
different forms of cytochrome P-450. Sex differences in cytochrome P-450 do exist 
(Waxman 1988; Morgan et al., 1985; McIntosh et al., 1980; Kato et al., 1986; Yamazoe 
et al.,. 1986a) but there are also differences in the lipid composition of the membrane 
(Belina et al., 1975) which are thought to be correlated to changes in drug metabolism 
(Cooper and Feuer 1972 a, b; Feuer, 1978). In an attempt to ascertain the respective 
roles of the cytochrome P-450 and lipid in control of sex differences in drug 
metabolism, we have isolated and reconstituted the various components into a functional 
enzyme system. As can be seen from figure 3.15., in the assay conditions used, an 
increase in the metabolism of lignocaine to its N-deethylated derivative is seen when the 
male-specific isozyme of cytochrome P-450 is incorporated into a membrane containing 
a mixture of DLPC and DLPE in the proportions found in the microsomes (3:l(w/w) 
DLPC:DLPE) (DePierre and Ernster 1975) rather than DLPC alone. An effect of 
incorporation of PE on cytochrome P-450-dependent metabolism is well documented as 
outlined earlier (Section 4.8.). This is similar to the effect of DLPE seen in our earlier 
work (section 4.2.) using delipidated microsomes. This indicates that the male-specific 
isozyme is susceptible to alteration of activity by lipid composition. This could be due to 
the enzyme (Morgan et al., 1985; Waxman 1984) being dependent on membrane charge 
or membrane fluidity, both of which are altered by the incorporation of DLPE (Strobel et 
al., 1970; Ingelman-Sundberg et al., 1980) or indeed it might be due to an alteration in 
the protein-protein interaction, (Taniguchi et al., 1984). These results would also
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suggest that cytochrome is not needed for the effect of DLPE to be seen and thus, the 
lipid must interact with the cytochrome P-450 and/or the NADPH cytochrome P-450 
reductase only.
In figure 3.16. the effect of incorporation of isozyme into microsomal lipids 
derived from male and female animals is shown. The female derived lipids gave a 
decrease in N-deethylase activity. This is similar to the effect seen by Barr and Skett 
(1984) using partially purified cytochrome P-450 and reductase preparation and our 
earlier work (section 3.2.) using delipidated microsomes. It is noted that the sex 
difference seen for the N-deethylase in the microsomal preparations is only fully 
expressed if the correct lipid preparation is used i.e., male-derived enzymes and male 
lipid mixture. In all experiments it was seen that the microsomal lipid was more effective 
than DLPC in reconstituting N-deethylase activity and male-derived lipids gave a higher 
enzyme activity than the DLPC/DLPE mixture (figure 3.17.). This agrees with earlier 
work with partially purified enzymes (Barr, 1985) and with previous findings with 
rabbit cytochrome P-450 LM2 (Ingelman-Sundberg et al., 1981). As discussed earlier 
(Section 4.8.) the microsomal lipids, as prepared, contain a complex mixture of 
phospholipid as well as triglycerides and cholesterol and any of these components could 
account for the differences seen. Sex differences exist in the proportions and fatty acid 
composition of the hepatic microsomal phospholipids (Belina, 1975; Rowe and Wills 
1976; Lambert and Wills 1977a, b) and these differences could lead to the effects seen.
In summary, the N-deethylation of lignocaine catalysed by a purified male- 
specific cytochrome P-450 from rat liver is greater when reconstituted in microsomal 
lipid than in DLPC. Microsomal lipids derived from the male were more effective than 
female-derived lipids in reconstituting enzyme activity.
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4 .4 .  T H E  E F F E C T  O F D IF F E R E N T  F R A C T IO N S O F L IP ID
EX TRA CTED  FROM  M ALE AND FEM A LE RATS ON THE
M ETA BO LISM  OF LIG N O C A IN E BY A R EC O N STITU TED
ENZYM E SYSTEM.
In the previous series of experiments it had been established that the male- 
specific lignocaine N-deethylase activity of delipidated microsomes and a purified 
cytochrome P-450 could be modulated by total microsomal lipids, with the male-derived 
lipids giving a higher activity. Thus, it seemed likely that part, if not all, of the sex 
differences in lignocaine N-deethylase was mediated by sex-dependent microsomal 
lipids. As explained in the Introduction (1.8) the total microsomal lipid is likely to 
contain, aside from phospholipid, differing quantities of cholesterol, fatty acids and 
triglycerides and this mixture is difficult to create artificially. The lipid membrane of the 
endoplasmic reticulum is known to be sexually differentiated (Belina et al., 1975) and 
the control of sex differences in metabolism seen previously may reside in any of the 
lipid fractions or in the fatty acid composition of the phospholipid. In order to 
investigate which fraction of the microsomal lipid is responsible for the activity seen in 
the total microsomal lipid, total lipids were extracted from the microsomes and 
fractionated into the two main classes, phospholipid and neutral lipids. Working on the 
assumption that a single fraction or a mixture of the different lipid fractions may be 
responsible for the sex differences seen in the rat liver microsomes, it was thought that 
delipidation of solubilised microsomal proteins and subsequent reconstitution with 
different fractions of lipids of known origin, would be a good method for studying, in 
isolation, the role of different lipid fractions in the control of sex differences in drug 
metabolism. Figure 3.18. shows the effects of incorporating male-derived enzyme into 
vesicles prepared from phospholipid (PL) and a neutral lipid (NL)/PL mixture derived 
from male and female livers. It is seen that the enzymes derived from male rats showed a 
lower N-deethylating activity in female-derived phospholipid and phospholipid/neutral
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lipid fraction than in the respective male-derived lipids. For the male-derived lipid 
fractions, the mixture of PL and NL gave a greater N-deethylating activity than PL alone 
but this was not the case for the female-derived lipids. Neutral lipids alone do not form 
vesicles and thus no result was obtained for NL alone. The 3-hydroxylating activity of 
both the male- and female-derived enzyme preparation was not significantly affected by 
any lipid fraction (figure 3.19. and 3.21.). The effect of phospholipid on cytochrome P- 
450-dependent oxidation is well documented (Lu and Levin, 1974; Lambeth, 1985) and 
it was thought that the requirement for phospholipid was to provide a generalised 
hydrophobic environment (it can be replaced in part by detergent). Haaparanta et al. 
(1980) noted that, for the cytochrome P-450 LM2-catalysed O-deethylation of 7- 
ethoxycoumarin and oxygenation of benzopyrene, the existence of negatively charged 
phospholipid caused significant stimulation of activity in a reconstituted system. It is 
also thought that phospholipid composition or concentration could affect the functioning 
of the microsomal enzyme system by a variety of mechanisms (i.e. change in fatty acid 
side chain; unsaturation of the phospholipid fatty acyl side chain and change in the 
phospholipid/cholesterol ratio).(Wills 1980; Dhami et al., 1980). Figure 3.20. shows 
the effect of incorporating female enzymes into vesicles prepared from phospholipid 
(PL) and phospholipid/neutral lipid (NL/PL) mixture derived from male and female 
livers. It is seen that the enzymes derived from the female showed a decreased N- 
deethylating activity in female derived lipids when compared to the male derived lipid 
fractions. From the two experiments, it is interesting to note that the N-deethylating 
activity was higher in the male-derived vesicles than the female derived vesicles for both 
male- and female-derived enzymes. One possible reason for this enhancement is the 
presence of more cholesterol in the male-derived neutral lipid fraction. Indeed, 
cholesterol has been reported to affect the metabolism of drugs when incorporated into 
DLPC vesicles (Skett and Cuthill 1986) (see introduction 1.10.4.).
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4 .4 .1 .  The Microsomal Phospholipid Composition in Male and
Female Rat Liver.
Figure 3.22. shows the phospholipid composition of liver microsomes in male 
and female rats. The phospholipids were separated into their major individual fractions, 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), 
and phosphatidylinositol (PI). It is seen that the total microsomal phospholipid 
phosphorus was significantly higher in the male than the female animals. This is similar 
to the finding of Belina et al. (1975). Among individual microsomal phospholipids, 
phosphatidylcholine was significantly higher in the male than the female rats (again in 
agreement with the report of Belina et al. (1975)). Phosphatidylethanolamine was 
significantly higher in the male than the female rats (not reported by Belina et al. (1975)) 
whereas phosphatidylinositol and phosphatidylserine were similar in both sexes. The 
higher concentration of PE in the male lipids fits in well with the fact that PE can 
stimulate lignocaine N-deethylase activity as does male-derived lipid. The ratio of 
PC/PE, however, was not sex differentiated and therefore of little or no significance. It 
seems unlikely that PS and PI are involved in maintaining sex differences in lignocaine 
metabolism. Fatty acid analysis of the microsomal phospholipid extracts showed that 
there was no sex differences in palmitoleate (C16>1) or palmitate (C16.0). However the 
stearate (C18.0) was significandy higher in the female microsomal phospholipid fraction
than in the male microsomal phospholipid fraction. The microsomal lipid of females had 
half as much arachidonate (C20.4) as in the male and linoleate (C18;2) was considerably 
higher in the male than the female There was little difference in oleate (C18;1) content. It 
should be noted that the total unsaturated fatty acid content of male livers was 
considerably higher than the females. This sex difference in saturated/unsaturated ratio 
was similar to that reported by Feuer et al. (1980). There are thus, marked sex 
differences in some of the phospholipid classes and in the fatty acid composition of the 
microsomal phospholipids in the rat.
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4 .5 .  TH E E FFE C T  OF TH E FATTY ACID ACYL CH A IN OF
P H O S P H A T ID Y L C H O L IN E  ON T H E  M E T A B O L IS M  OF
LIGNOCAINE BY A RECONSTITUTED DRUG M ETABOLISING
ENZYME SYSTEM.
In 1968 Lu and Coon reported that one of the three components of their resolved 
and reconstituted fatty acid hydroxylation system was a heat stable, organic extractable 
factor. This same lipid fraction was found later to be essential for the reconstitution of a 
drug metabolising system. When this lipid fraction was fractionated by a silicic acid 
column (Lu et al., 1969a), the active fraction was found to have the same Rf value as the 
phosphatidylcholine standard. Furthermore, synthetic phosphatidylcholine was found to 
be as active as the crude lipid fraction in the reconstituted system. With this fact in mind 
and because of the data discussed in the previous section on the sex differences in fatty 
acyl side chain of the extracted phospholipid, we chose phosphatidylcholine having 
various acyl side chains to investigate the role of the fatty acyl chain in maintaining sex 
differences in lignocaine metabolism. Delipidated solubilised microsomes, prepared 
from male Wistar rats, were used in these studies and were incorporated into vesicles 
prepared from various PCs (phosphatidylcholine) containing fatty acids of differing 
chain length and degree of unsaturation [dicaproylphosphatidylcholine (6:0); 
dilauroylphosphatidylcholine (12:0); distearoylphosphatidylcholine (18:0); 
dibehenoylphosphatidylcholine (22:0); dioleoylphosphatidylcholine (18:1) and 
diarachidoylphosphatidylcholine (20:4)]. All of the PCs were found to restore the N- 
deethylase activity of the cytochrome P-450 but to differing extents (figure 3.24.). 
Phosphatidylcholines having longer acyl chains were more efficient and the unsaturated 
PC (18:1) reconstituted the enzyme activity better than did the saturated PC of the same 
chain length (18:0). Diarachidoyl (20:4) PC gave the highest enzyme activity. It seems 
therefore that the longer the chain length and the more unsaturated the acyl side chain is, 
the better it is at reconstituting lignocaine N-deethylase activity. These results would
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seem to correlate well with earlier reports that feeding a lipid-free diet causes an 
inadequate synthesis of microsomal hydroxylating enzymes and cytochrome P-450 and 
that induction of cytochrome P-450 by phenobarbitone is much less efficient when 
saturated fatty acids are incorporated into the diet as the sole source of dietary lipid than 
when unsaturated fats are fed (Marshall and McLean 1971; Rowe and Wills 1976; Wills 
1980). It has therefore been postulated that the polyunsaturated fatty acids might play an 
important role in the activity of the microsomal drug metabolising system (Marshall and 
McLean 1971). The fatty acids present in the microsomal lipid have also been seen to 
change the spin state of cytochrome P-450 and this has been related to the ability of the 
terminal oxidase to function (Gibson and Tamburini, 1984; Rispin et al., 1984; Gibson 
et al., 1980). Contrary to the results seen from the N-deethylase activity, the 3- 
hydroxylating activity is unaffected by the fatty acid chain length or the number of 
double bonds except when the chain length is reduced to 6 carbon atoms (DCPC). Short 
chain PC is known to prefer the micellar phase rather than a vesicle system which could 
affect the protein-lipid reconstitution system (Dencher 1986).
Lignocaine N-deethylase activity is, thus, activated preferentially by long chain, 
unsaturated fatty acyl side chains on the phospholipid. This would seem to correlate well 
with the higher content of linoleate (18:2) and arachidonate (20:4) and the lower content 
of stearate (18:0) in the male-derived lipid fraction, which also activates the N- 
deethylase activity.
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4 .6 .  T H E  E F F E C T  OF DIA BETES M ELL ITU S IN D U CED  BY 
STREPTO ZO TO CIN  ON THE M ETABOLISM  OF LIGNOCAINE 
BY THE RAT LIYER.
In order to further substantiate the apparent role of microsomal lipid composition 
and fatty acyl side chain on hepatic drug metabolism we decided to investigate this 
hypothesis in another (in this case pathological) condition in which drug metabolism is 
known to be affected. Diabetes mellitus, whether genetic or chemically-induced is 
known to markedly affected drug metabolism (Skett and Joels 1985; Skett 1987). The 
effect of diabetes mellitus are remarkably similar to the differences seen between male 
and female animals e.g. lignocaine N-deethylase is reduced in diabetic male animals but 
unaffected by diabetes in the female. The 3-hydroxylase is not effected by diabetes in 
either sex. Diabetes mellitus, thus affects the male-specific enzyme activity and only in 
the male. This is very similar to the effects of the lipids noted in the earlier part of the 
work described in this Thesis.
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4 .7 .  EFFECT OF LIPID EXTRACTED FROM THE DIABETIC RAT ON 
M ETA B O LISM  OF LIG N O C A IN E BY A R EC O N STITU TED  
ENZYM E SYSTEM.
It was decided to test whether some or all of the effects of diabetes on lignocaine 
metabolism could be ascribed to changes in lipid composition of the microsomes. We 
investigated the effect of incorporating delipidated microsomal protein derived from male 
rat liver into vesicles prepared from microsomal lipid derived from control, 3-day and 
21-day diabetic rats on the metabolism of lignocaine to its N-deethylated metabolite. The 
animals used were clearly diabetic as judged from serum glucose levels (> 16mM) and 
the fact that the livers from diabetic rats were significantly lighter than those from 
controls when expressed as g/100 g body weight. The liver weights of the 21-day 
diabetic rats were lower than the livers of 3-day diabetic rats, but these values were 
similar when expressed relative to the body weights. Similar result were obtained by 
Topping and Targ (1975). It is noted that the microsomal lipid extracted from diabetic 
rats gave a significantly lower N-deethylase activity as compared to the control. The 
inhibition was greater in the microsomal lipid derived from 21-day diabetic rats. There 
was no effect of lipids extracted from diabetic rat livers on the 3-hydroxylation of 
lignocaine. This would seem to indicate that the alteration of microsomal lipids does, 
indeed, play a role in the effect of diabetes mellitus on lignocaine metabolism in rat liver. 
If the microsomal lipids are separated into the neutral and phospholipid fraction and the 
fraction used to reconstitute enzyme activity as described previously, it is seen that the 
phospholipids derived from diabetic rat liver were significantly poorer than the control 
PL in reconstituting the metabolising system. Phospholipids derived from 21-day 
diabetic rats gave the lowest N-deethylase activity. There was no effect on lignocaine 3- 
hydroxylase of phospholipids derived from diabetic rats. The effects seen might be due 
to alteration in the phospholipid composition caused by the streptozotocin treatment such
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as that demonstrated by Faas and Carter (1983) who suggested that the fatty acid 
composition in the total lipid extract was altered to decrease palmitoleic, oleic and 
arachidonic acids and increased linoleic and docosahexaenoic acids. It was further noted 
in this study that the N-deethylase activity was altered by the use of the lipid fractions 
derived from diabetic rats in the same manner as seen for the total microsomal lipid. The 
addition of the neutral lipid fraction to the phospholipid fraction gave a higher N- 
deethylase activity in all experiments performed. As with other fractions tested, no effect 
of the neutral lipid/phospholipid mixture was seen on lignocaine 3-hydroxylase activity. 
The reason for this enhancement is unclear, but one can only suggest that the neutral 
lipid fraction as prepared contain cholesterol whose effect on drug metabolism is well 
documented (see introduction 1.10.4.). It thus appears that the activity of the diabetic 
lipid resides in the phospholipid fraction but this effect can be enhanced by the neutral 
lipid fraction. Other workers (Past and Cook, 1983) have shown that the diabetes affects 
the microsomal profile differently in the male and female rat and these authors suggested 
that such differences might contribute to the well documented sex differences in the 
effect of diabetes on microsomal drug metabolism in rats (Kato and Gillette, 1965; 
Reinke et al., 1978; Faas and Carter, 1980). Most of the investigators have explained 
the changes in the activity in the hepatic drug metabolism in terms of changes in the 
hepatic-P-450-composition (Past and Cook, 1982) but the results in this study 
demonstrate that the changes in the lipid composition caused by the treatment alter the N- 
deethylase activity. It could be argued that the diabetic lipids are simply acting as an 
inhibitory factor in these reconstitutions. An independent set of experiments have been 
carried out, however, showing that the lipids isolated from diabetic rats do not act as 
inhibitory factors when added directly to microsomal incubations. (Dr. Skett personal 
communication).
It is of further interest that the microsomal lipids from the diabetic male animal 
gave enzyme activities similar to that of the control female, exactly as would be expected
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in whole microsomal preparations. It would, thus, be of great interest to examine if the 
effect of the diabetic lipid was manifested in reconstitutions with the male-specific 
isozyme of cytochrome P-450 as was seen for the male and female microsomal lipids 
earlier in the study.
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4 . 7 . 1 .  The Effect of Lipid Fractions Extracted from Streptozotocin-
Diabetic Rat Liver on the Metabolism of Lignocaine by the Male-
Specific Lignocaine N-deethylase.
The effects of incorporating the male-specific cytochrome P-450 isozyme into 
vesicles prepared from control; 3-day and 21-day diabetic male-derived microsomal 
lipids has been studied and it is seen that there is an inhibition of the N-deethylation of 
lignocaine when the enzyme is incorporated into microsomal lipid derived from 3-day 
diabetic animals, the inhibition was even greater when the same enzyme was 
incorporated into 21-day diabetic microsomal lipid. The same effects are seen if 
phospholipid/neutral lipid mixtures are used for the reconstitution. The same arguments 
could be put forward here as discussed previously (Section 4.4.) to rationise the effects 
seen, namely that alteration in phospholipid composition or concentration could affect 
the functioning of the microsomal enzyme system by a variety of mechanisms (i.e. 
change in fatty acid side chain; unsaturation of the phospholipid, change in the 
phospholipid/ cholesterol ratio) (Steir, 1976). Indeed the rat liver microsomal fatty acid 
composition and fatty acid desaturation have been studied in streptozotocin diabetic rats, 
(Faas and Carter 1980; 1983; Holman et al., 1983) and it was found that streptozotocin 
induced diabetes changes the fatty acid composition of rat liver microsomal 
phospholipid. The authors demonstrated (Faas and Carter 1980; 1983) that the fatty acids 
such as linoleic and docosahexaenoic acids were increased whereas palmitoleic, oleic 
and arachidonic acids were decreased in the major microsomal phospholipids. 
Furthermore it has been found that, in alloxan-induced diabetic rats, the conversion of 
phosphatidylethanolamine to phosphatidylcholine by stepwise methylation was 
decreased (Faas and Carter 1983). It was suggested that most of these changes in fatty 
acid composition in the diabetic rat are caused by the diminished fatty acid desaturase 
activities, since the fatty acid composition can be corrected by insulin therapy (Nelson 
1980). Mathur et al. (1983) have demonstrated that the phospholipid fatty acid 
composition plays an important role in the membrane fluidity and certain enzyme
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activities. The nature of the dietary lipid, and especially the content of polyunsaturated 
fatty acids regulates oxidative drug and carcinogen metabolism in the liver endoplasmic 
reticulum (Rowe and Wills, 1976; Lambert and Wills, 1977a, b; Wills, 1980).
Thus, as with the effects of the male and female microsomal lipids, the effect of 
the lipid derived from the diabetic male rat liver appears to derive from a direct lipid- 
cytochrome P-450 interaction specific for the male-specific lignocaine N-deethylase or 
an interference with the cytochrome P-450 and NADPH-cytochrome P-450 reductase 
interaction. In the case of the male/female difference the basis of the effect seemed to lie 
in the relative fatty acid composition of the phospholipids. We hoped to get confirmation 
of this postulated correlation by analysing the composition of the microsomal lipid 
derived from the diabetic animals.
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4 .8 .  CHANGES IN M ICROSOM AL LIPID CO M POSITIO N  PRODUCED 
BY STREPTOZOTOCIN-INDUCED DIABETES IN RATS.
The phospholipid composition of liver microsomes in control and streptozotocin 
treated rats was investigated and it is seen that the microsomal phospholipid phosphorus 
was 8% lower in the 3-day diabetic animals compared to controls whereas the 
microsomal phospholipid phosphorus was decreased 40% in the 21-day diabetic animals 
compared to controls. The phospholipids were separated into their major individual 
fractions i.e. phosphatidylcholine (PC), phosphatidylethanolam ine (PE) 
phosphatidylserine (PS), and phosphatidylinositol (PI) and it was found that control 
m icrosom al phospholip id  contained 57% phosphatidylcholine, 25% 
phosphatidylethanolamine, 10% phosphatidylinositol and 4% phosphatidylserine. This 
is consistent with the finding of DePierre and Dallner (1975) and Faas and Carter
(1983). There were significant decreases in the content of phosphatidylcholine and 
phosphatidylethanolamine in the 3-day diabetic rats and in the 21-day diabetic 
microsomal phospholipid components appearing as a 34% decrease in 
phosphatidylcholine content, and a 25% decrease of the phosphatidylethanolamine 
content. Faas and Carter (1983), however, reported an increase in the total phospholipid 
in diabetic animals. Our study demonstrates that the fatty acid composition of 
microsomal phospholipid is altered by 3-day and 21-day diabetes in rats. Liver 
microsomal phospholipid fatty acid composition shows significantly increased 
proportions of stearate (C18;0) and linoleate (C18;2) and dramatically decreased 
proportions of arachidonate ( C ^ ) .  and palmitoleate (C16;1). All of these changes are
seen clearly in the 21-day diabetic animals. Faas et al. (1980, 1983) suggested that the 
lower proportion of palmitoleate (C16;1), is a result of diminished A9 desaturase activity
and the increase in linoleic acid and concomitant decrease in arachidonic acid may result 
from a diminished A  ^desaturase activity. This is also consistent with the finding of 
Topping and Targ (1975) and Takahashi et al. (1987). In 3-day diabetic animals there
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was no difference seen with respect to; stearate (C18.0), palmitoleate (C16.j) and oleate 
(^18: l)* There were no differences seen in the palmitate (Cj^.q) fraction in diabetes. 
These results agree with the finding of Mercuri et al. (1967).
If this data is compared to that for the sex differences in composition of 
microsomal phospholipid discussed in section 4.4.1., it is seen that there are marked 
similarities and differences. There is a similar decrease in PC and PE in both female and 
diabetic male lipids when compared to control males, stearate (18:0) is more prevalent in 
female and diabetic male phospholipid whereas arachidonate is lower in both as 
compared to the control male. On the other hand, palmitoleic acid (16:1) is decreased in 
diabetic phospholipids but does not exhibit a sex difference in distribution and linoleic 
acid (18:2) is lower in female phospholipids but higher than in the control male in 
diabetic male phospholipids.
As we know that the effect of the diabetic lipids is similar to female lipids when 
compared to control male lipids with respect to control of lignocaine N-deethylase 
activity and assuming that this is correlated to the composition of the lipid, we can rule 
out the content of palmitoleic, oleic and linoleic acids as of importance, this leaves the 
stearic and arachidonic acids and the increased amount of PC and PE as possible 
controlling influences. The ratio of PC/PE, however, changes little and is unlikely to 
influence activity (but cannot be entirely ruled out). Thus the content of stearate and 
arachidonate in microsomal phospholipids appears to be the most likely controlling 
influence for lignocaine N-deethylase in hepatic microsomes. Indeed, the content of 
arachidonic acid appears to correlate particularly well with lignocaine N-deethylase 
activity in all cases. The mechanism of this potential control is, at present, unknown.
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4 . 9 .  GENERAL DISCUSSION.
The early work on the mixed function oxidase system in the liver indicated the 
requirement for three essential components, namely cytochrome P-450, NADPH- 
cytochrome P-450 reductase and a heat stable, organic solvent extractable factor (Lu and 
Coon, 1968) later found to be phospholipid. This same fraction was later found to also 
be required for the hydroxylation of steroids, carcinogens, and the oxidative metabolism 
of many drugs, (Lu and Coon, 1968; Strobel et al., 1970). The requirement for lipids 
was further refined when dilauroylphosphatidylcholine (DLPC) was found the most 
effective in reconstituting the enzyme activity (Miwa and Lu, 1981). It has therefore 
found widespread use as an artificial membrane to characterise partially pure and highly 
purified forms of cytochrome P-450 (Guengerich, 1977a; 1977b; Johnson et al., 1979; 
Koop et al., 1981; Ryan et al., 1984a; 1984b; Hirada and Negishi, 1984). The 
continued use of dilauroylphosphatidylcholine (DLPC) is, however, an 
oversimplification of the endoplasmic reticulum and misrepresents the physiological 
situation, as DLPC does not exist in vivo. Taniguchi et al. (1984) have suggested that 
protein insertion and interaction is affected by this artificial phospholipid as compared to 
the natural lipids. In an attempt to ascertain the role of membrane lipid in the regulation 
of sex differences in drug metabolism, and based on evidence by Barr and Skett (1984) 
who demonstrated that the male-specific lignocaine N-deethylase activity was markedly 
inhibited by the female-derived microsomal lipid whereas the non-sex dependent 3- 
hydroxylase was unaffected, we have shown that the lipid component of the microsomal 
membrane is very important for the maintenance of the sex differences in drug 
metabolism. Our results do not agree with the work of Kamataki et al. 
(1980;1981;1982;1983;1986) who attributed the sex differences seen in microsomal 
metabolism purely to the cytochrome P-450 isozymes. We think that the main reason for
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this discrepancy is the continued use of the artificial dilauroylphosphatidylcholine 
(DLPC) by Kamataki and coworkers. As seen from the results, the use of the natural 
lipids give a totally different picture (Section 4.1.; 4.2.). Sex differences in cytochrome 
P-450 do exist (Introduction 1.3.1.) but there are also sex differences in microsomal 
lipid composition in the rat liver (Van Harken et al., 1969; Cooper and Feuer 1972a, b) 
and these have been correlated to altered drug metabolism in pregnancy (Neale and 
Parke 1973; Dhami et al., 1980; Turcan et al., 1981). Also Belina et al. (1975) indicated 
that changes in lipid composition follow sex differences in steroid metabolism. As seen 
from results with delipidated microsomes, the female-derived lipid was inhibitory to the 
N-deethylase but the 3-hydroxylase both in male- and female-derived microsomes was 
unaffected, also the activity of the N-deethylase was much lower when 
dilauroylphosphatidylcholine (DLPC) was used rather than the microsomal lipid, but 
again the 3-hydroxylase activity was unaffected in all cases. The male-specific 
lignocaine N-deethylase, thus, would appear to have a very specific requirement for 
lipid whereas the non-sex dependent 3-hydroxylase is less selective. We have extended 
this work with the isolation of the isozyme of cytochrome P-450 responsible for the N- 
deethylation of lignocaine. It turns out that this is most probably isozyme RLM5 of 
Morgan et al. (1985) and 2c of Waxman (1984). When this isozyme is incorporated into 
male-derived microsomal lipid, it shows the highest activity. The female-derived 
microsomal lipid gave a much lower activity. Again the microsomal lipids derived from 
male and female were more effective than the dilauroylphosphatidylcholine (DLPC). 
This data indicated that it is a direct interaction of the lipid with the enzyme (s) or an 
alteration of the protein-protein interactions caused by the lipid which leads to the change 
in enzyme activity and that it is the isozyme responsible for the N-deethylation that is 
particularly affected in this way. In order to assess which portion of the microsomal 
lipid causes these changes, the microsomal lipid has been fractionated into phospholipid 
and neutral lipid. Using delipidation and subsequent relipidation of microsomal lipid
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preparation, we have confirmed that the phospholipid is the most effective portion for 
the maintenance of the drug metabolism and the sex differences in drug metabolism. It is 
clear that the male-derived phospholipid was more efficient than the female-derived 
phospholipid when incorporated into both male- and female derived delipidated 
microsomes. The mixture of phospholipid and neutral lipid fractions was very effective, 
indeed it restored the N-deethylase activity to the level of the microsomes. A possible 
explanation for these effects is the presence of cholesterol in the neutral lipid fraction. 
Indeed, cholesterol has been reported to affected the metabolism of drugs when 
incorporated into DLPC vesicles (Skett & Cuthill 1986). Changes in the 
phospholipid/cholesterol ratio may cause a similar effect (Stier, 1976). Experiments 
were carried out using the male-specific isozyme responsible for the N-deethylation of 
lignocaine and again it was shown that the phospholipid fraction was the most effective 
fraction when reconstituted with this isozyme, but it was less effective than the whole 
microsomal lipid. It is only when the combination of phospholipid and neutral lipid was 
used the control activity was achieved. Again the male derived phospholipid was more 
effective than the female-derived phospholipid. This effect may be due to differences in 
the phospholipid composition as indicated by Belina et al. (1975) who showed that sex 
differences in steroid metabolism follow changes in microsomal lipid composition. We 
analysed the phospholipid composition and our analysis shows sex differences in 
microsomal phospholipid composition and in fatty acid acyl chain of the microsomal 
phospholipid. Also the analysis of the phospholipid from the diabetic animals showed 
that the streptozotocin treatment does alter the phospholipid composition and the ratio of 
acyl chains found. All these changes might be associated with differences in enzyme 
activity, which is in full agreement with the finding of Belina et al. (1975) and Feuer et 
al. (1980). The nature of the fatty acids has previously been shown to regulate oxidative 
drug metabolism in the liver endoplasmic reticulum (Rowe and Wills 1976; Lambert and 
Wills 1977a, b). In 1980 Wills demonstrated that the dietary lipid alters the rate of
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oxidative metabolism due to alterations of fatty acid composition of the endoplasmic 
reticulum, he suggested that the polyunsaturated fatty acids are important, as a 
constituent of membrane phospholipids, in holding the cytochrome P-450 in an active 
conformation in the membrane thus enhancing its efficiency. A diet of purified synthetic 
components which alter the fatty acid composition could markedly lower cytochrome P- 
450 concentration and hydroxylating enzyme activity in the liver microsomal fraction 
(Marshall and McLean 1971). Our results indicated clearly that the arachidonic acid is 
the most likely candidate for further investigation to ascertain its role in maintaining the 
drug metabolising activity.
162
163
Alvares, A.P., Schilling, G., Levin, W., and Kuntzman, R. (1967) Studies on the 
induction of CO-binding pigments in liver microsomes by phenobarbital and 3- 
methylcholanthrene. B iochem ica l and  B iophysical R esearch  C om m unications, 29, 521- 
526.
Autor, A. B., Ballou, D. P., and Coon, M. J. (1973) Stopped flow kinetic 
measurements of electron transfer in a reconstituted microsomal enzyme system 
containing cytochrome P-450. Federation Proceeding . 32, 762.
Barr, J. and Skett, P. (1984) The role of cytochrome P-450, NADPH-cytochrome P- 
450 reductase and lipids in sex differences in hepatic drug metabolism. B ritish  Journal 
o f  P harm acology  , 83, 396P.
Barr, J. (1985) Ph.D. Thesis, University of Glasgow.
Belina, H., Cooper, S.D. Farkas, R. and Feuer, G. (1975) Sex differences in the 
phospholipid composition of rat liver microsomes. B io ch em ica l P harm a co lo g y , 24, 
301-303.
Berg, A. and Gustafsson, J.-A. (1973) Regulation of hydroxylation of 5a-androstane- 
3a , 17p-diol in liver microsomes from male and female rats. Journa l o f  B io log ica l 
C hem istry  , 248, 6559-6567.
Bernhardt, R. and Ruckpaul, K. (1981) The effect of cholesterol on the structure and 
function of the endoplasmic reticulum. Pharm azie , 36,1-9.
Bjorkhem, I. (1976) Rate limiting step in microsomal cytochrome P-450 catalysed 
hydroxylations. P harm acology and  Therapeutics, 1, 327-348.
Bjorkhem, I., Daneilsson, H. and Wikvall, K. (1974) Hydroxylation of cholesterol by 
reconstituted systems from rat liver microsomes. Biochem ical and B iophysical Research  
C om m unica tions , 61, 934-941.
164
Black, S.D., French, J.S., Williams, C.H., Jr., Coon, M.J. (1979) Role of 
hydrophobic polypeptide in the N-terminal region of NADPH-cytochrome P-450 
reductase in complex formation with P-450 LM. B iochem ical and  B iophysica l Research  
C om m unications, 91, 1528-1535.
Black, S.D. and Coon, M.J. (1982) Structural features of liver microsomal NADPH- 
cytochrome P-450 reductase: hydrophobic domain, hydrophilic domain and connecting 
region. Journa l o f  B io log ica l Chem istry , 257, 5929-5938.
Bligh, E.G., Dyer, W.J. (1959) A rapid method of total lipid extraction and 
purification. Canadian Journal o f  B iochem ical P hysiology , 37,91-917.
Block, M. C., van Deenen, L.L.M., and, de Gier, J. (1977) The effect of cholesterol 
incorporation on the temperature dependence of water permeation through liposomal 
membranes prepared from phosphatidylcholines. B iochem ica  e t B iophysica  A c ta , 464, 
509-518.
Botelho, L. H., Ryan, D. E., and Levin, W. (1979) Amino acid composition and partial 
amino acid sequences of three highly purified forms of liver microsomal cytochrome P- 
450 from rats treated with polychlorinated biphenyls, phenobarbital, or 3- 
methylcholanthrene. Journa l o f  B iological Chem istry , 254, 5635-5640.
Brodie, B.B., Axelrod, J., Cooper, J.R., Gaudette, L., La Du, B.N., Mitoma, C. and 
Udenfriend, S. (1955) Detoxification of drugs and other foreign compounds by liver 
microsomes. Science, 121, 603-604.
Castro, J.A. and Gillette, J.R. (1967) Species and sex differences in the kinetic 
constants for the N-demethylation of ethylmorphine by liver microsomes. B iochem ical 
and  B iophysica l R esearch Com m unications, 28, 426-430.
Cater, B.R., Walkden, V., and, Hallinan, T. (1972) Is the liver cytochrome P-450- 
linked biotransformation system lecithin-dependent ?. B iochem ica l J o u r n a l , 127, 37P- 
38P.
Chaplin, M.D. and Mannering, G.J. (1970) Role of phospholipids in the hepatic 
microsomal drug metabolising system. M olecular Pharm acology, 6, 631-640.
165
Cheng, K.C. and Schenkman, J.B. (1982) Purification and characterization of two 
constitutive forms of rat liver microsomal cytochrome P-450. J o u rn a l o f  B io log ica l 
C hem istry , 257, 2378-2385
Cheng, K.C. and Schenkman, J.B. (1983) Testosterone metabolism by cytochrome P- 
450 isozymes RLM3 and RLM5 and by microsomes. Journa l o f  B io log ica l C hem istry , 
258,1173-1174.
Chiang, Y. and Coon, M.J. (1979) Comparative study of two highly purified forms of 
cytochrome P-450:Circular dichroism and other properties. A rch ives o f  B iochem istry  
a n d  B iophysics, 195, 178-187.
Colby, H. D. (1980) Regulation of hepatic drug and steroid metabolism by androgens 
and estrogens. A dvances in Sex  H orm one R esearch. 4, 27-72.
Conney, A. H., Gillette, J. R., Inscoe, J. K., Trams E. R., and Posner, H. S. (1959) 
Induced synthesis of liver microsomal enzymes which metabolise foreign compounds. 
S c ien ce , 130, 1478-1479.
Conney, A.H., Schneidman, K., Jacobson, M. and Kuntzman, M. (1965) Drug 
induced changes in steroid metabolism. A nnals o f  the N ew  York A cadem y o f  Science, 
123, 98-109.
Coon, M.J., Autor, A.P., Boyer, R.F., Lode, E.T. and Strobel, H.W. (1973a) On the 
mechanism of fatty acid, hydrocarbon, and drug hydroxylation in liver microsomal and 
bacterial enzyme systems. In O xidases and  re la ted  redox system s, eds. King, T.E., 
Mason, H.S. and Morrison, M., pp 529-553, University Park Press, Baltimore.
Coon, M.J., Haugen, D.A., Guengerich, F.P., Vermilion, J.L., and Dean, W.L. 
(1976) Liver microsomal membrane: Reconstitution of the hydroxylation system 
containing cytochrome P-450. In The structura l basis o f  m em brane fu n c tio n , eds. 
Hatefi, Y. and Diavadi-Ohaniance, L., pp 409-427. Academic Press New York
Coon, M.J., Strobel, H.W. and, Autor, A.P. (1972) functional components and 
mechanism of action of the resolved liver microsomal enzyme system catalysing fatty 
acid, hydrocarbon and drug hydroxylation.
Biochem ical. Socie ty  Sym posia., 34, 45-54.
166
Coon, M.J., Strobel, H.W., and Boyer, R.F. (1973b) On the mechanism of 
hydroxylation reactions catalysed by cytochrome P-450. D ru g  M eta b o lism  a n d  
D isp o sitio n , 1, 92-97.
Cooper, S.D. and Feuer, G. (1972a) Relationship between drug metabolising activity 
and phospholipids in hepatic microsomes. I. Effects of phosphatidylcholine, carbon 
tetrachloride and actinomycin D. C anadian Journa l o f  P hysio logy and  P harm acology, 
50, 568-575.
Cooper, S.D. and Feuer, G. (1972b) Effect of drugs or hepatotoxin on the relation 
between drug metabolizing activity and phospholipids in hepatic microsomes during 
choline deficiency. Toxicology and  A pplied  Pharm acology, 25, 7-19.
Cooper, D.Y., Levin, S., Narasimhulu, S., Rosenthal, O. and Estabrook, R.W. (1965) 
Photochemical action spectrum of the terminal oxidase of the mixed function oxidase 
systems. Science, 147, 400-402.
Cullis, P.R, Hope, M.J., de Kruijff, B., Verkleij, A. J. and Tilcock, C.P.S., (1985) In 
P hospholip ids and  C ellular Regulation  ed. Kuo, J. F. vol I, pp 3-59.CRC Press
Dallner, G. and Emester, L. (1968) Subfractionation and composition of microsomal 
membranes: A review. Journa l o f  H istochem istry and  C ytochem istry, 16, 611-632.
Dawson, J.H., Trudell, J.R., Linder, R. E., Barth, G., Bunnenberg, E. and Djerassi, 
C. (1978) Magnetic circular dichroism of purified forms of rabbit liver cytochromes P- 
450 and P-420. B iochem istry  , 17, 33-42.
Dencher, N. A., (1986) Spontaneous transmembrane insertion of membrane proteins 
into lipid vesicles facilitated by short-chain lecithins. B iochem istry, 25,1195-1200.
DePierre, J.W. and Dallner, G. (1975) Structural aspects of the membrane of the 
endoplasmic reticulum. Biochem ica e t B iophysica Acta , 415, 411-472.
DePierre, J.W. and Emster, L. (1975) The effect of phospholipase C treatment of 
microsomes on cytochrome P-450 and b .^ FE B S Letters, 55,18-21.
167
DePierre, J.W. and Emster, L. (1977) Enzyme topology of intracellular membranes. 
A n n u a l R ev iew  o f  B iochem istry , 46, 201-262.
DePierre, J.W. and Emster, L. (1980) In Topology o f  drug m etabolising enzym es in the  
m em brane  o f  the endoplasm ic  reticu lum , eds Coon, M.J., Conney, A.H., Estabrook, 
R.W., Gelboin, H.V., Gillette, J.R. and O'Brien, P.J. Yol.I. pp 431-445. New York: 
Academic.
Dhami, M. S. I., de la Iglesia, F. A., and Feuer, G. (1980) Association between 
membrane function and lipid composition in the hepatic endoplasmic reticulum: Effect of 
Pregnancy. In M icrosom es, D rug  O xidations and  C hem ical Carcinogenesis, eds Coon, 
M.J., Conney, A.H., Estabrook, R.W., Gelboin, H.V. and O'Brien, P.J. pp 567-570. 
New York, Academic Press.
Diehl, H., Capalna, S., and Ullrich, V. (1969) The photochemical action spectrum of 
the carbon monoxide inhibited hydroxylation of cyclohexane by rat liver microsomes. 
F E B S L e tters , 4, 99-102.
Dignam, J. D. and Strobel, H. W. (1977) NADPH-cytochrome P-450 reductase from 
rat liver: purification by affinity chromatography and characterization. Biochem istry , 16, 
1116-1123.
Dixon, R. L., Hart, L. G. and Fouts, J. R. (1961) The metabolism of drugs by liver 
microsomes from Alloxan-diabetic rats. Journa l o f  P harm acology a n d  E xperim enta l 
Therapeu tics , 133, 7-11.
Dixon, R. L., Hart, L. G., Rogers, L. A. and Fouts, J. R. (1963) The metabolism of 
drugs by liver microsomes from alloxan-diabetic rats: Long term diabetes. Journa l o f  
P harm acology and  Experim ental Therapeutics, 142, 312-317.
Duppell, W. and Ullrich, V. (1976) Membrane effects on drug monooxygenase activity 
in hepatic microsomes. Biochem ica e t B iophysica A cta , 426, 399-407
Duppell, W., Lebeault, J. M. and Coon, M. J. (1973) Properties of yeast cytochrome 
P-450-containing enzyme system which catalyzes the hydroxylation of fatty acids, 
alkanes, and drugs. European Journal o f  B iochem istry , 36,583-592.
168
Einarsson, K., Gustafsson, J.-A. and Stenberg, A. (1973) Neonatal imprinting of liver 
microsomal hydroxylation and reduction of steroids. Journa l o f  B io log ica l C hem istry , 
248, 4987-4997.
El Defrawy El Masry, S., Cohen, G.M. and Mannering, G.J. (1974) Sex dependent 
differences in drug metabolism in the rat. I. Temporal changes in microsomal drug 
metabolising system of the liver during sexual maturation. D ru g  M eta b o lism  a n d  
D istribu tion , 2, 267-278.
Eling, T.E. and Di Augustine, R.P. (1971) A role for phospholipids in the binding and 
metabolism of drugs by hepatic microsomes. B iochem ical Journal, 123, 539-549.
Estabrook, R.W., Cooper, D.Y., and Rosenthal, O. (1963) The light reversible carbon- 
monoxide inhibition of the steroid C21-hydroxylase system of the adrenal cortex. 
B io ch em is try , 338, 741-755.
Estabrook R.W. Shigematsu,A. and Schenkman,J.B. (1970) The contribution of the 
microsomal elect ron transport pathway to the oxidative metabolism of the liver. A dvances  
in E nzym e R egula tion , 8, 121-128.
Estabrook, R.W. and Werringloer, J. (1978) The measurement of difference spectra: 
application to the cytochromes of microsomes. In M eth o d s in E nzym ology , eds 
Fleischer, S. and Packer, L. Vol. LII, Ch. 22, pp 212-221. New York: Academic.
Estabrook, R.W., Hilderbrandt, A.G., Baron, J., Netter, K.J. and Leibman, K. (1971)
A new spectral intermediate associated with cytochrome P-450 function in liver 
microsomes. B iochem ical and B iophysical Research Com m unications, 42,132-139.
Faas, F.H. and Carter, W.J. (1980) Altered fatty acid desaturation and microsomal fatty 
acid composition in the streptozotocin diabetic rat. Lipids, 15, 953-961.
Faas, F.H. and Carter, W.J. (1983) Altered microsomal phospholipid composition in 
the streptozotocin diabetic rat. Lipids, 18, 339-342.
169
Feuer, C.F., Dhami, M.S.G., de la Iglesia and Feuer, G. (1980) Association between 
membrane function and phospholipid composition in the hepatic endoplasmic reticulum: 
Effect of development. In M icrosom es, D rug O xidations and  C hem ical Carcinogenesis, 
eds. Coon, M.J., Cooney, A.H., Estabrook, R.W., Gelboin, H. V. Gillette, J. R. and 
O'Brien, P. J. vol. I, 559-566. New York: Academic.
Feuer, G. (1978) Role of phospholipids in the development of the hepatic endoplasmic 
reticulum associated with drug metabolism. R esearch  C om m unications in C hem ica l 
P atho logy and  P harm acology , 22, 549-560.
Folch, J., Lees, M. and Slone-Stanley, G.H.S. (1957) A simple method for the 
isolation and purification of the total lipids from animal tissues. Journa l o f  B io log ica l 
C hem istry , 226, 497-509.
French, J.S., Guengerich, F.P. and Coon, M.J. (1980) Interactions of cytochrome P- 
450, NADPH-cytochrome P-450 reductase, phospholipid and substrate in reconstituted 
liver microsomal enzyme system. Journal o f  B iological C hem istry , 255,4112-4119.
Garfinkel, D. (1958) Studies on pig liver microsomes. I. Enzymic and pigment 
composition of different microsomal fractions. A rc h iv e s  o f  B io c h em is try  a n d  
B io p h ysics  77, 493-509.
Gibson, G.G. and Tamburini, P.P. (1984) Cytochrome P-450 spin state: inorganic 
biochemistry of haem-iron ligation and functional significance. Xenobiotica, 14,21-A l.
Gibson, G.G., Cinti,D.L. Sligar, S.G. and Schenkman,J.B. (1980) The effect of 
microsomal fatty acids and other lipids on the spin state of partially purified cytochrome 
P-450. Journa l o f  B io logica l C hem istry , 255,1867-1873
Guengerich, F.P. (1977a) Separation and purification of multiple forms of microsomal 
cytochrome P-450: Activities of different forms of cytochrome P-450 towards several 
compounds of environmental interest. Journa l o f  B io log ica l C hem istry , 252, 3970- 
3979.
Guengerich, F.P. (1977b) Preparation of highly purified cytochrome P-450 and 
NADPH cytochrome P-450 reductase from pulmonary microsomes of untreated rabbits. 
M olecular Pharm acology, 13,911-923.
170
Guengerich, F.P. (1978) Separation and purification of multiple forms of microsomal 
cytochromes P-450: Partial characterization of three homogeneous cytochromes P-450 
isolated from the livers of phenobarbitone and 3-methylcholanthrene treated rats. Journal 
o f  B io log ica l C hem istry , 253, 7931-7939.
Guengerich, F.P. and Holladay, L. A. (1979) Hydrodynamic characterization of highly 
purified and functionally active liver microsomal cytochrome P-450. B iochem istry , 18, 
5442-5449.
Gum, J.R. and Strobel, H.W. (1981) Isolation of the membrane-binding peptide of 
NADPH-cytochrome P-450 reductase: characterization of the peptide and its role in the 
interaction of reductase with cytochrome P-450. Journal o f  B io log ica l C hem istry , 256, 
7478-7486.
Gum, J.R. and Strobel, H.W. (1979) Purified NADPH cytochrome P-450 reductase: 
Interaction with hepatic microsomes and phospholipid vesicles. Journa l o f  B io log ica l 
C hem istry, 22, 2811-2820.
Gunsalus, I.C. and Sligar, S.G. (1978) Oxygen reduction by the P-450 
monooxygenase systems. A dvances in Enzym ology, 47, 1-44.
Gustafsson J.-A., Mode, A., Norstedt, G., Hokfelt, T., Sonnenschein, G. Eneroth, P. 
and Skett, P. (1980) The hypothalamo-pituitary-liver axis: a new hormonal system in 
control of hepatic steroid and drug metabolism. B iochem ica l A ction  o f  H orm ones, 7, 
48-91.
Gustafsson, J-A., and Ingelman-Sundberg, M. (1974) Regulation and properties of a 
sex-specific hydroxylase system in female rat liver microsomes active on steroid 
sulfates. Journa l o f  B io logica l Chem istry, 249, 1940-1945.
Gustafsson, J.-A., and Ingelman-Sundberg, M. (1975) Regulation and substrate 
specificity of a steroid sulfate-specific hydroxylase system in female rat liver 
microsomes. Journa l o f  B io logica l Chem istry,250, 3451-3458.
171
Gustafsson, J.-A. (1973) The formation of 16,17-dihydroxylated C19 steroids from 16- 
dehyro C19 steroids in liver microsomes from male and female rats. B io ch em ica  e t 
B iophysica  A cta , 296, 179-188.
Gustafsson, J.-A. and Eriksson, H. (1971) Metabolism of corticosterone in the isolated 
perfused rat liver. Eurpean Journal o f  B iochem istry, 20, 231-236
Gustafsson, J.-A., Mode, A. Norstedt, G. and Skett, P. (1983) Sex steroid induced 
changes in hepatic enzymes. A nnua l R eview  o f  P hysiology, 45, 51-60.
H aaparanta, T., Rydstrom, J., and Ingelman-Sundberg, M. (1980) In 
M icrosom es,D rug  O xidations and  C hem ical Carcinogenisis, eds. Coon, M. J.,Cooney, 
A. H., Estabrook, R. W.,Gelboin, H. V. Gillette, J. R. and O'Brien, P. J. vol. I, 533- 
536. New York: Academic.
Hammer, C.T. and Wills, E.D. (1978) The role of purified components of the diet in the 
regulation of the fatty acid composition of the rat liver endoplasmic reticulum and lipid 
peroxidation. B iochem ical J o u r n a l, 174, 585-594.
Haugen, D.A., Armes, L.G., Yasunobu, K.T. and Coon, M.J. (1977) Amino terminal 
sequence of phenobarbital-inducible cytochrome P-450 from rabbit liver microsomes: 
similarity to hydrophobic terminal segments of preproteins. B io c h e m ic a l a n d  
B iophysica l R esearch  Com m unications. 77,967-973.
Higgins, J. A. (1979) Asymmetry of choline incorporation into phosphatidylcholine of 
rat liver microsomes. B iochem ica et B iophysica A cta  , 558, 48-57.
Higgins, J. A. (1981) Biogenesis of endoplasmic reticulum phosphatidylcholine. 
Translocation of intermediates across the membrane bilayer during methylation of 
phosphatidylethanolamine. B iochem ica et B iophysica Acta, 640, 1-15.
Hildebrandt, A. and Estabrook, R. W. (1971) Evidence for participation of cytochrome 
b5 in hepatic microsomal mixed function oxidase system. Archives o f  B iochem istry and
B io p h y s ic s ., 143, 66-79.
Hirada, N. and Negishi, M. (1984) Mouse liver testosterone 15a-hydroxylase 
(Cytochrome P-450 15a). Journal o f  B iological Chem istry, 259,1265-1271.
172
Holman R. T., Johnson S. B., Gerrard J. M. Mauer S. M., Kurcho-Sandberg and 
Brown D. M. (1983) Arachidonic acid deficiency in streptozotocin-induced diabetes. 
P roceed ings o f  the national A cadem y o fS c i  ence U S A . ,  80, 2375-2379.
Huang, C. (1969) Studies on phosphatidylcholine vesicles. Formation and physical 
characteristics. B iochem istry , 8, 344-352.
Hutson, J. L. and Higgins, J. A. (1982) Asymmetric synthesis followed by 
transmembrane movement of phosphatidylethanolamine in rat endoplasmic reticulum. 
B iochem ica  e t B iophysica  A cta  , 687, 247-256.
Imai, Y. and Sato, R. (1967) Conversion of P-450 to P-420 by neutral salts and some 
other reagents. European Journal o f  B iochem istry, 1, 419-426.
Imai, Y. and Sato, R. (1974) A gel-electrophoretically homogeneous preparation of 
cytochrome P-450 from liver microsomes of phenobarbital pretreated rabbits. 
B iochem ica l and B iophysical R esearch Com m unications, 60, 8-14.
Ingelman-Sundberg, M. and Glaumann, H. (1977) Reconstitution of the liver 
microsomal hydroxylase system into liposomes. FE B S Letters, 78, 72-76.
Ingelman-Sundberg, M., Glaumann, H. and Johnson, I. (1980) In M icrosom es, D rug  
O x id a tio n s  a n d  C h e m ic a l C a rc in o g e n e s is , eds Coon, M.J., Conney, A.H., 
Estabrook,R.W., Gelboin, H.V., Gillette, J.R. and O'Brien, P.J. Vol.I. pp 513-516.
Ingelman-Sundberg, M. and Glaumann, H. (1980) Incorporation of purified 
components of the rabbit liver microsomal hydroxylase system into phospholipid 
vesicles. B iochem ica  et B iophysica  Acta, 599, 417-435.
Ingelman-Sundberg, M., Haaparanta, T. and Rydstrom, J. (1981) Membrane charge as 
effector of cytochrome P-450 (LM2) catalysed reactions in reconstituted liposomes. 
B iochem istry , 20, 4100-4106.
Inoue, K. (1974) Permeability properties of liposomes prepared from 
dipalmitoyllecithin, dimyristoyllecithin, egg lecithin, rat liver lecithin and beef brain 
sphingomyelin. Biochem ica e t B iophysica  A c ta , 339, 390-402.
173
Iyanagi, T. and Mason, H.S. (1973) Some properties of hepatic reduced nicotinamide 
adenine dinucleotide, phosphate-cytochrome c reductase. B iochem istry, 12,2297-2308.
Johnson, E.F., Schwab, G.E. and Muller-Eberhard, U. (1979) Multiple forms of 
cytochrome P-450: Catalytic differences exhibited by two homogeneous forms of rabbit 
cytochrome P-450. M olecular Pharm acology, 15,708-718.
Jones, P.D., Holloway, P.W., Peluffo, R.D. and Wakil,S.J. (1969) A requirement for 
lipids by the microsomal stearoyl co-enzyme A desaturase system. Journal o f  B iological 
C hem istry, 244, 744-754.
Kamataki, K. Ando, M., Yamazoe, Y., Ishii, K. and Kato, R. (1980) Sex differences 
in the O-dealkylation activity of 7-hydroxycoumarin O-dealkyl derivatives in rat liver 
microsomes. Biochem ical Pharm acology, 29, 1015-1022.
Kamataki, T., Maeda, K., Shimada, M., and Kato, R. (1986) Effects of phenobarbital, 
3-methylcholanthrene and polychlorinated biphenyls on sex-specific forms of 
cytochrome P-450 in liver microsomes of rats. Journal o f  B iochem istry, 99, 841-845.
Kamataki, T., Maeda, K., Yamazoe, Y., Nagai, T. and Kato, R. (1981) Partial 
purification and characterization of cytochrome P-450 responsible for the occurrence of 
sex difference in drug metabolism in the rat. B iochem ica l and  B iophysica l R esearch  
C om m unications, 103, 1-7.
Kamataki, T., Maeda, K., Yamazoe, Y., Nagai, T. and Kato, R. (1982) Evidence for 
the involvement of multiple forms of cytochrome P-450 in the occurrence of sex related 
differences of drug metabolism in the rat. Life Sciences, 31,2603-2610.
Kamataki, T., Maeda, K., Yamazoe, Y., Nagai, T. and Kato, R. (1983) Sex difference 
of cytochrome P-450 in the rat: Purification, characterization and quantitation of 
constitutive forms of cytochrome P-450 from liver microsomes of male and female rats. 
A rch ives o f  B iochem istry and  B iophysics, 225, 758-770.
Kamin, H. Master, B. S. S. and Gibson, Q. (1966), NADPH cytochrome c 
oxidoreductase, in Flavins and  F lavoproteins, Slater, E. C., Ed. Elsevier, Amsterdam, 
306-346.
174
Katagiri, M., Ganguli, B. N. and Gunsalus, I. C. (1968) The roles of putidaredoxin 
and cytochrome P-450cam in methylene hydroxylation. Journal o f  B io log ica l C hem istry,
247, 5777-5784.
Kates, M. (1964) Simplified procedures for hydrolysis or methanolysis of lipids. 
Journa l o f  L ip id  Research, 5, 132-135.
Kato, R. (1974) Sex related differences in drug metabolism. D rug M etabolism  R eview s, 
3, 1-22.
Kato, R. and Gillette, J.R. (1965) Sex differences in the effects of abnormal 
physiological states on the metabolism of drugs by rat liver microsomes. Jo u rn a l o f  
P harm acology and  Experim ental Therapeutics, 150,285-291.
Kato, R. and Kamataki, T. (1982) Cytochrome P-450 as the determinant of sex 
difference of drug metabolism in the rat. Xenobiotica, 12,787-800.
Kato, R. and Onoda, K. (1970) Studies on the regulation of the activity of drug 
oxidation in rat liver microsomes by androgens and oestrogens. B io c h e m ic a l  
P harm acology, 19, 1649-1660.
Kato, R. and Takahishi, A. (1968) Thyroid hormone and activities of drug metabolising 
enzymes and electron transport systems of rat liver microsomes. M o le c u la r  
P harm acology, 4, 109-120.
Kato, R., Chiesara, R. and Frontino, G. (1962) Influence of sex difference on the 
pharmacological action and metabolism of some drugs. Biochem ical Pharm acology, 11, 
221-227.
Kato, R., Yamazoe, Y. and Shimada, M. (1986) Effect of growth hormone and ectopic 
transplantation of pituitary gland on sex-specific forms of cytochrome P-450 on 
testosterone and drug oxidations in rat liver. Journal o f  B iochem istry, 100, 895-902.
Klingenberg, M. (1958) Pigments of rat liver microsomes. A rch ives o f  B iochem istry  
a n d  B iophysics, 76, 376-386.
175
Koop, D.R., Anders, A.V. and Coon, M J. (1981) Properties of electrophoretically 
homogeneous constitutive forms of liver microsomal cytochrome P-450. Journa l o f  
B io log ica l Chem istry, 256,10704-10711.
Kornberg, R.D. and, McConnell, H.M. (1971) Inside-Outside transitions of 
phospholipids in vesicles. B iochem istry  , 10, 1111-1120.
Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head 
of bacteriophage T4. N ature, 227, 680-685
Laitinen, M. Hietanen, E., Vainio, H. and Hanninen, O. (1975) Dietary fats and 
properties of endoplasmic reticulum: 1. Dietary lipid induced changes in composition of 
microsomal membranes in liver and gastroduodenal mucosa of rat. Lipids, 10, 461-466.
Lambert, L. and Wills, E.D. (1977a) The effect of dietary lipid peroxides, sterols and 
oxidised sterols on cytochrome P-450 and oxidative demethylation in the endoplasmic 
reticulum. B iochem ical Pharm acology, 26, 1417-1421.
Lambert, L. and Wills, E.D. (1977b) The effect of dietary lipids on 3, 4, 
benzo(a)pyrene metabolism in the hepatic endoplasmic reticulum. B io c h e m ic a l  
Pharm acology, 26, 1423-1427.
Lambeth, J.D. (1985) On the role of phospholipids and membranes in the regulation of 
oxidative enzymes. In Phospholipids and  cellular regulation , ed. Kuo, J. F. vol n , 189- 
227.CRC Press
Lang, M., Laitinen, M., Hietanen, E. and Vainio, H. (1976) Modification of 
microsomal membrane components and induction of hepatic drug biotransformation in 
rats on high cholesterol diet. Acta pharm acologica e t Toxicologica, 39,273-288.
Learning, A.B., Mathur, R. S. and Levine, J. H. (1982) Increased plasma testosterone 
in streptozotocin-diabetic female rats. Endocrinology, 111, 1329-1333.
Lee, T.C. and Snyder, F. (1973) Phospholipid metabolism in rat liver endoplasmic 
reticulum. Structural analysis, turnover studies and enzymic activities. B iochem ica  e t  
B iophysica  Acta , 291,71-82.
176
Levin, W., Ryan, D., West, S. and Lu, A.Y.H. (1974) Preparation of purified lipid 
depleted cytochrome P-450 and reduced nicotinamide dinucleotide phosphate 
cytochrome c reductase from rat liver microsomes. J ourna l o f  B io lo g ica l Chem istry, 
249, 1747-1754.
Lowry, O.H., Rosebrough, N.J., Farr, A.I. and Randall, R.J. (1951) Protein 
measurement with folin phenol reagent Journal o f  B io logica l Chem istry, 193,265-275.
Lu, A.Y.H. and Coon, M.J. (1968) Role of haemoprotein P-450 in fatty acid w- 
hydroxylation in a soluble enzyme system from liver microsomes. Journa l o f  B iological 
C hem istry , 243, 1331-1332.
Lu, A.Y.H. and West, S.B. (1980) Multiplicity of mammalian microsomal cytochrome 
P-450. P harm acologica l R eview s, 31, 277-295.
Lu, A.Y.H., and Levin, W. (1974) The resolution and reconstitution of the liver 
microsomal hydroxylation system. Biochem ica e t B iophysica  Acta , 344,205-240.
Lu, A.Y.H., Jacobson, M., Levin, W., West, S.B. and Kuntzman, l.R. (1972) 
Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign 
compounds and endogenous substrates. IV. Hydroxylation of aniline. A rch ives  o f  
B iochem istry  and  B iophysics, 153, 294-297.
Lu, A.Y.H., Junk, K.W. and Coon, M.J. (1969b) Resolution of the cytochrome P-450 
containing w-hydroxylation system of liver microsomes into three components. Journal 
o f  B io log ica l C hem istry, 244, 3714-3721.
Lu, A.Y.H., Kuntzman, R., West, S. and Conney, A.H. (1971) Reconstituted liver 
microsomal enzyme system that hydroxylates drugs, other foreign compounds and 
endogenous substrates.I. Determination of substrate specificity by the cytochrome P- 
450 and P-448 fractions. B iochem ica l and  B iophysica l R esearch  Com m unications, 42, 
1200-1206.
177
Lu, A.Y.H., Kuntzman, R., West, S., Jacobson, M. and Conney, A.H. (1972) 
Reconstituted liver microsomal enzyme system that hydroxylates drugs and other 
foreign compounds and endogenous substrates. II. Role of cytochrome P-450 and P- 
448 fractions in drug and steroid hydroxylations. Jo u rn a l o f  B io lo g ica l C hem istry , 
247,1727-1735.
Lu, A.Y.H., Strobel, H.W. and Coon, M.J. (1969a) Hydroxylation of benzphetamine 
and other drugs by a solubilised form of cytochrome P-450 from liver microsomes: lipid 
requirement for drug demethylation. B io c h e m ic a l a n d  B io p h y s ic a l R e se a rc h  
C om m unications, 36, 545-551.
Lu, A.Y.H., Strobel, H.W. and Coon, M.J. (1970) Properties of a solubilised form of 
the cytochrome P-450 containing mixed function oxidase of liver microsomes. 
M olecular Pharm acology, 6, 213-220
MacGeoch C., Morgan E. T., Halpert J. and Gustafsson J. -A. (1984) Purification, 
Characterization, and pituitary regulation of the sex-specific cytochrome P-450 1513- 
hydroxylase from liver microsomes of untreated female rats. Jo u rn a l o f  B io log ica l. 
C hem istry, 259, 15433-15439.
Mannering, G., J. (1971) Properties of cytochrome P-450 as affected by environmental 
factors: Qualitative changes due to administration of polycyclic hydrocarbons. 
M etabolism , 20, 228-245.
Marshall, W. J. and Mclean, A. E. M. (1971) A Requirement for dietary lipids for 
induction of cytochrome P-450 by phenobarbitone in rat liver microsomal fraction. 
B iochem ica l Journal, 122, 569-573.
Mathur, S. N., Simon, I., Lokesh, B. R., and Spector, A.A. (1983) Phospholipid fatty 
acid modification of rat liver microsomes affects acylcoenzyme A: Cholesterol 
acyltransferase activity. B iochem ica e t Biophysica Acta, 751, 401-411.
McIntosh, P.R., Peacock, A.C. and Gelboin, H.V. (1980) The induction of liver 
microsomal proteins by 3-methylcholanthrene in rats of different age, sex and strain. 
B iochem ica  e t B iophysica Acta , 627,290-300.
178
Mercuri, O., Peluffo, R. O., and Brenner, R. R. (1967) Effect of insulin on the 
oxidative desaturation of a-linolenic, oleic and palmitic acids. Lipids, 2, 284-285
Mihara, K. and Sato, R. (1978) Detergent solubilised NADH cytochrome b5 reductase.
In M ethods in E nzym ology. eds Fleischer, S. and Packer, L. Vol. LII, pp 103-108. 
New York: Academic.
Miwa, G.T. and Cho, A.K. (1976) Stimulation of microsomal N-demethylation by 
solubilised NADPH cytochrome c reductase. L ife  Sciences, 18, 983-988.
Miwa, G.T. and Lu, A.Y.H. (1981) Studies on the stimulation of cytochrome P-450 
dependent monooxygenase activity by dilauroylphosphatidylcholine. A rch ives  o f  
B iochem istry  and  B iophysics, 211, 454-458.
Morgan E. T., MacGeoch C., and Gustafsson J.-A. (1985) Hormonal and 
developmental regulation of expression of the hepatic microsomal steroid 16a— 
hydroxylase cytochrome P-450 apoprotein in the rat. Journal o f  B iochem ical Chemistry, 
260, 11895-11898.
Narasimhulu, S., Cooper, D.Y., and, Rosenthal, O. (1965) Spectrophotometric 
properties of a triton-clarified steroid 21-hydroxylase system of adrenocortical 
microsomes. L ife  Sciences, 4, 2101-2107.
Neale M. G. and Parke D. V. (1973) Effects of pregnancy on the metabolism of drugs 
in the rat and rabbit. B iochem ical P harm aco logy , 22, 1451-1461.
Nelson, D. H. (1980) Corticosteroid-induced changes in phospholipid membranes as 
mediators of their action. Endocrine Review s, 1,180-199.
Norred, W. P., and Wade, A. E. (1972) Dietary fatty acid-induced alterations of hepatic 
microsomal drug metabolism. B iochem ical Pharmacology, 21, 2887-2897.
Oakley, B. R. Kirsch, D. R. and Morris, N. R. (1980) A simplified ultrasensitive silver 
stain for detecting proteins in polyacrylamide gels. Analytical Chem istry, 105, 361-363
179
Omura, T. and Sato, R. (1964a) The carbon monoxide-binding pigment of liver 
microsomes. I Evidence for its haemoprotein nature. Journa l o f  B io log ica l Chem istry,
239., 2370-2378.
Omura, T. and Sato, R. (1964b) The carbon monoxide-binding pigment of liver 
microsomes. II. Solubilisation, purification and properties. Jo u rn a l o f  B io log ica l  
C hem istry , 239, 2379-2385.
Omura, T., Sanders, E., Estabrook, R.W., Cooper, D.Y. and Rosenthal, O. (1966) 
Isolation from the adrenal cortex of a non-haem iron protein and a flavoprotein 
functional as reduced triphosphopyridine nucleotide cytochrome P-450 reductase. 
A rch ives o f  B iochem istry  and  B iophysics, 117, 660-673.
Omura, T., Siekevitz, P. and Palade, G. E. (1967) Turnover of constituents of the 
endoplasmic reticulum in membranes of rat hepatocytes. J o u rn a l o f  B io lo g ica l  
C hem istry, 242, 2389-2396.
Overturf, M. and Dryer, R.L. (1969) Experiments in the biochemistry of animal lipids, 
In E xp erim en ts  in  P h ys io lo g y  a n d  B iochem istry , ed Kerkut,G.A., 2, pp 189-163. 
London: Academic.
Paine, A. J. and McLean, A. E. M. (1973) The effect of dietary protein and fat on the 
activity of arylhydrocarbon hydroxylase in rat liver, kidney and lung. B iochem ica l 
P harm acology, 22, 2875-2880.
Palade, G. E. and Porter, K. R. (1954) Studies on the endoplasmic reticulum 1. Its 
identification in cell in situ. Journal o f  Experim ental M edicine, 100, 641-656.
Palade, G. E. and Siekevitz, P. (1956) Liver microsomes; integrated moiphological and 
biochemical study. Journal o f  B iophysical and  B iochem ical Cytology, 2,171-200.
Parke, D.V. (1981) The endoplasmic reticulum: its role in physiological functions and 
pathological situations. In C oncepts in D rug M etabolism , eds JennerJ5, and Testa, B. 
Part B, Ch. 2, pp 53 -166.
180
Past, M.R. and Cook, D.E. (1983) Catalytic activities of cytochrome P-450 from female 
rat liver: correlation with sex differences in drug metabolism in diabetic liver. Research  
Com m unications in C hem ical P athology and Pharm acology, 40, 379-390.
Past, M.R. and Cook, D.E. (1982) Drug metabolism in a reconstituted system by 
diabetes dependent hepatic cytochromes P-450. R esearch C om m unications in Chem ical 
P atho logy and  Pharm acology, 37, 81-90.
Phillips, A.H. and Langdon, R.G. (1962) Hepatic triphosphopyridine nucleotide 
cytochrome c reductase: Isolation, characterization and kinetic studies. Jo u rn a l o f  
B io log ica l Chem istry, 237, 2652-2660
Porter K.R. (1953) Observations on a submicroscopic basophilic component of 
cytoplasm. Journal o f  Experim ental M edicine, 97,727-750.
Quinn, P.J. (1981) The fluidity of cell membranes and its regulation. P ro g ress  in 
B iophysics and  M olecu lar B io logy, 38,1-81.
Reinke, L. A., Stohs, S. J., and Rosenberg, H. (1978) Altered activity of hepatic mixed 
function monooxygenase enzymes in streptozotocin-induced diabetic rats. Xenobiotica, 
8, 611-619.
Remmer, H., Schenkman J., Estabrook R. W., Sesame H., Gillette J., Narasimhulu
S., Cooper, D.Y. (1966) Drug interaction with hepatic microsomal cytochrome. 
M olecular Pharm acology, 2,187-190.
Rispin, A.S., Don, H. and Nebert, D.W. (1984) Change in the cytochrome P-450 iron 
spin state as a function of castration, testosterone or oestrogen treatment, vigorous 
exercise or starvation. B iochem ical Pharm acology, 33,1619-1624.
Ristau, O., Rein, H., Janig, G.R. and Ruckpaul, K. (1978) Quantitative analysis of the 
spin equilibrium of cytochrome P-450LM2 fraction from rabbit liver microsomes. 
B iochem ica  e t B iophysica  A c ta , 536,226-234.
Roberts, R. B. (1958) In Microsomal particles and protein synthesis. B io p h ysica l 
Society  Sym posia. Pergamon Press, New York,Oxford.
181
Roseman, M.S., Litman, B J ., and Thompson, T.E., (1975) Transbilayer exchange of 
phosphatidylethanolamine for phosphatidylcholine and A-acetimidoyl-phosphatidyl- 
ethanolanhne in single-walled bilayer vesicles, Biochem istry, 14,4826-4.830.
Rothman, J.E. and Kennedy, E.P., (1977) Rapid transmembrane movement of newly 
synthesized phospholipids during membrane assembly. P roceed ings Qf the  national 
A cadem y o fS c i  ence U S A . ,  74, 1821-1825
Rouser, G. Fleischer, S. and Akira, Y. (1970) Two dimensional thin layer 
chromatographic separation of polar lipids and determination of phospholipids by 
phosphorus analysis of spots. L ip ids, 5, 494-496.
Rowe, L. and Wills, E. D. (1976) The effect of dietary lipids and vitamins on lipid 
peroxide formation, cytochrome P-450 and oxidative demethylation in the endoplasmic 
reticulum. B iochem ical P harm acology, 25,175-179.
Rumack, B. H., Holtzmann, J. and Chase, H. P. (1973) Hepatic drug metabolism and 
protein malnutrition. J ourna l o f  P harm acology and  E xperim enta l Therapeutics, 186, 
441-446.
Ryan, D.E. Dixon, R., Evans, R.H., Ramanathan, L., Thomas, P.E., Wood, A.W. 
and Levin, W. (1984a) Rat hepatic cytochrome P-450 isozyme specificity for the 
metabolism of the steroid sulphate, 5-Androstane-3-, 17-disulphate. A rch ives  o f  
B iochem istry  and  B iophysics , 233, 636-642.
Ryan, D.E., Iida, S., Wood, A.W., Thomas, P.E., Lieber,C.S. and Levin, W. 
(1984b) Characterization of three highly purified cytochromes P-450 from hepatic 
microsomes of adult rats. Journal o f  B iological Chem istry, 259,1239-1250.
Ruckpaul, K. and Bernhardt, R. (1984) Biochemical aspects of the monooxygenase 
.system in the endoplasmic reticuluni of mampiali^n liver. Li C ytochrom e P-450, eds. 
Jtugkpaul, K. and Rein, H.,pp 9-57. Akadenue-Verlqg, Berlin
182
Schenkman, J. B.,Jansson, I., Gibson, G. G., Sligar, S. G. and Cinlt, D. I. (1980) 
The roles of membranes and substrates in the modulation of cytochrome P-450 
function.In M icrosom es, D rug  O xidations and  C hem ical C arcinogenisis, eds. Coon, 
M.J., Cooney, A.H., Estabrook, R.W., Gelboin, H. V. Gillette, J. R. and O'Brien, P. 
J. vol. I, 479-487. New York: Academic.
Schenkman, J.B., Remmer, H. and Estabrook, R.W. (1967) Spectral studies of drug 
interaction with hepatic microsomal cytochrome. M olecular Pharm acology, 3,113-123.
Schmitz, B. (1986) Reconstitution proteins into lipid vesicles- a discussion of condition 
and methods. In Topics in lip id  research  eds Klein and Schmitz pp 253-263. Royal 
Society of Chemistry.
Scotto, A. W., and Zakim, D. (1986) Reconstitution of membrane protein: Catalysis by 
cholesterol of insertion of integral membrane proteins into performed lipid bilayers. 
B iochem istry , 25, 1555-1561.
Scotto, A. W., Goodwyn, D., and Zakim, D. (1987) Reconstitution of membrane 
proteins: sequential incorporation of integral membrane proteins into preformed lipid 
bilayers. B iochem istry , 26, 833-839.
Sheets, J. J. and Estabrook, R. W. (1985) Multiple sites of steroid hydroxylation by 
liver microsomal cytochrome P-450 system: primary and secondary metabolism of 
androstenedione. B iochem istry, 24,6591-6597.
Shephard, E.A. Pike, S.F., Robin, B.R. and Phillips, I.R. (1983) A rapid one-step 
purification of NADPH-cytochrome c (P-450) reductase from rat liver microsomes. 
A naly tica l B iochem istry, 129, 430-433.
Shimakata, T., Mihara, K., and Sato, R. (1971) Lack of correlation between cyanide- 
binding spectrum and fatty acid desaturase activity in liver microsomes. Biochem ical and  
B iophysica l R esearch  Com m unications, 44, 533-538.
Shiverick, K.T. and Neims, A.H. (1979) Multiplicity of testosterone hydroxylases in a 
reconstituted hepatic cytochrome P-450 from uninduced male rats. D rug M etabolism  and  
D isposition , 7, 290-295.
183
Singer, S J . and Nicolson, G.L. (1972) The fluid mosiac model of the structure of cell 
membranes. Cell membranes are viewed as two-dimensional solutions of oriented 
globular proteins and lipid. Science , 175, 720-731.
Skett, P. (1977) Hypophyseal control of hepatic steroid metabolism in the rat. PhD 
Thesis submitted to department of Chemistry, Karolinska Institute, Stockholm, 
Sweden.
Skett, P. (1986) Sex-dependent effect of streptozotocin-induced diabetes mellitus on 
hepatic steroid metabolism in the rat A cta  Endocrinologica, 111, 217-221.
Skett, P. (1987). Hormonal regulation and sex differences of xenobiotic metabolism. 
P rogress in D rug  M etabolism , 10, 85-140
Skett, P. and Cuthill, S. (1986) Influence of vesicle lipid composition on drug 
metabolism by a reconstituted mixed function oxidase enzyme system. British Journal o f  
Pharm acology, 86, 555P.
Skett, P. and Gustafsson, J.-A. (1979) Hypothalamo-pituitary regulation of liver 
function. A review. M edica l B iology, 57, 374-389.
Skett, P. and Joels, L.A. (1985) Different effects of acute and chronic diabetes mellitus 
on hepatic drug metabolism in the rat. Biochem ical Pharm acology, 34,287-289.
Skett, P. and Weir, A. (1983) Sex and substrate dependent effects of the thyroid gland 
on drug metabolism in the rat. Biochem ical Pharm acology, 32, 3115-3117.
Skett, P. and Young, S. (1982) The effect of pituitary hormones on hepatic drug 
metabolism in the ra t A cta  Endocrinologica, 100,421-42.
Skett, P., Cochrane, R.A and Joels, L.A. (1984) The role of androgens in their effect of 
diabetes mellitus on hepatic drug metabolism in the male rat. Acta Endocrinologica, 107, 
506-512.
184
Skett, P., Mode, A., Eneroth, P. and Gustafsson, J.-A., (1979) The effect of various 
centrally active drugs on hepatic steroid metabolism in male and female rats. 
B iochem ica l Pharm acology, 28, 719-722.
Skett, P., Mode, A., Rafter, J., Sahlin, L. and Gustafsson, J.-A. (1980) The effects of 
gonadectomy and hypophysectomy on the metabolism of imipramine and lidocaine by 
the liver of male and female rats. Biochem ical Pharm acology, 29,2759-2762.
Sladek, N.E. and Mannering, G J. (1966) Evidence for a new P-450 haemoprotein in 
microsomes from methylcholanthrene treated rats. B io c h em ic a l a n d  B io p h ysica l 
R esearch  C om m unications, 24, 668-674.
Sladek, N.E. and Mannering, G J. (1969a) Induction of drug metabolism. I. 
Differences in the mechanism by which polycyclic hydrocarbons and phenobarbital 
produce their inductive effects on microsomal N-demethylation systems. M olecu la r  
P harm acology, 5, 174-185.
Sladek, N.E. and Mannering,G.J. (1969b) Induction of drug metabolism. II. 
Qualitative difference in the microsomal N-demethylating systems stimulated by 
polycyclic hydrocarbons and phenobarbital. M olecular Pharm acology, 5,186-199.
Stier, A. (1976) Lipid structure and drug metabolising enzymes. B io c h e m ic a l  
P harm acology, 25, 109-113.
Stier, A. and Sackman, E. (1973) Spin labels as enzyme substrates. Heterogenous lipid 
distribution in liver microsomes. J o u rn a l o f  P h a rm a co lo g y  a n d  E xp erim en ta l  
Therapeutics, 176, 766-771.
Strobel, H.W., Lu, A.Y.H., Heidema, J. and Coon, M.J. (1970) Phosphatidylcholine 
requirement in the enzymatic reduction of haemoprotein cytochrome P-450 and in the 
fatty acid, hydrocarbon and drug hydroxylation. Journal o f  B io log ica l Chem istry, 245, 
4851-4854.
185
Subbiah, M.T.R. and Yunker, R.L. (1984) Evidence for the presence of non­
lipoprotein factors in diabetic serum capable of stimulating rat hepatic cholesterol 7 a -  
hydroxylase in vitro. B iochem ical and  Biophysical R esearch  Com m unications, 121, 
743-748.
Sugiyama, T., Miki, N., and Yamano, T. (1980) NADH- and NADPH-dependent 
reconstituted p-nitroanisole O-demethylation system containing cytochrome P-450 with 
high affinity for cytochrome b5. Journal o f  B iochem istry, 87, 1457-1467.
Takahashi, R., Horrobin, D. F., Watanabe, Y., Kyte, V. and Billard, V. (1987) Short­
term diabetes increases triacylglycerol arachidonic acid content in the rat liver. 
B iochem ica  e t B iophysica  Acta , 921,151-153.
Taniguchi, H., Imai, Y. and Sato, R. (1984) Role of the electron transfer system in 
microsomal drug monooxygenase reaction catalysed by cytochrome P-450. Archives o f  
B iochem istry  and  B iophysics, 232, 585-596.
Taniguchi, H., Imia, Y., Iyanagi, T. and Sato, R. (1979) Interaction between NADPH 
cytochrome P-450 reductase and cytochrome P-450 in the membrane of 
phosphatidylcholine vesicles. Biochem ica. et B iophysica. Acta, 550, 341-356.
Thomas, P. E., Lu, A.Y.H., Ryan, D. E., West, S. B., Kawalek,J. and Levin, W. 
(1976) Immunochemical evidence for six forms of rat liver cytochrome P-450 obtained 
using antibodies against purified rat liver cytochrome P-450 and P-448. M o le c u la r  
Pharm acology, 12,746-758.
Thompson, G. A. (1973) Phospholipid metabolism in animals. In F orm  and  Function  
o f  P hospho lip id , eds. Ansell,G.B., Hawthorne,J.N. and Dawson,R.M.C. pp 67-96. 
Amsterdam: Elsevier.
Topping, D. L. and Targ, M. E. (1975) Time-course of change in blood glucose and 
ketone bodies, plasma lipids and liver fatty acid composition in streptozotocin-diabetic 
male rats. H orm one R esearch, 6,129-137.
Tsia, A.C., Thie, G.M., and, Lin, C.R.-s. (1977) Effect of cholesterol feeding on tissue 
lipid peroxidation, glutathione peroxidase activity and liver microsomal functions in rats and 
guinea pigs. Journa l o f  N utrition  , 107, 310-319.
186
Tsong, T. Y., and Yang, C. S. (1978) Rapid conformational changes of cytochrome P- 
450: Effects of dimyristoyl lecithin. P roceedings o f  the  na tional A cadem y o f  Science  
U S A . ,  75, 5955-5959.
Turcan, R. G. and Tamburini, P. P., Gibson, G. G., Parke, D. V. and Symons, A. M. 
(1981) Drug metabolism, cytochrome P-450 spin state, and phospholipid changes 
during pregnancy in the rat. B iochem ical Pharm acology, 30, 1223- 1225.
Valtersson, C., Filippsson, L. and Dallner, G. (1986) Localisation of 
phosphatidylethanolamine in microsomal membranes and regulation of its distribution 
by fatty acid composition. Journa l o f  L ip id  Research, 27, 731-741.
Van der Hoeven, T. A., Haugen, D. A. and Coon, M. J. (1974) Cytochrome P-450 
purified to apparent homogeneity from PB induced rabbit liver microsomes : Catalytic 
activity and other properties. B iochem ical and  B iophysica l R esearch  Com m unications, 
60, 569-574.
Van Harken, D. R., Dixon, C. W. and Heimberg, M. (1969) Hepatic lipid metabolism 
in experimental diabetes: The effect of concentration of oleate on metabolism of 
triglycerides and on ketogenesis. Journal o f  B iological Chem istry, 244,2278-2283.
Vermillion, J.L. and Coon, M. J. (1974) Highly purified detergent-solubilised 
NADPH-cytochrome P-450 reductase from phenobarbital-induced rat liver microsomes. 
B iochem ical and  B iophysica l Research Com munications, 60,1315-1322
Vermillion, J.L., Ballou,D., Massey, V., and Coon, M. J. (1981) Separate roles for 
FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase, 
Journal o f  B io log ica l C hem istry, 256, 266-269.
Vogel, A.I. (1956) Practical Organic Chemistry, 3rd edn. (Longman, Green and Co., 
London)
von Bahr, C., Hedlund, I., Karl&n, B., Backstrom, D. and Grasdalen, H. (1977) 
Evidence for two catalytically different binding sites of liver microsomal cytochrome P- 
450: Importance for species and sex differences in oxidation pattern of lidocaine. A cta  
Pharm acologica e t Toxicologica, 41,39-48.
187
Vore, M., Hamilton, J. G. and Lu, A. Y. H. (1974) Organic solvent extraction of liver 
microsomal lipid. B iochem ica l and  B iophysica l R esearch  C om m unications, 56, 1038- 
1044.
Wade, A. E., Norred, W. P., and Evans, J. S. (1978) In N u tr it io n  a n d  d ru g  
in terrela tions, eds. Mathcock, J. N. and Coon, M. J. p 475-503. Academic Press, New 
York
Warren, B. L., Pak, R., Finlayson, M., Gontovinick, L., Sunahara, G. and Bellward, 
G. D. (1983) Differential effects of diabetes on microsomal metabolism of various 
substrates: comparison of streptozotocin and spontaneously diabetic Wistar rats. 
B iochem ical Pharm acology, 32, 327-335.
Waxman D. (1984) Rat hepatic cytochrome P-450 isozyme 2c identification as a male- 
specific, developmentally induced steroid 16 a-hydroxylase and comparison to a female 
specific cytochrome P-450 isozyme. Journa l o f  B io lo g ica l C hem istry, 259, 15481- 
15490.
Waxman D. and Walsh, C. (1983) Cytochrome P-450 isozyme 1 from phenobarbital- 
induced rat liver: Purification, characterization, and interactions with metyrapone and 
cytochrome b5. B iochem istry, 22, 4846-4855.
Waxman, D. J. and Walsh, C. (1982) PB induced rat liver cytochrome P-450, 
purification and characterization of two closely related forms. Journa l o f  B io log ica l 
C hem istry, 257, 10446-10457.
Waxman, D. J. (1988) Interactions of hepatic cytochrome P-450 with steroid hormones. 
Regioselectivity and stereospecificity of steroid metabolism and hormonal regulation of 
rat cytochrome P-450 enzyme expression. Biochem ical Pharm acology, 37,71-84.
White, R. E. and Coon, M. J. (1980) Oxygen activation by cytochrome P-450. A nnua l 
R eview  o f  B iochem istry, 49, 315-356.
Whitmer, D. I., Russell, P. E., Ziurys, J. C. and Gollan, J. L. (1986) Hepatic 
microsomal glucuronidation of bilirubin is modulated by the lipid microenvironment of 
membrane-bound substrate. Journal o f  B iological C hem istry, 261, 7170-7177.
188
Williams, C. H. and Kamin, H. (1962) Microsomal triphosphopyridine nucleotide- 
cytochrome c reductase of liver. Journal o f  B iological Chem istry, 237, 587-595
Williamson, D. G. and O'Donnell, V. J. (1969) Effects of adrenal mitochondrial lipid 
on the reduced nicotinamide-adenine dinucleotide phosphate supported 11(3— 
hydroxylation of deoxycorticosterone. Interaction of phospholipid with cytochrome P- 
450. B iochem istry , 8, 1289-1300.
Wills, E. D. (1980) The role of the polyunsaturated fatty acid composition of the 
endoplasmic reticulum in the regulation of the rate of oxidative drug and carcinogen 
metabolism. In M icrosom es,D rug O xidations and Chem ical Carcinogenisis, eds. Coon, 
M. J., Cooney, A. H., Estabrook, R.W., Gelboin, H. V. Gillette, J. R. and O'Brien, 
P. J. vol. I, 545-548. New York: Academic.
Yamazoe Y.,Shimada, M., Kamataki, T. and Kato, R. (1986a) Effects of 
hypophysectomy and growth hormone treatment on sex specific forms of cytochrome P- 
450 in relation to drug and steroid metabolism in rat liver microsomes. Japanese Journal 
o f  Pharm acology, 42, 371-382.
Yamazoe Y., Shimada, M., Murayama, N., Kawano, S. and Kato, R. (1986b) The 
regulation by growth hormone of microsomal testosterone 6(3-hydroxylase in male rat 
liver .J o u rn a l o f  B iochem istry, 100, 1095-1097.
Yang, C. S., and Tsong, T. Y. (1980) Effects of phospholipids on the spin-state 
transition of cytochrome P-450. In M icrosom es, D ru g  O xida tions a n d  C hem ica l 
C a rc in o g en is is , eds. Coon, M. J.,Cooney, A. H., Estabrook, R. W., Gelboin, H. V. 
Gillette, J. R. and O'Brien, P. J. vol. I, 199-202. New York: Academic.
Yates, F. E., Herbst, A. L., and Urquhart, J. (1958) Sex differences in the rate of A 
ring reduction of 3-ketosteroids in vitro by rat liver. Endocrinology, 63, 887-902.
Yavin, E. and Zutra, A. (1977) Separation and analysis of 32P-labeled phospholipids by 
simple and rapid thin-layer chromatographic procedure and its application to cultured 
neuroblastoma. A nalyica l B iochem istry, 80,430-437.
189 /GMSGOtV™
[u n iv e r s i t y
LIBRARY
